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Nervous system function is closely tied to its structure, which ensures 
proper connectivity and neural activity. Neuronal architecture is assembled by a 
series of morphogenetic events, including the coordinated migrations of neurons 
and axons during development. Subsequently, the neuronal architecture 
established earlier must persist in the face of further growth, maturation of the 
nervous system, and the mechanical stress of body movements. In this work, we 
have shed light on the molecular mechanisms governing both the initial assembly 
of the nervous system and the long-term maintenance of neural circuits. In 
particular, we identified heparan sulfate proteoglycans (HSPGs) as regulators of 
neuronal migrations. Our discovery and analysis of viable mutations in the two 
subunits of the heparan sulfate co-polymerase reveals the importance of the 
coordinated and dynamic action of HSPGs in neuronal and axon guidance during 
development. Furthermore, we uncovered that the HSPG LON-2/glypican 
functions as a modulator of UNC-6/netrin signaling through interactions with the 
UNC-40/DCC receptor. During larval and adult life, molecules such as the protein 
SAX-7, homologous to mammalian L1CAM, function to protect the integrity of 
nervous system architecture. Indeed, loss of sax-7 leads to progressive 
disorganization of neuronal architecture. Through a forward genetic screen, we 
identified LON-1 as a novel maintenance molecule that functions post-
embryonically with SAX-7 to maintain the architecture of the nervous system. 
Together, our work highlights the importance of extracellular interactions to 
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modulate signaling events during the initial development of the nervous system, 
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Nervous system development  
Proper function of the nervous system is essential for life and dependent upon 
the execution of a series of exquisitely regulated spatial and temporal events that 
take place during embryonic and post-natal development. How such a complex 
system is generated has continued to be an intensively researched subject within 
the field of neurobiology. While our knowledge surrounding the stages of nervous 
system development and their corresponding molecular programs has greatly 
expanded, many basic biological questions remain to be answered concerning 
the formation of a functional nervous system.  
 
Embryonic vertebrate nervous system development begins when the ectoderm is 
molecularly induced to give rise, in part, to neural tissue which goes on to 
become neurons or glial cells of the central and peripheral nervous system. 
Following this induction of neural tissue, patterning sets up the regional 
differences along the axes of the nervous system, and immature neurons migrate 
to their final positions, becoming fully differentiated neurons. Growth cones 
extend from neurons to guide axons across long distances to reach and 
innervate their targets to assemble neural circuits within the brain and the 
peripheral nervous system. Within neural circuits, neurons communicate with 
neurons and other cells through synaptic connections via dendrites and axons, 
which function to receive and transmit information, respectively. In addition to the 
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proliferations of neurons and glia during nervous system development, cell death 
and the elimination of synapses also occur.  
 
Axon guidance  
How particular growth cones can precisely and efficiently guide axons though a 
complex molecular environment, dynamically responding to specific cues while 
ignoring others, remains to be fully determined. Axons are often guided over long 
distances to reach their final target. During this process, neurons extend an actin-
rich growth cone at the tip of their developing axon which integrates and 
responds to the molecular environment to precisely guide the axon to its 
appropriate target. Insight into this process first came from the observations of 
Ramón y Cajal, who described the existence of a growth cone as a “terminal 
lump, that we will call a growth cone, [that] sometimes displays fine short, spiny 
and divergent expansions” (Ramón y Cajal 1890a, Ramón y Cajal 1890b). He 
was the first to point out the precision with which growth cones guide axons to 
their targets, and proposed his “neurotropic hypothesis” that attractive chemical 
cues direct the guidance of neuronal processes (Ramón y Cajal 1892). Despite 
making these observations more than a century ago, they remarkably remain 
generally true today.  
 
Axons are guided to their targets by short- and long-range attractants and 
repellents, as well as by contact-mediated attraction and repulsion (Tessier-
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Lavigne & Goodman 1996). Attractants and repellents are sensed through 
receptors expressed on the growth cone at the tip of the growing axon, which 
upon transduction of these cues, responds with cytoskeletal rearrangements to 
affect axon guidance (reviewed by (O'Donnell et al 2009)). Research dedicated 
to the identification of the molecular cues that impact axon guidance identified 
four major classes of axon guidance molecules: netrins, semaphorins, ephrins, 
and slits (Chan et al 1996, Flanagan & Vanderhaeghen 1998, Ishii et al 1992, 
Kidd et al 1999, Kidd et al 1998a, Kolodkin et al 1993, Kolodkin et al 1992, 
Kolodkin & Tessier-Lavigne 2011, Seeger et al 1993). In addition to these 
molecules, morphogens, cell adhesion molecules, extracellular matrix molecules, 
and growth factors also play important roles in axon guidance events (Kolodkin & 
Tessier-Lavigne 2011, Raper & Mason 2010, Tessier-Lavigne & Goodman 
1996). The work in this thesis on guidance investigates UNC-6/netrin and SLT-
1/Slit-mediated guidance events and therefore these pathways will be described 
in more detail.   
 
A screen for Drosophila mutants with CNS axon guidance defects led to the 
identification of the Slit signaling pathway through the isolation of mutants for the 
Slit receptor Robo (Seeger et al 1993). robo mutants isolated from the screen 
exhibited an increase in midline axon crossing events, due to its normal role in 
the repulsion of axons away from the midline (Seeger et al 1993). While Robo 
functions in the subset of axons that are not meant to cross the midline, Robo 
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also functions in axons that do cross the midline to ensure they only cross the 
midline once (Kidd et al 1998a).  Following the identification of the Robo receptor 
as an immunoglobulin superfamily protein (Kidd et al 1998b), its secreted ligand 
Slit was also identified in Drosophila (Kidd et al 1999). Robo and Slit signaling 
pathway molecules were found to be highly conserved in C. elegans (Hao et al 
2001, Zallen et al 1998) and in mammals (Brose et al 1999, Kidd et al 1998a, Li 
et al 1999) where they also function in repulsive midline axon guidance.   
 
UNC-6/netrin was first molecularly cloned in C. elegans (Ishii et al 1992) after 
unc-6 mutants were initially identified by their uncoordinated locomotion in a 
screen (Brenner 1974) and found to exhibit defects in circumferential and 
sensory axon guidance (Hedgecock et al 1990, Hedgecock et al 1985). UNC-
6/netrin is a secreted laminin-like molecule and can function as either an 
attractive or a repulsive cue, depending on the receptors expressed in the 
developing growth cone (Chan et al 1996, Ishii et al 1992, Leung-Hagesteijn et al 
1992). UNC-6/netrin signaling through the UNC-40/DCC receptor mediates 
attractive guidance towards netrin at the ventral midline, whereas UNC-6/netrin 
signaling through either the UNC-5/UNC5 receptor alone or the UNC-5/UNC5 
and UNC-40/DCC receptors together mediates repulsive guidance away from 
netrin at the ventral midline (Chan et al 1996, Hedgecock et al 1990, Leung-
Hagesteijn et al 1992). Both the UNC-5/UNC5 and UNC-40/DCC receptors are 
members of the immunoglobulin superfamily (Chan et al 1996, Leung-Hagesteijn 
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et al 1992) and these UNC-6/netrin pathway molecules were found to be highly 
conserved in flies and mammals where they also function to mediate attractive 
and repulsive guidance (Harris et al 1996, Hong et al 1999, Keino-Masu et al 
1996, Keleman & Dickson 2001, Kennedy et al 1994, Kolodziej et al 1996, 
Leonardo et al 1997, Mitchell et al 1996, Serafini et al 1994). 
 
Our understanding of axon guidance has been emerging over the past century in 
a step-wise fashion. After the initial hypothesis that axons were guided to their 
targets though chemical cues, this was shown to be true with in vitro studies 
where axons would turn towards or away from tissues expressing unidentified 
attractants or repellents, respectively. Genetic studies in model organisms have 
molecularly identified a number of guidance cues, receptors, and downstream 
effectors (Tessier-Lavigne & Goodman 1996). This brings us to a point where 
another layer of understanding is required to fully grasp how growth cones 
precisely and efficiently guide axons to their targets. Tackling the mechanisms 
that modulate the ligands and receptors of axon guidance pathways will likely 
provide the most insight into how a specific pathway is extracellularly regulated to 
guide axons, as cytoskeletal rearrangements downstream of multiple axon 
guidance pathways have been shown to converge onto the same molecules to 
alter growth cone mobility. For instance, both the UNC-6/netrin and SLT-1/slit 
signaling pathways have been shown to mediate cytoskeletal rearrangements 
through MIG-10/lamellipodin, CED-10/rac1, UNC-34/enabled, and UNC-
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115/abLIM to guide the axon of the AVM neuron ventrally in C. elegans (Chang 
et al 2006, Gitai et al 2003, Quinn et al 2006, Quinn et al 2008, Yu et al 2002). 
Therefore, mechanisms that impart specificity onto the UNC-6/netrin and SLT-
1/slit signaling pathways are likely to do so upstream of cytoskeletal 
rearrangements, either though regulation of the ligands, receptors, or both.    
 
C. elegans as a model to study nervous system development 
During C. elegans nervous system development 222 neurons are born 
embryonically, and 80 are born post-embryonically during the first and second 
larval stages in hermaphrodites (Sulston & Horvitz 1977, Sulston et al 1983, 
White et al 1986). These 302 neurons fall into 118 classes and form roughly 
7000 synaptic connections (White et al 1986). Although most neurons are born 
close to their final positions, a handful of neurons in C. elegans undergo long-
range migrations after their birth, including the CAN, HSN, and ALM neurons 
(Hedgecock et al 1987, Sulston et al 1983). Embryogenesis comprises the 
majority of neurodevelopmental events, including the guidance of axons into the 
nerve ring as well as the two largest nerve cords, the ventral and dorsal nerve 
cords, in addition to the assembly of neurons into multiple distinct ganglia in the 
head and tail. 
 
The nematode C. elegans has proven to be an invaluable model organism with 
which to study the mechanisms of axon guidance during nervous system 
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development. Studies using the worm have pioneered our knowledge of the 
molecular pathways that guide axons. For example, the first chemotropic axon 
guidance molecule, UNC-6/netrin, was molecularly identified using C. elegans 
(Ishii et al 1992), prior to its identification in vertebrates (Serafini et al 1994). In 
addition, molecules identified in C. elegans have a high level of conservation to 
flies, mice, and humans. Therefore, mechanisms of axon guidance that we 
uncover using C. elegans are likely to be conserved as well.  
 
There are many reasons why C. elegans is an ideal model organism for the study 
of nervous system development. C. elegans is an extremely genetically tractable 
model organism allowing for the fast identification of molecules important for 
nervous system development. For example, forward genetic screens can be 
carried out rapidly and whole-genome sequencing can be used to quickly identify 
causal genetic mutations (Doitsidou et al 2010, Minevich et al 2012, Zuryn et al 
2010). Transgenic animals can quickly and easily be generated by microinjection 
(Mello & Fire 1995), which has a variety of experimental applications. One 
application is CRISPR, a new genome-editing technique (Jinek et al 2012) which 
functions efficiently in many organisms including C. elegans (Friedland et al 
2013), and can be used to manipulate the genome, for example to engineer a 
mutation into the genome or to tag a gene of interest. Worms are easy to 
maintain and have a short life cycle, which means that experimental 
manipulations can be assessed quickly and repeated with large sample sizes in a 
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short time span. Specifically in regards to analysis of neurodevelopmental 
phenotypes for mutants of essential genes, RNAi knockdown by feeding can be 
performed specifically in subsets of neurons to circumvent lethality (Firnhaber & 
Hammarlund 2013).    
 
Painstakingly detailed reconstructions have provided an abundance of 
information concerning developmental processes in C. elegans. The complete 
cell lineage has been reconstructed from electron micrographs (Kimble & Hirsh 
1979, Sulston & Horvitz 1977, Sulston et al 1983) and appears to be largely 
invariant between animals. C. elegans is especially suited for 
neurodevelopmental studies, as its simple nervous system consists of just 302 
neurons in the hermaphrodite, and it is the only model organism for which we 
have a complete neural wiring diagram detailing all of the connections of the 
nervous system (White et al 1986). Adult human brains are estimated to contain 
roughly 86 billion neuronal cells and 84 billion non-neuronal cells (Azevedo et al 
2009), which creates a major obstacle in the study of reproducible cell and axon 
guidance events. Fortunately in C. elegans, cell and axon guidance can be easily 
studied at a single-cell resolution in intact, living animals on account of their 
transparent bodies and the ease of labeling their cells with fluorescent markers. 
This coupled with the knowledge of when every neuron is born, its final position, 
and its synaptic partners (Sulston et al 1983, White et al 1986) makes studies 
concerning cell and axon migrations particularly powerful in C. elegans.  
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Postnatal challenges to the nervous system 
Assembling a functional nervous system is not an easy task. It requires a 
complex molecular interplay of spatially and temporally regulated factors sensed 
and integrated by developing cells to ensure proper assembly of critical 
connections. After the completion of these early neurodevelopmental events, the 
challenge of maintaining the structural and functional integrity of the nervous 
system begins. These initially established structures and features of the nervous 
system are not static, and instead undergo dynamic alterations even through 
adulthood. In the face of these changes, the embryonically established 
neuroanatomical structures must persist to maintain the integrity of the nervous 
system (Benard & Hobert 2009).    
 
Postnatal growth, addition and elimination of neurons, glia, and synapses, 
myelination, and movement are examples of the challenges the prenatally 
established neuroanatomical structures face postnatally and through adulthood 
(Benard & Hobert 2009). Growth is not limited to an increase in height and body 
weight, but also a postnatal increase in the weight of the brain, roughly four-fold 
in the first several years after birth (Dekaban 1978, Dobbing & Sands 1973) 
which includes a 100% increase in volume in the first year alone (Knickmeyer et 
al 2008). Brain weight continues to increase roughly until the age of 19, and then 
begins to decline between the ages of 45 and 50, reaching its lowest around the 
age of 86 (Dekaban 1978). These changes in overall weight and volume likely 
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reflect the combined effect of a number of maturation events that occur in the 
brain during childhood, adolescence, and adulthood. For instance, myelination of 
axons is highly active during the first several years of life, and continues well into 
adulthood (Benes et al 1994, Holland et al 1986, Yakovlev & Lecours 1967), and 
this accounts for an overall increase in white matter through the age of 20 (Giedd 
et al 1999).      
 
In addition to growth, the nervous system must also accommodate the 
proliferation and elimination of cells. Even in adulthood a small fraction of new 
neurons are born and migrate to specific regions of the human brain, namely the 
hippocampus (Eriksson et al 1998) and the olfactory bulb (Curtis et al 2007). In 
rodents these adult-born neurons become functionally integrated within existing 
circuits (Carleton et al 2003, van Praag et al 2002). Therefore these adult-born 
neurons create a challenge not only for the new neurons which must integrate 
into pre-existing circuits, but also for the neuronal structures that must 
accommodate the integration of new cells and processes.  Programmed cell 
death occurs not only prenatally, but postnatally and into adulthood as well, 
eliminating glial cells and a small fraction of neurons (Buss et al 2006), therefore 
leaving the remaining cells with the task of adapting to the loss.  
 
Density of synapses increases postnatally, to ultimately decline to reach the level 
observed in adulthood (reviewed in (Stiles & Jernigan 2010)), and overall 
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changes in synaptic density are a reflection of changes in timing of synaptic 
proliferation and elimination observed in different brain regions (reviewed in 
(Toga et al 2006)). For example, in the auditory cortex the maximum synaptic 
density is achieved by three months, and synaptic elimination continues until age 
12 (Huttenlocher & Dabholkar 1997). Conversely, in the prefrontal cortex the 
highest density of synapses is observed at 15 months with elimination continuing 
into adolescence (Huttenlocher & Dabholkar 1997). Moreover, in the visual 
cortex maximum synaptic density is achieved by eight months and synaptic 
elimination occurs through the age of three (Huttenlocher et al 1982). Nervous 
systems must remain flexible in order to adapt to these changes, while 
simultaneously maintaining the stability necessary to preserve the integrity of 
preexisting structures and circuits essential for function. 
  
Another challenge that the nervous system encounters on a daily basis is the 
mechanical stress of movement, especially on the peripheral nervous system 
(Benard & Hobert 2009). Physical stress theory proposes that physical stress 
leads to adaptive responses in tissues, including the nervous system (Mueller & 
Maluf 2002). Nerves experience mechanical stresses from normal conditions of 
posture and movement, and respond adaptively through elongation and 
displacement (reviewed in (Topp & Boyd 2006)). In extreme cases outside of 
normal daily movements, traumatic physical stress, especially to the central 
nervous system, cannot be tolerated. For example, repetitive concussive head 
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injuries in athletes and combat soldiers leads to neurodegeneration, indicating 
that the trauma resulting from the mechanical impact to the nervous system 
cannot be rectified over the long term (McKee et al 2009). Expanding our 
understanding of the basic mechanisms that function to maintain the integrity of 
the nervous system in the face of mechanical stress may provide insight into both 
the impacts of mechanical stress on normal physiological conditions as well as in 
the face of traumatic injury.  
  
C. elegans as a model to study long-term maintenance of nervous system 
architecture   
In order to understand the basic mechanisms of how the integrity of the nervous 
system is maintained over time in the face of these challenges, we have turned 
to the model organism C. elegans. C. elegans also encounters many of the same 
challenges as mammalian nervous systems in the long-term preservation of 
nervous system integrity. For example, C. elegans also undergoes post-
embryonic addition of new neurons. At hatch, C. elegans has 222 neurons, and 
80 additional neurons are added postembryonically (Sulston & Horvitz 1977, 
Sulston et al 1983) and therefore are faced with the challenge of integrating 
within existing circuits. Additionally, worms also undergo a great deal of growth 
between hatch and adulthood that amounts to an approximately six-fold increase 
in length and 100-fold increase in volume (Benard & Hobert 2009, Knight et al 
2002). Furthermore, the sinusoidal body waves of locomotion as well as 
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pharyngeal pumping are likely to exert mechanical stress on nervous system 
structures (Benard & Hobert 2009). Indeed, molecules have been identified that 
function to counteract the mechanical stress of locomotion and protect the 
architecture of the nervous system (Benard et al 2009, Benard et al 2006, 
Pocock et al 2008, Sasakura et al 2005).  
 
C. elegans is an unparalleled model with which to ask how the structural and 
functional integrity of the nervous system is preserved in the face of maturational 
changes and physical stress. With the tools and information currently available, it 
would be highly challenging to address these questions in any other model. C. 
elegans has a simple nervous system which in the hermaphrodite consists of just 
302 neurons. The entire neural wiring diagram has been solved for C. elegans 
and its neuroanatomy is largely invariable between animals (White et al 1986). It 
is the only model organism for which a complete neural wiring diagram exists. 
This allows for the observation of changes across genotypes and ages in 
positioning, organization, fasciculation, or other aspects of neuroanatomy that 
would generally be consistent among individual animals. In addition, this means 
that we have the information needed to know where specific neuronal cell bodies 
and axons are meant to be initially, and so we can compare this to their 
positioning in later stages in different genotypic backgrounds. This level of 




C. elegans becomes a reproductively mature adult within three days and its 
mean life span is roughly three weeks. This short life cycle allows for the rapid 
study of post-embryonic and adult phenotypes, making C. elegans an ideal 
model for the study of changes to the nervous system over time. In addition, 
knockdown of gene function by RNAi can be started at any life stage, therefore 
allowing for the investigation of genes with post-embryonic functions while 
circumventing any developmental roles.  
 
Perhaps the most compelling rationale for the use of C. elegans for studies on 
the long-term maintenance of nervous system architecture is that molecules with 
dedicated functions in the post-embryonic maintenance of nervous system 
architecture have been identified using C. elegans (Aurelio et al 2002, Barsi-
Rhyne et al 2013, Benard et al 2009, Benard et al 2006, Bülow et al 2004, 
Cherra & Jin 2016, Johnson & Kramer 2012, Pocock et al 2008, Sasakura et al 
2005, Shao et al 2013, Wang et al 2005, Woo et al 2008, Zallen et al 1999). One 
of the molecules critical for the long-term maintenance of neural architecture in 
C. elegans is SAX-7/L1CAM, which is homologous to vertebrate L1 cell adhesion 
molecule family members (Chen et al 2001, Pocock et al 2008, Sasakura et al 
2005, Wang et al 2005). Roles for L1 family members in the postnatal nervous 
system have been shown through conditional ablation studies (Amor et al 2014, 
Kolata et al 2008, Kriebel et al 2011, Law et al 2003, Zonta et al 2011). In 
addition, rodent models lacking L1 family members exhibit an altered distribution 
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of neurons (Demyanenko et al 2004, Demyanenko et al 2001), though whether 
these defects are developmental or a result of a failure to maintain neuronal 
positioning remains to be determined.  
 
Despite the identification of molecules that function to maintain the architecture of 
the nervous system, our mechanistic understanding of how these molecules 
carry out these functions remains limited. It is clear that mechanisms exist to 
preserve the long-term integrity of the nervous system in the face of challenges, 
and that C. elegans is an ideal model for this type of investigation. Research 
dedicated to understanding the mechanisms by which these molecules function 
will provide important insight into how the nervous system adopts the flexibility 
needed to accommodate to important maturational changes and physical 
stresses, while providing stability to early-developed structures integral to the 
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The regulation of cell migrations is essential to animal development and 
physiology. Heparan sulphate proteoglycans (HSPGs) shape interactions 
between morphogens and guidance cues with their respective receptors to elicit 
appropriate cellular responses. Dysfunction of HSPG synthesis results in 
pleiotropic consequences, including tumorous growth. Human mutations in the 
genes EXT1 and EXT2 that encode the two subunits of the heparan sulphate 
(HS) copolymerase result in osteosarcomas called multiple exostoses. Analysis 
of mutations in the Drosophila HS copolymerase of the tout-velu family has 
uncovered key roles of HSPGs during morphogenesis. The use of the powerful 
C. elegans model for understanding HSPGs functions has been precluded, 
however, by the unavailability of viable mutations in the HS copolymerase genes. 
Here, we report our identification and analysis of viable mutations in the genes 
rib-1 and rib-2, which encode the HS copolymerase. We show that these 
hypomorphic mutations of rib-1 and rib-2 severely reduce the levels of HS 
synthesis and lead to dramatic morphogenetic defects and abnormal cell and 
axonal migrations during the development of the nematode. We analyze the 
expression pattern of the HS copolymerase and find that it is very dynamic during 
embryonic and larval morphogenesis, while also being sustained in distinct 
tissues throughout life, consistent with both developmental and post-
developmental roles for HSPGs. We analyze neuronal migrations and find that 
multiple HSPGs synthesized in the migrating neuron and neighboring cells 
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together contribute to regulate their guidance. Our findings establish a model to 
dissect the diverse and specific functions of HSPGs in C. elegans and uncover 
general principles of their roles in development and tissue homeostasis. 
 
INTRODUCTION  
Cell migrations are a key feature of animal development and physiology. The 
orientation of migrating cells relies on molecular cues present in their 
extracellular environment to reach their targets. Many guidance factors and 
morphogens are regulated by heparan sulfate proteoglycans (HSPGs), which are 
cell-surface or extracellular proteins characterized by the attachment of heparan 
sulfate (HS) chains to their extracellular domain (Bernfield et al 1999). HSPGs 
interact with molecules at the cell surface and in the extracellular matrix via both 
their HS chains and core proteins, and are part of multiple signaling pathways, 
including of guidance cues (Slit, netrin) and morphogens (Hedgehog, FGF, Sonic 
Hedgehog, Wnts, and BMPs) (Bernfield et al 1999, Bishop et al 2007, Bülow & 
Hobert 2006). HSPGs function as co-factors, for instance to regulate the gradient 
formation of morphogens and to modulate the interactions between extracellular 
ligands and their receptors, playing crucial roles in morphogenesis, nervous 
system development, and physiology (Bülow & Hobert 2006, Lin 2004).  
 
The HS chains of HSPGs are linear glycosaminoglycan polysaccharides 
composed of alternating repeats of D-glucuronic acid (GlcA) and N-
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acetylglucosamine (GlcNAc) (reviewed in (Esko & Selleck 2002)). HS chain 
synthesis in the Golgi apparatus is initiated by the addition of a tetrasaccharide 
linker on specific Serine residues on the core protein. HS chains are then 
elongated by the HS copolymerase, which is a heterodimer composed of two 
glycosyltransferases of the EXT family. HS chains are subsequently chemically 
modified (e.g. by epimerases and sulfotransferases). Dysfunction of the 
biosynthesis of HS chains results in pleiotropic consequences across metazoans, 
including developmental defects and tumor growth. In humans, mutations in the 
genes EXT1 and EXT2, which encode the two subunits of the HS copolymerase, 
result in osteosarcomas called multiple exostoses (Cook et al 1993, Francannet 
et al 2001, Le Merrer et al 1994, Wu et al 1994, Wuyts & Van Hul 2000). In 
Drosophila, mutations in the HS copolymerase genes tout-velu, brother of tout-
velu and sister of tout-velu lead to striking defects, including the loss of segment 
polarity and disruption of Hh diffusion (Bellaiche et al 1998, Han et al 2004, The 
et al 1999), and their analysis has yielded key insights into general principles of 
morphogenesis. 
 
In C. elegans, the mutations of the HS copolymerase genes rib-1 and rib-2 
available to date are embryonic lethal (Franks et al 2006, Kitagawa et al 2007, 
Morio et al 2003), which has restricted their analysis. The field has been limited 
to study these lethal alleles by examining homozygous mutant animals that are 
maternally rescued (M+/- Z-/-), which are virtually normal thanks to the 
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contribution of wild-type gene product from their heterozygous mothers (Edwards 
& Hammarlund 2014, Franks et al 2006, Morio et al 2003). RNAi has been used 
to knockdown the genes rib-1 and rib-2, but the resulting phenotypes are weak at 
best (Edwards & Hammarlund 2014, Pedersen et al 2013), indicating low 
efficiency of the interference for these genes. Mutations in the enzymes that 
catalyze the initiation of the HS chains (production of the tetrasaccharide linker) 
are not specific for HS as they also catalyze the initiation of chondroitin sulfate 
(CS) chains, leading to phenotypic consequences that are the result of the 
combined loss of HSPGs and CSPGs. Mutations disrupting individual HSPG core 
proteins (e.g. sdn-1/syndecan, lon-2/glypican, cle-1/collagen type XVIII, and unc-
52/perlecan) and HS modifying enzymes (e.g. the hse-5 epimerase and the hst-
1, hst-2, hst-3.1, hst-3.2 and hst-6 sulfotransferases) have been identified and 
studied, revealing specific roles of individual HSPGs and their chemical 
modifications during development, respectively (Ackley et al 2003, Blanchette et 
al 2015, Bülow et al 2002, Bülow & Hobert 2004, Bulow et al 2008, Diaz-Balzac 
et al 2014, Gysi et al 2013, Kinnunen et al 2005, Merz et al 2003, Pedersen et al 
2013, Rhiner et al 2005). However, a general view of the function of heparan 
sulfate proteoglycans has not been available in this powerful model organism. 
 
Here we report a C. elegans model of loss of function of the two subunits of the 
HS copolymerase genes. We identified viable mutations in each of the HS 
copolymerase genes rib-1 and rib-2, which severely reduce HS levels and result 
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in dramatic morphogenetic defects and abnormal cell and axonal migrations. We 
find the HS copolymerase is expressed dynamically during development, as well 
as later in adulthood, consistent with HSPGs functioning in both morphogenesis 
and physiology. Our findings indicate that proper neuronal migration is ensured 
by the coordinated synthesis of HSPGs in the migrating neuron itself as well as in 
adjacent cells that secrete the extracellular matrix along which the growth cone 
extends. Our analysis highlights the functional importance of HSPGs and 





Cell and axonal migrations are impaired in mum-1/rib-1 and mum-3/rib-2 
mutants 
In order to identify genes required for neural development, a genetic screen for 
maternal-effect mutants was carried out (Hekimi et al 1995). Mutations qm32 and 
qm46 were identified in this screen and define the genes mum-1 and mum-3, 
respectively (mum stands for maternal-effect uncoordinated and morphologically 
abnormal). mum-1 and mum-3 mutants display very similar defects, which 
include severe uncoordination, defective egg-laying, and morphological 
abnormalities, as well as some embryonic and larval lethality (Hekimi et al 1995, 
Takagi et al 1997). As we report below, mum-1(qm32) and mum-3(qm46) are 
23 
 
loss-of-function alleles in the genes rib-1 and rib-2, respectively, which encode 
the two subunits of the HSPG copolymerase. For clarity, we henceforth refer to 
mum-1(qm32) as rib-1(qm32), and to mum-3(qm46) as rib-2(qm46). 
 
To characterize the underlying neuroanatomical defects of rib-1(qm32) and rib-
2(qm46), we built strains of these mutants carrying a number of integrated 
transgenes, which drive the expression of fluorescent proteins and allow the 
visualization of specific neurons (see Table 2.1). We examined the nervous 
system of rib-1 and rib-2 mutants with single-cell resolution and found that 
numerous neuronal migrations are affected by loss of function of rib-1 or rib-2 
compared to wild type. For instance, we found that the CAN neuron, which 
migrates from the head region towards the midbody region in wild-type animals, 
was frequently positioned too anterior or too posterior in rib-1 and rib-2 mutants 
(Fig. 2.1A). Also, the HSN neuron that migrates from the tail region to the 
midbody region in the wild type is often located too posterior in rib-1 and rib-2 
mutants (Fig. 2.1B). Moreover, the AVM neuron is frequently located in the 
posterior of the body in rib-1 and rib-2 mutants, instead of being anterior to the 
vulva (Fig. 2.1C). The penetrance and expressivity of these defects is similar in 
both rib-1 and rib-2 single mutants. Thus, loss of function of the genes rib-1 or 
rib-2 disrupts the guided migration of several neurons that undergo long-range 




We also found that axonal projections are defective in rib-1 and rib-2 single 
mutants. For example, we observed that the axon of the interneuron PVQ, which 
projects into the ipsilateral fascicle of the ventral nerve cord in the wild type, 
frequently projects in the contralateral fascicle or even laterally in rib-1 and rib-2 
mutants (Fig. 2.1D). Similarly, the axon of the motorneuron HSN, which projects 
ventrally and into the ipsilateral fascicle of the ventral nerve cord in the wild type, 
is misguided in rib-1 and rib-2 mutants as it projects into the contralateral fascicle 
or laterally in these mutants (Fig. 2.1D). Another example is the axon of the 
mechanosensory neuron AVM, which extends ventrally towards the ventral nerve 
cord in the wild type, but projects laterally in rib-1 and rib-2 mutants (Fig. 2.1C). 
The axons of cholinergic and GABAergic motorneurons are also misguided in rib-
1 and rib-2 mutants: contrary to the wild type, where most motorneuron axons 
exit the ventral midline on the right side to migrate along on the right side of the 
worm’s body wall, many motorneuron axons abnormally project to the left side in 
rib-1 and rib-2 mutants (Fig. 2.1E). Finally, the dorsal nerve cord, which is 
composed of several motor axons that run as a single fascicle in the wild type, is 
frequently defasciculated into several bundles in rib-1 and rib-2 mutants (Fig. 
2.1F). It is worth nothing that the capacity to migrate is not lost in rib-1 and rib-2 
mutants as soma and axons often overshoot their target. Rather, the guidance of 
migrations during development is disrupted by the loss of function of the genes 













Fig. 2.1. Neuronal migration defects in mum-1/rib-1(qm32) and mum-3/rib-2(qm46) 
mutants. 
A. Lateral views of animals expressing the transgene Pceh-10::gfp to visualize the CAN 
neurons (CANL and CANR). In the wild type, the soma of the CAN neuron is located laterally 
in the midbody region and its axon extends laterally along the antero-posterior axis. mum-
1/rib-1 and mum-3/rib-2 mutants display defective CAN soma migration and are frequently 
observed in very anterior positions. In addition, the CAN axon in mum-1/rib-1 and mum-3/rib-
2 mutants project in abnormal directions (arrowhead), or fail to extend fully in the posterior 
direction. The table indicates the sum of soma and axon defects of the CAN neurons (axon 
guidance was only scored in animals that had normal soma migration). 
B. Ventral views of animals expressing the transgene Ptph-1::gfp to visualize the HSN 
neurons (HSNL and HSNR). In wild type, the soma of HSN is located laterally just posterior 
to the vulva and its axon extends ventrally and projects along the ipsilateral side of the 
ventral nerve cord. mum-1/rib-1 and mum-3/rib-2 mutants display defective HSN soma 
positions and defective axons that extend laterally or project into the opposite side of the 
ventral nerve cord. The table indicates the sum of soma and axon defects of the HSN 
neurons (axon guidance was only scored in animals that had normal soma position). White 
asterisk denotes position of the vulva.  
C. Lateral views of animals expressing the transgene Pmec-4::gfp to visualize the AVM 
neuron. In the wild type, the AVM soma is located in the anterior midbody region and its axon 
projects ventrally to reach the ventral nerve cord and then extends anteriorly. mum-1/rib-1 
and mum-3/rib-2 mutants display defective AVM soma (posterior to the vulva), as well as 
defective axons that project laterally instead of ventrally. The table indicates the sum of soma 
and axon defects of the AVM neuron (axon guidance was only scored in animals that had 
normal soma position). 
D. Ventral views of animals expressing the transgene Psra-6::DsRed2 to visualize the PVQ 
neurons (PVQL and PVQR). In the wild type, the axon of PVQ extends along the ipsilateral 
side of the ventral nerve cord. mum-1/rib-1 and mum-3/rib-2 mutants display defective PVQ 
axons, including axons that extend laterally or project into the opposite side of the ventral 
nerve cord. 
E. Ventral views of animals expressing the transgenes Punc-17::gfp and Punc-47::mCherry 
to visualize the cholinergic (green) and GABAergic (red) motorneurons, respectively. The 
position of the vulva is indicated by an asterisk. In the wild type, most motorneuron axons 
extend along the right side of the animal, whereas on the left side only three cholinergic and 
no GABAergic axons extend in the area shown in the picture. mum-1/rib-1 and mum-3/rib-2 
mutants display defective guidance of motorneuron axons of both cholinergic and GABAergic 
motorneuron axons, as more axons project along the left side of the animal compared to wild 
type (arrowheads). 
F. Dorsal views of animals expressing the transgene Prgef-1::gfp to visualize the dorsal 
nerve cord. The dorsal nerve cord runs as one tight fascicle in the wild type. In mum-1/rib-1 
and mum-3/rib-2 mutants, the dorsal nerve cord is frequently split into two or more fascicles. 
Indicated area is enlarged in insets. 
Scale bars 20 μm. *** P ≤ 0.001 (z-tests, P values were corrected by multiplying by the 




In a similar way, the migration of mesodermal cells, which share guidance 
mechanisms with neurons (Hedgecock et al 1990), is defective in rib-1 and rib-2 
single mutants. For instance, the canals of the excretory cell (two anterior and 
two posterior canals) run laterally in the wild type but are frequently too short or 
extend along the ventral or dorsal aspect of the body in rib-1 and rib-2 mutants 
(Fig. 2.2A). Another example of misguided mesodermal cells in rib-1 and rib-2 
mutants is that of the distal tip cell (DTC), whose path determines the shape of 
the gonad. In wild-type animals, the anterior DTC migrates anteriorly along the 
right side of the animal and the posterior DTC migrates posteriorly along the left 
side of the animal; then, the DTCs turn dorsally, and turn again to migrate 
towards the midbody region, resulting in the anterior arm of the gonad being on 
the right side of the animal and the posterior arm of the gonad being on the left 
side. In rib-1 and rib-2 mutants, the anterior arm of the gonad is often found on 
the left side of the animal and the posterior arm on the right side, and in some 
cases, both gonad arms can lie on the opposite side of the animal (Fig. 2.2B). 
Lastly, the excretory gland is also found in abnormal positions in rib-1 and rib-2 
mutants (Fig. 2.2C). Thus, loss of function of the genes rib-1 or rib-2 disrupts the 












mum-1(qm32) and mum-3(qm46) are viable hypomorphic mutations of the 
genes rib-1 and rib-2 that encode the two subunits of the HSPG 
copolymerase 
To gain insight into the molecular mechanisms that are disrupted in the mum-1 
and mum-3 mutants, we determined the molecular identity of the mutations qm32 
and qm46. First, we narrowed down the genetic position of the mum-1(qm32) 
mutation by genetic mapping and assayed cosmids corresponding to the genetic 
position of mum-1 for transformation rescue of the mum-1(qm32) mutants (Fig. 
2.3B). We found that cosmid F12F6 fully rescued the mum-1 mutants for larval 
development, uncoordination and egg laying defects (Fig. 2.3A,B). We tested 
PCR products corresponding to each of the genes located on this cosmid and 
found that a 9 kb PCR product containing the gene F12F6.3/rib-1 fully rescued 
the mum-1 mutants for larval development, uncoordination and egg-laying 
Fig. 2.2. Other migration defects in mum-1/rib-1(qm32) and mum-3/rib-2(qm46) 
mutants. 
A. Ventral views of animals expressing the transgene Ppes-6::gfp to visualize the canals of 
the excretory cell. In the wild type, the excretory cell extends four lateral canals, two that are 
anteriorly-directed along the sides of the head and two that are posteriorly-directed along the 
sides of the body. mum-1/rib-1 and mum-3/rib-2 mutants display defective excretory canals 
that can be too short (arrows), or extend ventrally or dorsally instead of laterally 
(arrowheads). Scale bar, 10 μm. Asterisk denotes significant difference: *** P ≤ 0.001 (z-
tests, P values were corrected by multiplying by the number of comparisons). 
B. Diagrams of the gonad arms (dorsal view). In the wild type, the anterior arm of the gonad 
is located on the right side of the animal, and the posterior arm is located on the left side. 
Gonad arms are abnormally positioned in mum-1/rib-1 and mum-3/rib-2 mutants, where one 
or both gonad arms can lie on the opposite side of the animal. 
C. Diagrams of the excretory glands (dorsal view). In the wild type, the excretory glands are 
located just posterior of the terminal bulb of the pharynx. mum-1/rib-1 and mum-3/rib-2 





defects (Fig. 2.3A,B). In addition, construct Prib-1::rib-1(+) completely rescued 
the axon guidance defects of AVM and PVQ in mum-1 mutants (Fig. 2.3C). We 
verified the predicted gene structure by sequencing the cDNA clone yk187a9. 
We sequenced the genomic region of the gene rib-1 in mum-1(qm32) mutants 
and found that the qm32 molecular lesion is a T to A base pair change at position 
39528 of cosmid F12F6, which converts the Stop codon of rib-1 into a Lys 
residue (Fig. 2.3B). This mutation likely results in the translation of an open 
reading frame present in the 3’UTR, which would extend the protein RIB-1 by 
114 aa residues, until the next in-frame Stop codon. The activity of the mutant 
RIB-1 protein in rib-1(qm32) is likely impaired by the presence of the abnormal 
extension or the instability of the translated protein. Stronger mutations of rib-1, 
namely deletion alleles tm516 and ok556, result in complete embryonic lethality 
(Franks et al 2006, Kitagawa et al 2007). Thus, qm32 is a viable hypomorphic 
mutation in the gene rib-1 that encodes one of the two subunits of the HSPG 
copolymerase and is homologous to Drosophila tout-velu and mammalian EXT1 
(Fig. 2.3D). 
 
The second subunit of the C. elegans HSPG copolymerase is encoded by the 
gene rib-2. Given the phenotypic similarities between the rib-1(qm32) and mum-
3(qm46) mutants and that the genetic position of mum-3(qm46) corresponds to a 
chromosomal interval containing the gene rib-2, we tested whether mum-








mutants by a 5.6 kb PCR product of the gene rib-2(+) and found that it fully 
rescued their larval development, locomotion, and egg laying (Fig. 2.4A,B). In 
addition, construct Prib-2::rib-2(+) completely rescued the axon guidance defects 
of AVM and PVQ in mum-3 mutants (Fig. 2.4C). We verified the predicted gene 
structure by sequencing the cDNA clone yk3c1. We sequenced the genomic 
region of the gene rib-2 in mum-3(qm46) mutants and found that the qm46 
molecular lesion is a G to A transition at position 4366 of cosmid K01G5. The 
qm46 mutation results in an Arg to Gln amino acid substitution at residue 434, 
which is near the exostosin domain in the 814 amino acid long RIB-2 protein. A 
stronger mutation of rib-2, deletion allele tm710, results in complete embryonic  
Fig. 2.3. mum-1(qm32) is a viable hypomorphic mutation of the gene rib-1, which 
encodes one of the two HS copolymerase subunits. 
A. Pictures of wild type and mum-1/rib-1 mutant animals. Some of the mum-1/rib-1 mutants 
die as embryos or misshapen larvae, but the majority reach adulthood and display 
morphological defects, as described in (Hekimi et al 1995). 
B. Molecular identification of mum-1(qm32). mum-1 was previously mapped between dpy-13 
and unc-31 on linkage group I (Hekimi et al 1995). We narrowed down its genetic position by 
a combination of three-factor and two-factor mapping (results were unc-24 70/79 mum-1 
9/79 dpy-20; 10 Dpy-20 non Mum-1/4320 F2s ; and lin-3 6/7 mum-1 1/7 dpy-20; which 
placed mum-1 between lin-3 and dpy-20, between 4.98 and 5.07 cM, according to the 95% 
confidence intervals). Cosmids (thin lines) and PCR products (thick lines) encompassing the 
gene rib-1(+) rescued the morphological and uncoordination defects of the mum-1 mutants. 
mum-1(qm32) is a missense mutation at base 39528 of cosmid F12F6 and changes the Stop 
into a Lys codon, which leads to a putative extension of 114 amino acids until the first in 
frame Stop codon. 
C. Rescue of the guidance defects of the neurons AVM and PVQ of mum-1(qm32) with DNA 
corresponding to the genomic region of rib-1(+) (plasmid Prib-1::rib-1::Venus). Error bars are 
standard error of the proportion. Asterisks denote significant difference: *** P ≤ 0.001 (z-
tests, P values were corrected by multiplying by the number of comparisons). 
D. An alignment of the predicted amino acid sequences of C. elegans RIB-1 and its 










lethality (Franks et al 2006). Thus, qm46 is a viable hypomorphic mutation in the 
gene rib-2 that encodes the second subunit of the HSPG copolymerase and is 
homologous to Drosophila brother of tout-velu and mammalian EXT2 and EXTL3 
family members (Fig. 2.4D). 
 
HS levels are impaired in rib-1(qm32) and rib-2(qm46) mutants  
The genes rib-1 and rib-2 encode the two subunits of the C. elegans HS 
copolymerase that synthesizes HS chains onto core proteins to generate HSPGs 
(Fig. 2.5A; (Kitagawa et al 2007)). HS chains are composed of alternating 
glucuronic acid and N-acetylglucosamine residues. The first step of HS chain 
biosynthesis is the addition of a tetrasaccharide linker onto specific Ser residues 
of the core protein. Next, proteins homologous to RIB-2, like mammalian EXTL3 
Fig. 2.4. mum-3(qm46) is a viable hypomorphic mutation of the gene rib-2, which 
encodes the second HS copolymerase subunit. 
A. Pictures of wild type and mum-3/rib-2 mutant worms. Some of the mum-3/rib-2 mutants 
die as embryos or deformed larvae, but the majority reach adulthood and display 
morphological defects, as described in (Hekimi et al 1995). 
B. Molecular identification of mum-3. mum-3(qm46) was previously mapped on linkage 
group III, between unc-32 and dpy-18 (Hekimi et al 1995), which includes the second HSPG 
copolymerase gene rib-2. A PCR product containing the genomic locus of rib-2(+) rescued 
the morphological and uncoordination defects of the mum-3(qm46) mutants. mum-3(qm46) 
is a missense mutation at base 4366 on cosmid K01G5 that changes an Arg to a Gln at 
residue 434. 
C. Rescue of the guidance defects of the neurons AVM and PVQ of mum-3(qm46) with DNA 
containing the genomic region of rib-2(+) (PCR product Prib-2::rib-2). Error bars are standard 
error of the proportion. Asterisks denote significant difference: *** P ≤ 0.001 (z-tests, P 
values were corrected by multiplying by the number of comparisons). 
D. An alignment of the predicted amino acid sequence of C. elegans RIB-2 and its 




and Drosophila sister of tout-velu (Sotv), catalyze the addition of the initial N-
acetylglucosamine residue onto the tetrasaccharide linker (Kitagawa et al 2001). 
Subsequently, proteins homologous to RIB-1 and RIB-2 together, like 
mammalian EXT1 and EXT2 or Drosophila tout-velu (Ttv) and brother of tout-velu 
(Botv), function as a complex to polymerize HS chains by adding disaccharide 
units of glucuronic acid and N-acetylglucosamine (Kitagawa et al 2007). To 
directly determine the impact of the mutations rib-1(qm32) and rib-2(qm46) on 
HS biosynthesis, we probed for total HS content by western blot analysis. We 
extracted proteins from wild-type (N2) animals, rib-1(qm32) and rib-2(qm46) 
single mutants, as well as transgenic rib-1(qm32) animals expressing rib-1(+) 
and transgenic rib-2(qm46) animals expressing rib-2(+), which rescue their 
developmental defects. We treated the extracts with heparinases I and III, and 
performed western blot analysis using an antibody that specifically recognizes 
heparinase-digested HS chains (3G10, (David et al 1992)). As expected, no 
signal was detected in untreated control samples (Fig. 2.5B). We found that the 
total HS content was severely reduced in the rib-1(qm32) and the rib-2(qm46) 
mutants compared to the wild type (Fig. 2.5B). Providing wild-type transgenic 
copies of rib-1 or rib-2 rescued HS biosynthesis, confirming that loss of the genes 
rib-1 or rib-2 leads to the disruption of HS biosynthesis in the qm32 and qm46 
mutants (Fig. 2.5B). The partial rescue of HS levels is likely due to the transgenic 
strains in fact being a mixture of rescued transgenic animals as well as non-







Fig. 2.5. Loss of function of the genes rib-1 and rib-2 impairs HS synthesis. 
A. Schematic representation of the biochemical synthesis of HS chains onto HSPG core 
proteins in the Golgi. HS chain synthesis starts by the addition of a tetrasaccharide linker 
(xylose-galactose-galactose-glucuronic acid) onto specific Ser residues on the core proteins to 
serve as a primer for HS polysaccharide growth. RIB-1 and RIB-2, homologous to the exostosin 
(EXT) proteins, catalyze the extension of HS chains, which are composed of repeating 
glucuronic acid (square) and N-acetylglucosamine (hexagon) residues. RIB-2, like mammalian 
EXTL3 and Drosophila Sotv, catalyzes the first step with the addition of the first N-
acetylglucosamine onto the tetrasaccharide linker on HSPG core proteins. Then, RIB-1 and RIB-
2 together, like mammalian EXT1 and EXT2, and Drosophila Ttv and Botv, function as a 
heterodimer to extend the HS chains. 
B. Western blot analysis of HS chains in rib-1(qm32) mutants (top) and in rib-2(qm46) mutants 
(bottom). HS chains were detected with antibodies specific for HS epitope 3G10, which is 
detectable after cleavage by heparinase. For the three left lanes, protein extracts were not 
heparinase treated (control, indicated by “-“), and as expected no HS signal is detected. For the 
three right lanes, protein extracts were treated with heparinases I and III (Hep I+III, indicated by 
“+”). The HS signal is severely reduced in the rib-1(qm32) and the rib-2(qm46) mutants 
compared to wild type (N2), indicating that HS chain synthesis is strongly affected in rib-1 and 
rib-2 mutants. The HS signal is partially rescued in rib-1 mutants expressing the transgene Prib-
1::rib-1(+) and rib-2 mutants expressing the transgene Prib-2::rib-2(+). Therefore, HS 
biosynthesis is disrupted in the rib-1(qm32) and the rib-2(qm46) mutants, and their 
developmental and biochemical phenotypes can be rescued by reintroducing wild-type rib-1(+) 
and rib-2(+), respectively. 
C. Western blot analysis of LON-2::GFP in the rib-1(qm32) and rib-2(qm46) mutants. The anti-
GFP antibody detects high molecular weight bands in extracts of transgenic animals expressing 
LON-2::GFP; as controls, these high molecular weight bands are absent in wild type N2 and in 
three GFP controls that do not express LON-2::GFP (lqIs4, rib-1;lqIs4, and rib-2;lqIs4). In 
transgenic animals expressing a mutant version of LON-2 lacking the three HS attachment sites 
(LON-2ΔGAG::GFP; Gumienny & Taneja-Bageshwar, 2012), the detected band is smaller than 
LON-2::GFP. Similarly, the band detected in extracts of the rib-1 and rib-2 mutants expressing 
LON-2::GFP is smaller, indicating that the HS chains of glypican/LON-2 are affected in rib-1 and 
rib-2 mutants. 
D. Western blot analysis of SDN-1::GFP (Rhiner et al., 2005) in the rib-1(qm32) mutants. The 
anti-GFP antibody detects high molecular weight bands in extracts of transgenic animals 
expressing SDN-1::GFP; as controls, these high molecular weight bands are absent in the wild 
type N2 or the GFP control rib-1; lqIs4. In extracts of rib-1 mutants expressing SDN-1::GFP, the 
band detected is smaller, indicating that the HS chains of syndecan/SDN-1 are affected in rib-1 
mutants.  




generations and the extrachromosomal array carrying the transgene is lost 
during cell divisions. Nevertheless, our results indicate that the alleles of rib-
1(qm32) and rib-2(qm46) strongly disrupt HS chain synthesis. 
 
Having examined the impact of rib-1 or rib-2 function on global HS levels, we 
tested how two distinct HSPGs, namely LON-2/glypican and SDN-1/syndecan, 
are affected in rib-1(qm32) and rib-2(qm46) single mutants. To detect LON-
2/glypican, we expressed LON-2 tagged with GFP (using transgene LON-
2::GFP, (Gumienny et al 2007)) in wild type (N2), rib-1(qm32), and rib-2(qm46) 
mutant backgrounds, and carried out western blot analysis with anti-GFP 
antibodies. Whereas two high molecular weight bands corresponding to LON-
2::GFP were detected in wild-type lysates, only one of the bands is detected in 
lysates of rib-1 and rib-2 mutants (Fig. 2.5C), indicating that HS synthesis onto 
LON-2/glypican is affected by the loss of function of rib-1 or rib-2. In support of 
this, we found that wild-type worms expressing a mutant version of LON-2 in 
which the HS attachment sites are mutated (LON-2ΔGAG::GFP, (Taneja-
Bageshwar & Gumienny 2012)) also produced only one high molecular weight 
band similar to the migration of LON-2::GFP in the rib-1 and rib-2 mutants (Fig. 
2.5C). To detect the HSPG SDN-1/syndecan, we expressed SDN-1/syndecan 
tagged with GFP (SDN-1::GFP, (Rhiner et al 2005)) in wild-type (N2) and rib-1 
mutant worms, and probed for GFP in lysates of these worms. In wild-type 
lysates, we detected two high molecular weight bands corresponding to SDN-
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1::GFP, but detected a single band in lysates of rib-1 mutants (Fig. 2.5D), 
indicating that loss of rib-1 impairs HS synthesis onto SDN-1/syndecan. Our 
results show that the mutants rib-1(qm32) and rib-2(qm46) drastically reduce the 
HS content and affect the biosynthesis of HSPGs. 
 
The HS copolymerase is dynamically expressed during development 
To gain insight into the roles of HSPGs during development, we determined the 
expression pattern of the HS copolymerase. We constructed expression 
reporters for the genes rib-1 and rib-2. First, we designed a transcriptional fusion 
(Prib-1::gfp) between the upstream regulatory region of rib-1 and the green 
fluorescent protein gene (gfp). Since rib-1 is the second gene in an operon of two 
genes (Blumenthal et al 2002), we included the region upstream of the first gene 
in the operon, as well as the intergenic region of the operon that lies immediately 
upstream of rib-1 (see Materials and Methods). Second, we constructed a 
translational fusion (Prib-1::rib-1::venus) using the same upstream regulatory 
region as for Prib-1::gfp (see Materials and Methods) and fusing the coding 
region of rib-1 with the gene venus (a translational fusion of rib-1 with gfp gave 
no detectable expression; venus encodes a variant of gfp that fluoresces in acidic 
cellular environments (Nagai et al 2002)). We generated at least five transgenic 
lines for each of these two rib-1 reporters and examined transgenic animals by 
fluorescence microscopy. We observed that GFP fills the cytoplasm of cells 
expressing the transcriptional fusion Prib-1::gfp, as expected, and that VENUS 
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has a punctate cytoplasmic pattern in cells expressing the translational fusion 
Prib-1::rib-1::venus, consistent with the HS copolymerase being localized to the 
Golgi apparatus (Fig. 2.6A). Moreover, we found that both the transcriptional and 
the translational fusions have a very similar spatial and temporal expression 
pattern during development: expression was visible in neurons, some 
hypodermal cells, pharynx, and muscles of the digestive system and reproductive 
tissues (Fig. 2.6A). Importantly, we found that the translational fusion Prib-1::rib-
1::venus is functional, as it fully rescued the defective locomotion, egg-laying, 
morphology, and axon guidance of rib-1(qm32) mutants, indicating that the 
observed expression pattern of the translational fusion, and thus also of the 
transcriptional fusion, is functionally relevant and largely reflects the sites of 
endogenous expression of the gene rib-1.  
 
Since the transcriptional and translational fusions for rib-1 have similar 
expression patterns, and Prib-1::gfp expresses at higher levels and readily allows 
the identification of expressing cells, we characterized the expression pattern of 
Prib-1::gfp in more detail. One salient feature of the expression pattern of rib-1 is 
that it is very dynamic in hypodermal cells during development. During 
embryogenesis, Prib-1::gfp was detected along the entire layer of 
hypodermoblasts that surrounds the gastrulating embryo at about 200 minutes 
after fertilization (at this stage, numerous more interiorly located cells, likely 









embryogenesis, Prib-1::gfp was expressed at high levels in hypodermal cells of 
the elongating embryo (Fig. 2.6C), including in hypodermal cells that extend 
ventrally during ventral closure and in the two rows of dorsal hypodermal cells 
undergoing dorsal intercalation. Subsequent to these embryonic morphogenetic 
events, expression of Prib-1::gfp in body wall hypodermal cells was no longer 
visible during larval and adult stages, except for seam cells undergoing fusion 
during larval development. During vulva development, however, hypodermal cells 
that compose the developing vulva, including the utse, strongly expressed Prib-
1::gfp (Fig. 2.6D). At first, a very low expression level was detected in vulval cells 
Fig. 2.6. Dynamic expression of the HS copolymerase during development. 
A. A transcriptional reporter and a functional translational reporter for the gene rib-1, Prib-
1::gfp and Prib-1::rib-1::venus, respectively, display similar expression patterns. Expression of 
rib-1 is observed in numerous cell types, including in the pharynx, hypodermal cells, neurons 
(arrows), the enteric muscle (triangle) and the anal depressor (circle). The RIB-1::Venus signal 
is punctate, consistent with a Golgi localization. Scale bars: 50 μm in top panels of entire 
worms, and 5 μm in lower panels. 
B. Larval and adult expression of rib-1. (i) Throughout larval and adult stages, the expression 
of Prib-1::gfp is observed in the pharynx, including in the pharyngeal-intestinal valve (ii, closed 
arrowhead) and muscles of the anterior and terminal pharyngeal bulbs (iii, pharyngeal muscle 
pm6); in the enteric muscle (open arrowhead, see a); in the ventral nerve cord (arrows, iv, see 
a); and the dorsal nerve cord (v). Prib-1::gfp expression in spermathecae (asterisks, vi, seen 
enlarged by an oocyte in vii) and in uterine muscles (viii) is first detected in adults, initially at 
very low levels, and becoming increasingly stronger as the reproductive phase progresses. 
Scale bars, 50 μm in panels of entire worms, and 5 μm in the rest of the panels. 
C. Embryonic expression of rib-1. Views of comma stage embryos in GFP epifluorescence 
and DIC. The transcriptional reporter Prib-1::gfp is predominantly expressed in lateral and 
ventral epidermal cells that undergo major morphogenetic movements during dorsal 
intercalation and ventral enclosure of the embryo. Scale bar, 5 μm. 
D. rib-1 is expressed during vulva development. Views of the developing vulva in fourth larval 
stage animals by GFP and DIC epifluorescence. Prib-1::gfp is expressed in epidermal cells of 





of late L3 larvae, then expression became strong in these cells in L4 larvae and 
young adults that had just molted, and finally expression ended in adults. These 
dynamic expression patterns in cells undergoing dramatic changes during 
morphogenesis suggest that HSPGs play important and acute roles during 
development. 
 
The nervous and digestive systems express Prib-1::gfp stably and continuously 
from embryogenesis into larval stages and throughout adulthood. Strong and 
sustained expression was seen in motorneurons, interneurons, sensory neurons 
(including AVM), neurons in the head and tail ganglia, with the GFP signal filling 
axons running along the ventral and dorsal nerve cords, the commissures, and 
sublaterals. Neurons of the ventral nerve cord and of the head ganglia were 
observed expressing Prib-1::gfp already in 1.5-, 2-, and 3-fold embryos, and 
expression persisted well into adulthood (Fig. 2.6A,B). Strong expression of Prib-
1::gfp was also observed in the pharynx from the 2-fold stage of embryogenesis 
onwards and remained strong even in adults (procorpus, metacorpus, terminal 
bulb, grinder, and pharyngeal-intestinal valve). The anal depressor, the anal 
sphincter, and the two enteric muscles also strongly expressed Prib-1::gfp 
throughout life. The continued expression of rib-1 in the nervous and digestive 
systems indicates that HSPGs not only play developmental roles in these cell 




Another set of cells initiated expression of rib-1 only during the adult reproductive 
phase: Prib-1::gfp first became detectable in the spermathecae in young adults 
and accumulated at very high levels in adults during the peak of fertilization and 
embryo production (Fig. 2.6B). Also, the uterine muscles expressed Prib-1::gfp 
only in reproducing adults and the signal became strongest around day three of 
adulthood (Fig. 2.6B). The observation that the HS copolymerase is expressed in 
cells of reproductive tissues coinciding with the time of active reproduction further 
indicates that the synthesis of HSPGs is required in diverse post-developmental 
contexts. 
 
We also constructed transcriptional and translational reporters for rib-2, the 
second gene encoding the HS copolymerase. Despite numerous attempts, the 
detected expression level was extremely weak in transgenic worms carrying 
these constructs. We could nonetheless observe diffuse Prib-2::gfp expression in 
comma-stage embryos, as well as in neurons, the pharynx, seam cells, and the 
developing vulva at later developmental stages. Thus, the expression pattern of 
rib-2 appears to overlap with that of rib-1, consistent with the notion that these 
genes encode proteins that function together as the HS copolymerase complex. 
 
Synthesis of HSPGs in multiple cell types contributes to axon guidance 
A prominent site of expression of the HS copolymerase is the nervous system, 
including at times of axon migrations during embryonic and larval development 
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(Fig. 2.6), and disruption of the HS copolymerase leads to numerous defects of 
axon guidance (Fig. 2.1). To determine which cells produce HSPGs required for 
axon guidance, we provided wild-type copies of rib-1(+) in subsets of cells to rib-
1 mutants and assessed whether the axon guidance defects of the PVQ neurons 
could be rescued. The axon of PVQ extends along the ventral nerve cord during 
embryogenesis, following the path of other axons, and is in proximity with the 
hypodermis and body wall muscles. We built several constructs to express rib-
1(+) in neurons including PVQ (using the heterologous promoter Prgef-1), in 
hypodermis (using the heterologous promoter Pdpy-7), or in body wall muscles 
(using the heterologous promoter Pmyo-3). We generated transgenic rib-1(qm32) 
worms expressing rib-1(+) in these tissues and analyzed PVQ axon guidance. As 
a control, expression of rib-1(+) under its own promoter completely rescued the 
guidance defects of the PVQ axon (Fig. 2.7A). Targeted expression of rib-1(+) 
only in neurons, only in hypodermis, or only in body wall muscles did not rescue 
the PVQ axon guidance defects of rib-1 mutants. However, co-expression of rib-
1(+) in the hypodermis, neurons, and body wall muscles led to rescue of the PVQ 
guidance defects (Fig. 2.7A), suggesting that HSPGs from distinct cell types 
together contribute to properly guide the PVQ axon. The rescue of the PVQ axon 
was strong but incomplete, possibly due to the expression level or timing of rib-1 
under these heterologous promoters being inappropriate. Nonetheless, 
expressing rib-1 simultaneously in these three tissues significantly rescued the 
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PVQ defects, indicating a functional requirement for HSPGs in several cell types 
to regulate the guidance of the PVQ axon. 
 
We next analyzed the spatial requirements for HS biosynthesis in the context of 
another migrating axon, that of the mechanosensory neuron AVM. During the 
first larval stage, the AVM axon pioneers its own ventral migration through a 
basement membrane along the body wall, sandwiched between the hypodermis 
and the body wall muscles. We expressed rib-1(+) in the hypodermis (using the 
heterologous promoter Pdpy-7), in body wall muscles (using the heterologous 
promoter Pmyo-3), or in the neuron AVM itself (using the heterologous promoter 
Pmec-7) in rib-1(qm32) mutants, and analyzed AVM axon guidance. As a control, 
expression of rib-1(+) under its own promoter completely rescued the guidance 
defects of the AVM axon (Fig. 2.7B). We found that the AVM axon guidance 
defects of rib-1 mutants were rescued by expression of rib-1(+) in the neuron 
AVM itself, or by expression of rib-1(+) from the hypodermis (Fig. 2.7B). These 
results suggest that HSPGs produced both in the AVM neuron itself and in the 
hypodermis crucially impact the guidance of the axon of AVM. Taken together, 
our results support the notion that HSPGs synthesized in distinct cell types 












HS chain synthesis is required for unc-6/netrin- and slt-1/Slit-mediated 
axon guidance  
To gain understanding of the role of HSPGs during neural development, we 
analyzed the requirements of HS chain synthesis for unc-6/netrin- or slt-1/Slit-
mediated axon guidance. For this, we focused on the guidance of the axon AVM 
(Fig. 2.8A), which has been extensively studied and is known to be guided by 
two complementary and highly conserved guidance pathways: attraction towards 
ventral UNC-6/netrin through its receptor UNC-40/DCC and repulsion away from 
dorsal SLT-1/Slit through its receptor SAX-3/Robo (Fig. 2.8B) (Chan et al 1996, 
Hao et al 2001, Hedgecock et al 1990, Hedgecock et al 1987, Ishii et al 1992, 
Leung-Hagesteijn et al 1992, Zallen et al 1998). rib-1 and rib-2 mutants are 
defective in AVM axon guidance (Fig. 2.1C), suggesting the loss of HS chain 
synthesis may be affecting unc-6/netrin signaling, slt-1/Slit signaling, or both. 
 
Disrupting HS chain synthesis is expected to impact all HSPGs. Therefore, if the 
Fig. 2.7. HS chain synthesis in multiple cell types contributes to axon guidance. 
A. The defects in the guidance of the PVQ axons in rib-1(qm32) mutants are rescued by the 
combined expression of rib-1(+) in the hypodermis (under the heterologous promoter Pdpy-7), 
neurons (under the heterologous promoter Prgef-1), and muscles (under the heterologous 
promoter Pmyo-3). 
B. The defects in the guidance of the AVM axon in rib-1(qm32) mutants are rescued by 
expression of rib-1(+) in the migrating neuron itself (under the heterologous promoter Pmec-7) 
or by expression in the hypodermis (under the control of the heterologous promoter Pdpy-7). 
Error bars are standard error of the proportion. Asterisks denote significant difference: *** P ≤ 
0.001, ** P ≤ 0.01, * P ≤ 0.05 (z-tests, P values were corrected by multiplying by the number of 





HS chains contribute significantly to axon guidance by both signaling pathways, 
then the defects of both unc-6/netrin and slt-1/Slit single mutants would be 
enhanced by loss of function of rib-1 or rib-2. We constructed several double 
mutant strains and indeed found that the two double mutants rib-1;unc-6 and rib-
2;unc-6, as well as the two double mutants rib-1;slt-1 and rib-2;slt-1, have 
stronger AVM axon guidance defects than the respective single mutants (Fig. 
2.8B). Mutation of rib-1 or rib-2 also enhanced AVM guidance defects in Pmyo-
3::slt-1 animals (Yu et al 2002) in which slt-1 is misexpressed from all body wall 
muscles (Fig. 2.8B). Given that the two key forces guiding the AVM axon are 
unc-6/netrin and slt-1/Slit, our observations support the model that HS chain 
synthesis plays a critical role in both unc-6/netrin- and slt-1/Slit- guidance 
pathways. 
 
To directly test the functional importance of the HS chain synthesis on unc-
6/netrin signaling, we used a netrin-dependent gain-of-function approach in the 
PVM axon. Similar to AVM, the axon of the neuron PVM is attracted ventrally 
towards secreted UNC-6/netrin via the UNC-40/DCC receptor. However, 
misexpression of a second receptor for UNC-6/netrin that mediates repulsive 
guidance, namely UNC-5/UNC5, using the transgene Pmec-7::unc-5 ((Hamelin 
et al 1993), Fig. 2.8C), results in the abnormal extension of the PVM axon to the 








Dorsal extension of the PVM axon never occurs in the wild type or mutants for 
the unc-6/netrin or slt-1/Slit signaling pathways (Fig. 2.8C). The AVM axon also 
extends dorsally upon misexpression of unc-5; however the axons of AVM and 
neighboring ALMR cannot be reliably distinguished in Pmec-7::unc-5 transgenic 
animals. We built strains mutant for rib-1 or rib-2 that carry the transgene Pmec-
7::unc-5 (Hamelin et al 1993) to misexpress unc-5 in PVM. If loss of rib-1 and rib-
2 functionally disrupts unc-6/netrin signaling, we would expect to see a decrease 
Fig. 2.8. unc-6/netrin and slt-1/Slit signaling pathways require functional HS chains to 
guide axons during development.  
A. We visualized the morphology of the AVM and PVM axons using the transgene Pmec-
4::gfp. Scale bar, 50 µm. 
B. During the first larval stage of wild-type C. elegans, the pioneer neuron AVM extends 
ventrally along the body wall until it reaches the ventral nerve cord. Its migration results from 
the combined attractive response to UNC-6/netrin (secreted at the ventral midline) via the 
UNC-40/DCC receptor and the repulsive response to SLT-1/Slit (secreted by the dorsal 
muscles) via its SAX-3/Robo receptor. Mutations rib-1(qm32) or rib-2(qm46) enhance the 
AVM guidance defects of animals where slt-1/Slit signaling is disrupted, either in mutants for 
slt-1/Slit or in animals misexpressing slt-1 in all body wall muscles (using a Pmyo-3::slt-1 
transgene). Mutation of rib-1 or rib-2 also enhances the AVM axon guidance defects of unc-
6/netrin mutants. That AVM guidance defects of mutants in both key guidance pathways, slt-1 
and unc-6, are enhanced by loss of rib-1 or rib-2 suggests that HS chains function in both the 
slt-1/Slit- and the unc-6/netrin-mediated pathways. Scale bar, 5 µm. 
C. unc-6/netrin signaling via the unc-5/UNC5 receptor requires functional HS chains. The 
pioneer axon of PVM normally migrates ventrally; however, upon misexpression of unc-
5/UNC5 in PVM using the transgene Pmec-7::unc-5, the axon of PVM projects dorsally in an 
unc-6/netrin- and unc-40/DCC-dependent manner. Loss of function of rib-1 or rib-2 partially 
suppresses this forced dorsal migration, indicating that unc-6/netrin signaling depends on 
functional HS chains. Scale bar, 5 µm. 
D. HS modifying enzymes function in the unc-6/netrin- and slt-1/Slit mediated-guidance of the 
AVM axon. Loss of HS modifying enzymes including the epimerase hse-5 and the 
sulfotransferases hst-2 and hst-6 enhance the AVM guidance defects of unc-6/netrin and slt-
1/Slit mutants, indicating that proper modifications of the heparan sulfate chains are important 
in guiding AVM through the unc-6/netrin and slt-1/Slit pathways.  
Error bars are standard error of the proportion. Asterisks denote significant difference: *** P ≤ 
0.001, ** P ≤ 0.01, * P ≤ 0.05 (z-tests, P values were corrected by multiplying by the number of 




in the unc-5-mediated dorsal migration of PVM. We found that loss of function of 
rib-1 and rib-2 significantly suppressed the unc-6/netrin-dependent unc-5-
mediated dorsal migration of PVM (Fig. 2.8C), indicating that unc-6/netrin 
signaling requires HS chains. This suppression of the dorsal extension of the 
PVM axon by mutations in rib-1 and rib-2 is specific as loss of function of other 
genes such as sdn-1/syndecan, slt-1/Slit and sax-3/Robo, could not suppress 
these abnormal dorsal extensions (Fig. 2.8C). Taken together, our findings 
suggest a requirement for HS chains synthesis in regulating unc-6/netrin- and slt-
1/Slit-mediated axon guidance. 
 
Modifications of the HS chains are required for unc-6/netrin and slt-1/Slit 
mediated axon guidance  
Our results indicate that the biosynthesis of HS chains onto core proteins is 
required for axon guidance mediated by unc-6/netrin and slt-1/Slit signaling. 
Once synthesized by the HS copolymerase, HS chains become extensively 
modified by epimerases and sulfotransferases (reviewed in (Bülow & Hobert 
2006)). In C. elegans, key modifying enzymes have been studied, including the 
glucuronyl C5-epimerase encoded by the gene hse-5, the 2O-sulfotransferase 
encoded by the gene hst-2, and the 6O-sulfotransferase encoded by the gene 
hst-6 (Bülow et al 2002, Bülow & Hobert 2004, Bulow et al 2008, Kinnunen et al 
2005, Townley & Bulow 2011). These HS modifying enzymes are required for 
axon guidance as mutations disrupting their function impair axon guidance 
53 
 
(Bülow et al 2002, Bülow & Hobert 2004, Bülow & Hobert 2006, Bulow et al 2008, 
Kinnunen et al 2005), but their specific roles in unc-6/netrin- and slt-1/Slit-
mediated guidance of AVM is unclear. To determine the functional importance of 
specific HS modifications in unc-6/netrin- and slt-1/Slit-mediated AVM axon 
guidance, we first analyzed single, double, and triple mutants of the genes 
coding for the HS modifying enzymes hse-5, hst-2 and hst-6, and found that loss 
of each single modifying enzyme led to minimal AVM axon guidance defects 
(Fig. 2.8D). However, the double mutants hse-5; hst-6 and hst-2 hst-6, in which 
the 6O-sulfotransferase and either the 2O-sulfotransferase or the C5-epimerase 
are mutant, display significant AVM guidance defects (Fig. 2.8D). The defects of 
these two double mutants are not further enhanced by the loss of the third key 
HS modifying enzyme in the triple mutant hse-5; hst-2 hst-6 (Fig. 2.8D). These 
observations indicate some level of compensation between the HS chain 
modifying enzymes and suggest that combinations of modifications on the HS 
chains impact unc-6/netrin- and slt-1/Slit-mediated AVM axon guidance. Next, we 
analyzed AVM ventral axon guidance in double mutant animals lacking one of 
the HS modifying enzymes encoded by hse-5, hst-2, and hst-6 as well as lacking 
unc-6/netrin or slt-1/Slit. We found that loss of function of any of the HS 
modifying enzymes hse-5, hst-2, or hst-6 enhanced the AVM guidance defects of 
null mutants for unc-6/netrin. Similarly, loss of function of any of the HS modifying 
enzymes hse-5, hst-2, or hst-6 enhanced the AVM guidance defects of 
presumptive null mutants for slt-1/Slit (Fig. 2.8D, ((Hao et al 2001)). These 
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results suggest that the sulfations and epimerizations of HS chains carried out by 
the enzymes encoded by hse-5, hst-2, or hst-6 are important for both unc-
6/netrin- and slt-1/Slit-mediated signaling in AVM axon guidance. Thus, not only 
is the polymerization of the HS chains on core proteins required for axon 
guidance during nervous system development, but also the subsequent 
modifications, as has been observed in other neurodevelopmental contexts 
(Bülow & Hobert 2006). These observations confirm the importance of HSPGs 




Animal development and tissue homeostasis rely on the regulation of molecules 
that instruct cellular responses. HSPGs regulate morphogens and guidance cues 
in the extracellular environment, but their mechanisms of action are still not 
understood, including how several HSPGs may together coordinate cellular 
responses. Here, we identify previously unavailable viable hypomorphic 
mutations for the genes rib-1 and rib-2, which encode the HS copolymerase of C. 
elegans. These mutations severely reduce HS biosynthesis and disrupt 
morphogenesis and nervous system development. We show that the action of 
HSPGs from various tissues contributes to the guidance of cellular migrations 




Viable mutations of the HS copolymerase in C. elegans 
The human EXT genes, namely EXT1, EXT2, EXTL1, EXTL2 and EXTL3, are 
members of the hereditary multiple exostoses gene family of tumor suppressors 
and are glycosyltransferases required for the biosynthesis of HS (reviewed in 
(Busse-Wicher et al 2014, Sugahara & Kitagawa 2000)). Only two genes in the 
C. elegans genome, rib-1 and rib-2, have recognizable homology to the 
mammalian EXT genes. Together, the RIB-1 and RIB-2 proteins form a 
functional heterodimer that catalyzes the elongation of HS chains. RIB-2 protein 
has alpha1,4-N-acetylglucosaminyltransferase activity involved in both the 
initiation and elongation steps of heparan sulfate biosynthesis, as it displays 
GlcNAc transferase I and II activities (Kitagawa et al 2001, Morio et al 2003), and 
RIB-1 and RIB-2 together have glycosyltransferase activity and catalyze the 
polymerization of HS chains (Kitagawa et al 2007). 
 
Through a forward genetic screen for mutants defective in nervous system 
development, we have identified viable partial loss-of-function mutations of the 
HS copolymerase in C. elegans. Each of the single mutants, rib-1(qm32) and rib-
2(qm46), displays severe mutant phenotypes, indicating that the genes rib-1 and 
rib-2 are not redundant, as their encoded products cannot substitute for each 
other, consistent with their specific biochemical roles in HS chain initiation and 
elongation. The point mutations rib-1(qm32) and rib-2(qm46) profoundly disrupt 
the function of these genes; we find that the global HS levels are severely 
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reduced in the viable single mutants, and that high molecular species of 
glypican/LON-2 and syndecan/SDN-1 are absent in homozygous populations of 
these viable mutants. Our results indicate that as predicted by sequence 
homology, the functions of RIB-1 and RIB-2 are indeed required for HS 
biosynthesis in C. elegans, consistent with the biochemical demonstration of the 
enzymatic activities of RIB-1 and RIB-2 and the observation that HS levels are 
decreased in maternally rescued null lethal mutants of rib-1 and rib-2 (Kitagawa 
et al 2007, Morio et al 2003).  
 
Despite the severe reduction in HSPGs in the rib-1(qm32) and rib-2(qm46) single 
mutants, it appears that residual HS copolymerase activity allows for viability. 
Approximately a third of the rib-1(qm32) and rib-2(qm46) animals are able to 
complete development and become fertile adults. In contrast, previously isolated 
deletion alleles that completely abolish the function of rib-1or rib-2 are embryonic 
lethal (Franks et al 2006, Kitagawa et al 2007, Morio et al 2003), which precluded 
their detailed analysis. Therefore, rib-1(qm32) and rib-2(qm46) are hypomorphic 
mutations and it is possible that HS copolymerase dimers composed of one 
mutant protein and one wild-type protein in the single mutants (e.g. mutant RIB-1 
and wild-type RIB-2) may be stabilized by the presence of one normal protein in 
the complex. Consistent with this notion, simultaneous disruption of both the rib-1 
and rib-2 genes in double hypomorphic mutants rib-1(qm32); rib-2(qm46), 




In support of the possibility that in single mutants the HS copolymerase may be 
stabilized by one of the two subunits being wild type, the hypomorphic mutants 
rib-1(qm32) or rib-2(qm46) are completely maternally rescued (Hekimi et al 
1995), whereas null mutants are incompletely maternally rescued (Kitagawa et al 
2007, Morio et al 2003). rib-1(qm32) or rib-2(qm46) single hypomorphic mutant 
animals of the first homozygous mutant generation (m+/- z-/-) are phenotypically 
indistinguishable from the wild type throughout life when their mother was 
heterozygous for the mutation (Hekimi et al 1995). In contrast, for rib-1 or rib-2 
null alleles, animals of the first homozygous mutant generation (m+/- z-/-) are 
maternally rescued only to the extent that the animals survive and become 
adults, but display abnormal locomotion and egg laying, becoming filled with 
dead embryos of the next homozygous generation (Kitagawa et al 2007, Morio et 
al 2003). The maternal rescue effect is also incomplete in the double 
hypomorphic rib-1(qm32); rib-2(qm46) mutants, as the first generation of double 
homozygous animals (m+/- z-/-) are severely egg-laying defective and become 
bloated with dead embryos. Thus, it appears that maternal product deposited in 
the oocyte is sufficient to support HS copolymerase activity and allow 
development to unfold normally in single rib-1(qm32) and rib-2(qm46) 
hypomorphic mutants, but insufficient for single null mutants. These observations 
highlight the importance of HS copolymerase activity, and therefore HSPGs, for 
the earlier stages of development as well as later in life. These observations 
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indicate that rib-1(qm32) and rib-2(qm46), while severe loss-of-function alleles, 
are hypomorphic, and their viability offers the opportunity to study the functional 
requirements of HSPGs throughout development. 
 
RIB-1 and RIB-2 are not expected to affect the biosynthesis of 
glycosaminoglycans other than HS. In C. elegans, both heparan sulfate and 
chondroitin sulfate (CS) have been detected (not hyaluronate, nor dermatan 
sulfate; (Toyoda et al 2000, Yamada et al 1999)). Like HS, CS chains are 
covalently linked to the polypeptide at serine residues through a tetrasaccharide 
linker. However, the initiation and elongation of the chains of HS and CS are 
carried out by different enzymes. In the case of CS, a polymer of alternating GlcA 
(glucuronic acid) and N-acetyl galactosamine (GalNAc) residues is synthesized, 
which is catalyzed by a bifunctional glycosyltransferase encoded by the sqv-5 
gene (Hwang et al 2003b). Furthermore, enzymes transporting and synthesizing 
precursors of HS and CS include a UDP-glucose dehydrogenase, UDP-
glucuronic acid decarboxylase, and nucleotide-sugar transporter, encoded by the 
genes sqv-4, sqv-1 and sqv-7, respectively (Hwang & Horvitz 2002a, Hwang & 
Horvitz 2002b). Mutations in these genes cause more severe phenotypes than 
mutations of rib-1 and rib-2 because synthesis of both types of proteoglycans, 
HSPGs and chondroitin sulfate proteoglycans (CSPGs), are affected. 
Interestingly, mutations in these sqv genes all display maternal effect, consistent 
with proteoglycans playing crucial roles from the earliest stages of development. 
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Mutations in other proteoglycan biosynthesis enzymes also display maternal 
effect (Hwang et al 2003a, Mizuguchi et al 2003). In contrast, null mutations of 
hst-1, hst-6, and hse-5 that affect specific modifications of the HS chains 
(epimerizations, sulfations) are less severe and viable (Bülow & Hobert 2004), as 
they affect later steps in the HSPG production. Thus, rib-1(qm32) and rib-
2(qm46) mutations allow for the study of the impact of a global and specific 
disruption of HSPG biosynthesis in the context of live animals. 
 
HSPGs required for morphogenesis and cell migrations 
Disruption of HS chain synthesis by the rib-1(qm32) and rib-2(qm46) mutations 
leads to pleiotropic phenotypic consequences, including abnormal 
morphogenesis during embryonic and larval development, where embryos and 
larvae can be misshapen, with concomitant lethality. Among escapers that reach 
adulthood, locomotion and egg-laying behaviors are defective, and the 
underlying neuroanatomy is highly abnormal. Whereas we detected no defects in 
neuron identity, the migrations of numerous neurons and their axons are 
misguided, including migrations that occur during embryonic and post-embryonic 
development, as well as along both body axes (antero-posterior and dorso-
ventral). It is worth nothing that the motility per se of migrating cells is not lost in 
rib-1 and rib-2 mutants as soma and axons often overshoot their targets. Rather, 
the guidance of migrations during development is disrupted by the loss of 
function of the genes rib-1 and rib-2.  
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The numerous and penetrant defects of neuronal migrations observed in rib-
1(qm32) and rib-2(qm46) mutants suggest that disruption of HSPG biosynthesis 
impacts numerous guidance pathways. In particular, our analysis of the guidance 
of the AVM pioneer neuron reveals that HS chains are required for unc-6/netrin- 
and slt-1/Slit-mediated axon guidance. HS has been shown in vitro to be required 
for netrin- and slit-mediated axon guidance using mouse neuronal explant assays 
(Matsumoto et al 2007, Ogata-Iwao et al 2011). As HS chains are attached to 
HSPGs, this result suggests that specific HSPGs are required for unc-6/netrin- 
and slt-1/Slit-mediated axon guidance. Indeed, sdn-1/syndecan has documented 
roles in the slt-1/Slit pathway in worms and flies (Blanchette et al 2015, Johnson 
et al 2004, Rhiner et al 2005, Steigemann et al 2004), though it has not been 
directly tested whether in these contexts the HS chains on SDN-1/syndecan are 
required for its function. Our work, along with the in vitro mouse neuronal explant 
assays (Matsumoto et al 2007, Ogata-Iwao et al 2011) suggests that the HS 
chains on SDN-1/syndecan may play an important role in slt-1/Slit-mediated axon 
guidance. We have also found that HS chains are important for in vivo unc-
6/netrin-mediated axon guidance, suggesting that a specific HSPG functions in 
unc-6/netrin-mediated axon guidance. Recent work from our lab has shown that 
lon-2/glypican functions in unc-6/netrin-mediated guidance, though we found that 
this function was independent of the HS chains on LON-2/glypican (Blanchette et 
al 2015). This suggests the possibility that another HSPG could interact with the 
unc-6/netrin signaling pathway to mediate axon guidance in a HS-dependent 
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manner. Alternatively, this result suggests that possibly the HS chains on LON-
2/glypican serve a role that we did not detect with our previous studies, for 
example in trafficking LON-2/glypican molecules to the membrane or in 
regulating the stability of LON-2/glypican. 
 
HSPGs are expressed and function from multiple tissues throughout 
development 
Given that HSPGs decorate most cells in metazoans and are implicated in 
numerous cellular processes at the cell surface, including cell-matrix, cell-cell, 
and ligand-receptor interactions, the HS copolymerase could be expected to be 
expressed ubiquitously. We indeed found that the HS copolymerase is broadly 
expressed, as functional reporter rib-1::gfp was detected in virtually all cell types 
at some point during development. Interestingly, the expression pattern of the HS 
copolymerase is dynamic, as the levels differed across tissues and at different 
stages of development. Expression was strong and transient in hypodermal cells 
of the embryo, the larva, and the developing vulva, likely reflecting the 
developmental needs of cells that undergo complex shape changes and/or 
migration during morphogenesis. It is possible that hypodermal cells, which 
secrete a basement membrane along which cells migrate, express the HS 
copolymerase at high levels. Also, cells that migrate during development may 
dynamically regulate the HSPGs at their surface to alter their adhesion 
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properties, reflected in the HS copolymerase expression peaking at times of 
migration. 
 
In addition to this dynamic expression pattern, the HS copolymerase is 
continuously expressed throughout the life of the animal in a number of 
structures, including the pharynx, the pharyngeal-intestinal valve, the anal 
depressor, sphincter, and enteric muscles, as well as the nervous system. These 
are morphologically complex cells and are under continuous mechanical stress 
throughout larval and adult life; for instance, the pharynx is constantly pumping 
bacteria exerting pressure on the pharynx itself and the pharyngeal-intestinal 
valve; the enteric muscles, the anal depressor, the sphincter, all contract to expel 
the worm’s waste; and the relatively long axons of neurons within the nerve cords 
are constantly subjected to being stretched as the animal moves. Other cell types 
accumulate increasing levels of HS copolymerase in reproducing adults, such as 
the spermatheca, which stretches to welcome oocytes to be fertilized and 
contracts to expel the zygotes, and the uterine muscles, which contract to lay 
embryos. Our observations point to a role for HSPGs in maintaining the integrity 
of tissues, possibly by regulating the attachment of cells that undergo 
considerable mechanical stress from repeated body contractions, and thus 




We analyzed the spatial requirements for the HS copolymerase by focusing on 
two specific migrating neurons, namely the embryonically migrating PVQ axon 
and the AVM axon that extends during the first larval stage. In both cases we 
found that combined expression of rib-1 from several cell types was necessary to 
restore a more complete function during development. For the guidance of the 
migrating PVQ axon, the combined expression of the HS copolymerase in the 
hypodermis, neurons, and body wall muscles was able to rescue PVQ axon 
guidance defects, while single tissue expression of rib-1 was not sufficient. This 
observation indicates that combined expression of HSPGs from multiple tissues 
is required to properly pattern the ventral midline. Distinct HSPGs from specific 
tissues may contribute to properly guide the PVQ axons at the ventral midline 
(Fig. 2.9A). Interestingly, the combined loss of two HSPGs, a glypican and a 
syndecan, in the double mutant lon-2 sdn-1 leads to a similar penetrance of 
defects in PVQ guidance as rib-1(qm32) and rib-2(qm46) mutants (Diaz-Balzac 
et al 2014), suggesting that the PVQ axon guidance defects observed in rib-1 
and rib-2 mutants may reflect the disruption of the glypican/LON-2 in the 
hypodermis and syndecan/SDN-1 in the PVQ neurons specifically. Consistent 
with this, glypican/lon-2 has been found to function non-cell autonomously from 
the hypodermis to guide the axon of AVM (Blanchette et al 2015), and 
syndecan/sdn-1 has been shown to function cell autonomously in the migrating 
neuron in a variety of contexts, such as to guide the AVM axon (Blanchette et al 
2015), HSN soma, ALM soma, and PVQ axons (Rhiner et al 2005). 
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Furthermore, PVQ axon guidance likely requires that the specific HSPGs 
contributing to its guidance be not only synthesized but also modified, as the 
combined loss of HS modifying enzymes leads to PVQ axon guidance defects. 
Indeed, loss of the C5-epimerase hse-5 and the 6-O-sulfotransferase hst-6 in 
hse-5; hst-6 double mutants, or loss of the 2-O-sulfotransferase hst-2 in double 
mutants hst-2 hst-6 leads to a similar penetrance of PVQ axon guidance defects 
as rib-1 and rib-2 mutants (Bülow & Hobert 2004). Together, it appears that the 
coordinated action of specific modified HS chains synthesized in different tissues 
onto distinct core proteins function to properly guide the PVQ axons at the ventral 
midline.  
 
Similarly, the defective guidance of the axon of the AVM neuron is strongly 
rescued by expression of the HS copolymerase in the AVM neuron itself, but 
expression in the underlying hypodermis also contributes to normal AVM 
development. In this case too, possible HSPGs functioning to guide AVM may be 
syndecan/sdn-1 in AVM and lon-2/glypican in the hypodermis (Fig. 2.9B), as 
previously identified by analysis of core protein mutants (Blanchette et al 2015).  
 
Our studies uncovered viable mutations in each of the two subunits of the HS 
copolymerase in C. elegans, which severely disrupt HS biosynthesis and lead to 
profound developmental defects. Given the evolutionary conservation of the 
guidance cues and signaling pathways and of HSPGs, analysis of HS 
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copolymerase in C. elegans is likely to provide insights into the coordinated roles 
of HSPGs in mammals as well. Our findings provide a model to to dissect the 
functions of HSPGs in C. elegans and uncover general principles of their roles in 
development and tissue homeostasis. 
 
Fig. 2.9. A model for the role of 
HSPGs in the guidance of PVQ 
and AVM axons.  
A. The PVQ axons extend along 
the ventral nerve cord, following 
preceding pioneer axons. PVQ 
axons are in contact with the 
extracellular matrix and in close 
proximity to muscles and 
hypodermis (skin). For proper 
guidance of the PVQ axons, 
combined HS function from the 
muscles, skin, and neurons is 
required, suggesting that multiple 
HSPGs coordinate the guidance of 
the PVQ axon.  
B. The ventral axon guidance of 
AVM requires HS function from the 
migrating neuron itself, or from the 
skin, and HS chains are required 
for both unc-6/netrin and slt-1/Slit 
guidance systems. Taken together, 
AVM is guided by a HSPG 
functioning from AVM, likely sdn-
1/syndecan, and a HSPG 
functioning from the skin, likely lon-




MATERIALS AND METHODS 
 
Nematode strains and genetics 
Nematode cultures were maintained at 20oC on NGM plates seeded with OP50 
bacteria as described (Brenner 1974). mum-1(qm32) and mum-3(qm46) alleles 
were outcrossed 5 times before building strains with reporters. Strains were 
constructed using standard genetic procedures and are listed in Table 2.1 with 
allele details listed in Table 2.2. When needed, genotypes were confirmed by 
genotyping PCR or sequencing, using primers listed in Table 2.3. 
 
Observations of cell and axon guidance 
Guidance of cells and axons was examined in L4 larvae and adult animals using 
specific reporters. Animals were mounted on agarose pads, anaesthetized with 
100 mM sodium azide, and examined under a Zeiss Axio Scope.A1 or a Zeiss 
Axioskop 2 Plus.  
CAN soma and axon: CAN was examined using the reporter lqIs4. Axons were 
scored as defective when they were located away from the lateral aspect of the 
animal, either ventrally or dorsally, when they failed to extend fully, or exhibited 
branching. Cell bodies were scored as defective for migration when they were 
located anterior to the midpoint between the pharynx and the vulva (the wild-type 
CAN soma position near the vulva). CAN soma was virtually never found 
posterior to the vulva.  
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PVQ axon:  PVQ was examined using the reporter hdIs29. Animals were scored 
as defective when axons projected laterally, fasciculated inappropriately, or failed 
to extend fully.  
AVM axon and AVM axon and soma: AVM neurons were examined in L4 larvae 
and adult animals using the reporter zdIs5. Worms were counted as having an 
AVM soma migration defect when it was located posterior to the vulva. Animals 
with the cell body of AVM posterior to the vulva (cell migration defect) were 
excluded from axon guidance analysis, but included in Fig. 2.1C for % Defective 
soma and axon. Worms were counted as mutant for AVM ventral axon guidance 
if: a) AVM failed to send an axon ventrally and instead projected laterally to the 
anterior; or b) the AVM axon projected laterally, in the anterior or the posterior 
direction, for at least ~15 μm (>3 AVM cell body diameters) before projecting to 
the ventral side. When the angle between the initial anterior/posterior axon 
projection and the ventral axon projection was >45°, it was counted as mutant; 
thus, AVM axons with a slight curve in their ventral trajectory were not 
considered defective.  
PVM axon: Axons of neurons PVM were examined in L4 larvae and adult 
animals using the reporter zdIs5. Worms were counted as having their PVM axon 
misoriented dorsally if the axon of PVM was projecting to the dorsal side of the 
animal. The vulva was used as a reference for the ventral side. Worms carrying 
the transgene evIs25 (Pmec-4::unc-5) whose zdIs5 labeled neurons were too 
misplaced to be reliably identified were excluded from the analysis. 
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HSN soma and axon: HSN was examined using the reporter zdIs13 in young 
adult animals. Animals were scored as defective for HSN axon guidance when 
axons projected laterally, posteriorly, fasciculated inappropriately, or failed to 
extend fully. Cell bodies were scored as defective for migration when they were 
either anterior to the vulva, or more posterior than the midpoint between the 
vulva and the tail.  
Motor neuron commissures: Cholinergic and GABAergic motor neurons were 
examined using the reporters ufIs34 and vsIs48, respectively. Cholinergic: In 
wild-type animals, only seven cholinergic motor neurons (DA3, DB4, DA4, DB5, 
DA5, DA6, DA7) have left-handed commissures between the terminal bulb of the 
pharynx and the anal depressor. Animals were scored as defective when more 
than seven cholinergic motor neuron commissures were on the left side of the 
animal between the posterior end of the terminal bulb of the pharynx and the anal 
depressor. GABAergic: Only the commissures of motor neuron DD1 and VD2 are 
left-handed in wild-type animals. Animals were scored as defective when 
additional GABAergic commissures were present on the left side of the animal. 
Dorsal cord: The dorsal nerve cord was examined using the reporter evIs111. 
Animals were scored as having a defasciculated dorsal nerve cord when the cord 
was split into two or more bundles for any length of the dorsal nerve cord, instead 
of running as a single tight bundle as seen in the wild type. 
Excretory canals: Excretory canals were examined using reporter bgIs312. Wild-
type animals exhibit four lateral canals, two projecting anteriorly in the head and 
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two projecting posteriorly along the length of the body. Animals were scored as 
defective when a canal was located in an abnormal position (including when an 
anterior canal extended posteriorly, or a posterior canal extended anteriorly, or a 
canal laid ventrally or dorsally instead of laterally), when canals were too short 
(i.e., a posterior canal did not extend beyond the vulva), or when an abnormal 
number of canals was present. 
Distal tip cell guidance analysis: The path of migration of the distal tip cells (DTC) 
brings about the shape of the mature gonad arms. In the wild type, the DTC 
migrates away from the vulva location along the antero-posterior axis of the 
animal. The DTC then turns dorsally to reach the dorsal side of the animal. Once 
the DTC reaches the dorsal aspect, it migrates back towards the vulva along the 
antero-posterior axis of the animal. To infer the path of DTC migration, gonad 
arms were examined in late L4 and young adult animals using DIC microscopy. 
Animals were counted as having abnormal gonad arms when a) the anterior 
gonad arm was on the left side instead of being on the right side; b) the posterior 
gonad arm was located on the right side instead of the left side; c) the distal 
portion of a gonad arm was located ventrally instead of dorsally; d) the proximal 
portion of the gonad arm was located dorsally instead of ventrally; or e) the 
proximal gonad arm was too short, resulting from a premature turn of the DTC 
towards the dorsal side. 
Excretory glands: Excretory glands were examined in larvae using DIC 
microscopy. Animals were counted as having abnormally located excretory 
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glands when they were anterior of the pharyngeal terminal bulb (excretory glands 
are located just posterior of the pharyngeal terminal bulb in wild-type animals). 
 
Genetic mapping of mum-1/rib-1 
For mapping mum-1, a three-point mapping experiment was carried out by 
picking Unc-non-Dpy and Dpy-non-Unc recombinants from heterozygous 
mothers of the genotype mum-1/unc-24 dpy-20, and the presence of mum-1 was 
assessed among the progeny of the homozygosed recombinants. Two-point 
mapping was carried out by picking Dpy worms from mum-1 dpy-20/++ 
heterozygous mothers, and the presence of mum-1 was assessed in the next 
generation. Also, Lin-non-Dpy recombinants were picked from heterozygous 
mum-1/lin-3 dpy-20.  
 
Microinjections and transgenic animals 
As the rib-1 and rib-2 mutants are severely morphologically abnormal, cosmids, 
constructs, and PCR products were injected into strains carrying the mum-1/rib-1 
or mum-3/rib-2 mutations in a heterozygous state, balanced by flanking visible 
markers. For rib-1, we used rib-1(qm32)/unc-24(e138) dpy-20(e1282ts) and for 
rib-2, we used rib-2(qm46)/unc-32(e189) dpy-18(e364) (see Table 2.1). 




Transgenic animals were generated by standard microinjection techniques (Mello 
& Fire 1995). Each construct or PCR amplicon was injected at 5 to 25 ng/µl with 
one or two coinjection markers which included pRF4-rol-6(su1006d) (100 - 150 
ng/µL), Pttx-3::mCherry (50 ng/µl), Pceh-22::gfp (50 ng/µL), pCB101.1 Prgef-
1::DsRed2 (50 ng/µL) , and Punc-122::rfp (50 ng/µL). pBSK+ (90-100 ng/µL) 
used to increase total DNA concentration if needed. For coinjection markers used 
for each rescued transgenic line, see Table 2.1. 
 
Rescue and expression constructs 
The gene rib-1/F12F6.3 is downstream of the gene srgp-1/F12F6.5 in an operon 
of two genes. The nearest gene upstream of the operon is transcribed in the 
opposite direction. The genomic region between the operon of srgp-1 and rib-1, 
and the upstream neighboring gene is 4352 bp, corresponding to coordinates 
22290 – 26642 on cosmid F12F6.  
 Prib-1::rib-1 (PCR product): A PCR product containing bases 34593 – 
39595 of cosmid F12F6 of the rib-1 locus was amplified with Pfu polymerase.  
 Prib-2::rib-2 (PCR product): A PCR product containing bases 581 to 
6196 of cosmid K01G5 of the rib-2 locus was amplified with Phusion polymerase.  
 Prib-1::gfp (pCB78): A PCR generated piece containing bases 23701 to 
26662 of cosmid F12F6 corresponding to the promoter region of the rib-1 operon, 
as well as the initial 7 codons of srgp-1, was cloned upstream of gfp in the 
pPD95.77 vector using enzymes PstI and XbaI.  
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 Prib-1::rib-1::Venus (pCB221): The rib-1 promoter region containing 
bases 23701 – 26580 of cosmid F12F6 was PCR amplified and cloned upstream 
of gfp in the pPD95.77 vector using enzymes SphI and PstI. A PCR generated 
piece containing bases 34452 - 39527 of cosmid F12F6 corresponding to the 
intergenic sequence between the genes rib-1 and srgp-1, as well as the rib-1 
coding sequence, was cloned downstream of the rib-1 promoter and upstream of 
gfp using enzymes PstI and AvrII. Then, gfp was replaced with a PCR amplified 
Venus and cloned in frame with rib-1 using enzymes MscI and ApaI. 
 Pdpy-7::rib-1 cDNA (pCB186): The rib-1 cDNA was amplified from 
yk1228g12 and ligated into a Pdpy-7 vector with a pPD95.75 backbone using 
enzymes XmaI – NcoI.  
 Pmyo-3::rib-1 cDNA (pCB196): A Pmyo-3 HindIII – XbaI fragment was 
ligated upstream of the rib-1 cDNA in a pCB186 HindIII – XbaI fragment in place 
of Pdpy-7. 
 Pmec-7::rib-1 cDNA (pCB204): The rib-1 cDNA was amplified from 
yk1228g12 and cloned into the pPD96.41 vector using enzymes AgeI – BglII.  
 Prib-1::rib-1 cDNA (pCB225): The rib-1 cDNA was ligated downstream of 
the rib-1 promoter (bases 23,701 to 26,580 of cosmid F12F6) using enzymes 
XmaI – ApaI in the pPD95.77 backbone.  
 Prgef-1::rib-1 cDNA (pCB199): The rib-1 cDNA was ligated downstream 




 All inserts of finalized clones were verified by sequencing. 
 
Molecular analysis of mum-1/rib-1 and mum-3/rib-2 mutant alleles 
The genomic regions of mum-1/rib-1 and mum-3/rib-2 were PCR amplified using 
Pfu polymerase and sequenced on two independent PCR products amplified 
from genomic DNA of qm32 and qm46, respectively, using primers to cover the 
entire genomic region. Primers listed in Table 2.3 sequence over the mutation in 
each of the two mutants.  
 
Western blot analysis of SDN-1::GFP expressed in worms 
Mixed-stage wild type (N2), SDN-1::GFP (opIs171), rib-1; SDN::GFP (rib-1; 
opIs171) and rib-1 GFP control (rib-1; lqIs4) worms were collected from plates 
devoid of bacteria in buffer and protease inhibitors (Roche). Worm pellets were 
subjected to repeated freeze-thaw cycles. Protein concentration was measured 
using the Pierce 660 nm Protein Assay on a Nanodrop. 80 µg of samples mixed 
with 2x Laemmli sample buffer (Bio-Rad) were frozen in liquid nitrogen, then 
boiled, separated by SDS-PAGE on a 4-20% Mini-Protean TGX gel (Bio-Rad), 
and transferred to PVDF membrane. Membranes were incubated in 1:3000 anti-
GFP primary antibody (Millipore #AB3080) and 1:9000 goat anti-rabbit HRP 
secondary antibody (Bio-Rad #166-2408EDU). For the loading control, 
membranes were incubated in 1:5000 anti-HSP90 antibody (CST #4874) and 
1:10000 goat anti-rabbit HRP secondary antibody (Bio-Rad #166-2408EDU). 
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Signal was revealed using Clarity Western ECL Substrate (Bio-Rad), and imaged 
using film (LabScientific). 
 
Western blot analysis of LON-2::GFP and LON-2ΔGAG::GFP expressed in 
worms 
Mixed-stage wild type (N2), GFP control (lqIs4), LON-2::GFP (TLG257), LON-
2ΔGAG::GFP (TLG199), rib-1; LON-2::GFP (VQ525), rib-2; LON-2::GFP 
(VQ528), rib-1 GFP control (rib-1; lqIs4) and rib-2 GFP control (rib-2; lqIs4) 
worms were collected from plates devoid of bacteria in buffer and protease 
inhibitors (Roche), mixed with 2x Laemmli sample buffer (Bio-Rad), and frozen in 
liquid nitrogen. Samples were boiled and spun down, separated by SDS-PAGE 
on a 4-20% Mini-Protean TGX gel (Bio-Rad), and transferred to PVDF 
membrane. Membranes were incubated in 1:3000 anti-GFP primary antibody 
(Millipore #AB3080) and 1:9000 goat anti-rabbit HRP secondary antibody (Bio-
Rad #166-2408EDU). For the loading control, membranes were incubated in 
1:5000 anti-HSP90 antibody (CST #4874) and 1:10000 goat anti-rabbit HRP 
secondary antibody (Bio-Rad #166-2408EDU). Signal was revealed using Clarity 
Western ECL Substrate (Bio-Rad), and imaged using film (LabScientific). 
 
Analysis of HS levels by western blot in worms   
Protein extraction: Mixed-stage worms from plates devoid of bacteria were 
collected in 50 mM Tris buffer and protease inhibitors (Roche # 11697498001), 
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and frozen in liquid nitrogen. Worm pellets were subjected to repeated freeze-
thaw cycles and protein concentration was measured using the 660 nm Protein 
Assay (Pierce # 22660) on a Nanodrop.  
Detection of HS: 80 µg of protein suspended in buffer and protease inhibitors 
(Roche) were used per sample. Undigested controls were treated exactly like the 
digested samples, except for the heparinase I and III enzyme treatment. To the 
digested samples, 10 mU of heparinase I and III enzyme (Sigma-Aldrich # 
H3917) was added. All samples were incubated at 37°C for 3 hours.  2x Laemmli 
sample buffer (Bio-Rad) was added and samples were frozen in liquid nitrogen. 
Samples were boiled, separated by SDS-PAGE on a 4-20% Mini-Protean TGX 
gel (Bio-Rad), and transferred to PVDF membrane. Membranes were incubated 
in 1:200 anti-Δ-Heparan Sulfate (3G10 epitope) primary antibody (Amsbio 
#370260-1) and 1:10000 horse anti-mouse HRP secondary antibody (Vector 
Labs #PI-2000). For the loading control, membranes were incubated in 1:5000 
anti-HSP90 antibody (CST #4874) and 1:9000 goat anti-rabbit HRP secondary 
antibody (Bio-Rad #166-2408EDU). Signal was revealed using Clarity Western 
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Table 2.1 Strains used in this study  
Strain  Genotype Transgene Reference 
N2   (Brenner 1974) 
LE311 lqIs4 III Pceh-10::gfp (Tsalik et al 2003) 
 hdIs29 V Podr-2::cfp; Psra-6::DsRed2 (Schmitz et al 2008) 
MT4005 zdIs5 I Pmec-4::gfp; lin-15(+) (Clark & Chiu 2003) 
SK4013 zdIs13 IV Ptph-1::gfp (Clark & Chiu 2003) 
VQ84 
 
vsIs48 X; ufIs34 Punc-17::gfp; Punc-47::mCherry (Chase et al 2004, 
Petrash et al 2013) 
NW1229 evIs111 III  Prgef-1::gfp; dpy-20(+) (Altun-Gultekin et al 
2001) 
OH1360 bgIs312 Ppes-6::gfp (Berry et al 2003) 
rib-1 and rib-2 alone and with AVM guidance factors  
VQ344 rib-1(qm32) IV; lqIs4 III  This study 
VQ355 rib-2(qm46) III; lqIs4 III  This study 
VQ196 rib-1(qm32) IV; hdIs29 V  This study 
VQ212 rib-2(qm46) III; hdIs29 V  This study 
VQ252 rib-1(qm32) IV; zdIs5 I  This study 
VQ200 rib-2(qm46) III; zdIs5 I  This study 
VQ661 rib-1(qm32 ) zdIs13 IV  This study 
VQ402 rib-2(qm46 )III; zdIs13 IV  This study 
VQ202 rib-1(qm32) IV; vsIs48; ufIs34  This study 
VQ208 rib-2(qm46) III; vsIs48; ufIs34  This study 
VQ209 rib-1(qm32) IV; evIs111 III  This study 
VQ213 rib-2(qm46) evIs111 III  This study 
VQ342 rib-1(qm32) IV; bgIs312  This study 
VQ343 rib-2(qm46) III; bgIs312  This study 
VQ230 rib-1(qm32)/unc-24(e138) dpy-
20(e1282ts) IV; hdIs29 V 
 This study 
VQ265 rib-1(qm32)/unc-24(e138) dyp-
20(e1282ts) IV; zdIs5 I 
 This study 
VQ465 rib-1(qm32) IV; unc-6(e78) X; zdIs5 I  This study 
VQ449 rib-2(qm46) IV; unc-6(e78) X; zdIs5 I  This study 
VQ405 rib-1(qm32) IV; slt-1(eh15) X; zdIs5 I  This study 
VQ404 rib-2(qm46) IV; slt-1(eh15) X; zdIs5 I  This study 
VQ443 rib-1(qm32) IV; kyIs209 X; zdIs5 I  This study 
VQ456 rib-2(qm46) IV; kyIs209 X; zdIs5 I  This study 
HS-modifying enzymes and AVM axon guidance factors 
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VQ551 hse-5(tm472) III; zdIs5 I   This study 
VQ547 hst-2(ok595) X; zdIs5 I  This study 
VQ546 hst-6(ok273) X; zdIs5 I  This study 
VQ569 hse-5(tm472) III; hst-2(ok595) X; 
zdIs5 I 
 This study 
VQ560 hse-5(tm472) III; hst-6(ok273) X; 
zdIs5 I 
 This study 
VQ571 hst-2(ok595) hst-6(ok273) X; zdIs5 I  This study 
VQ599 hst-2(ok595) hst-6(ok273) X; hse-
5(tm472) III; zdIs5 I 
 This study 
VQ395 unc-6(e78) X; zdIs5 I  (Blanchette et al 2015) 
VQ577 hse-5(tm472) III; unc-6(ev400) X; 
zdIs5 I 
 This study 
VQ573 hst-2(ok595) unc-6(ev400) X; zdIs5 I  This study 
VQ579 hst-6(ok273) unc-6(ev400) X; zdIs5 I  This study 
VQ401 slt-1(eh15) X; zdIs5 I  (Blanchette et al 2015) 
VQ427 kyIs209 X; zdIs5 I  (Blanchette et al 2015) 
VQ602 hse-5(tm472) III; slt-1(eh15) X; zdIs5 
I 
 This study 
VQ604 hst-2(ok595) slt-1(eh15) X; zdIs5 I  This study 
VQ606 hst-6(ok273) slt-1(eh15) X; zdIs5 I  This study 
VQ616 hse-5(tm472) III;  hst-2(ok595) hst-
6(ok273) slt-1(eh15)X; zdIs5 I 
 This study 
LON-2::GFP and SDN-1::GFP strains 
WS3404 opIs171 Psdn-1::sdn-1::gfp; lin-15(+) (Rhiner et al 2005) 
VQ450 rib-1(qm32) IV; opIs171 Psdn-1::sdn-1::gfp; lin-15(+) This study 
TLG257 lon-2(e678) X; texEx164 Plasmid HW483 (Plon-2::lon-2::gfp), 
Pttx-3::mCherry 
(Taneja-Bageshwar 
& Gumienny 2012) 
TLG199 lon-2(e678) X; texEx144 pSBL3SG006 (Plon-2::LON-
2ΔGAG::gfp), Pttx-3::mCherry 
(Taneja-Bageshwar 
& Gumienny 2012) 
VQ525 rib-1(qm32) IV; texEx164 Plasmid HW483 (Plon-2::lon-2::gfp), 
Pttx-3::mCherry 
This study 
VQ528 rib-2(qm46) III; texEx144 Plasmid HW483 (Plon-2::lon-2::gfp), 
Pttx-3::mCherry 
This study 
Transgenic Lines    
VQ370 rib-1(qm32) IV; zdIs5 I; 
qvEx80  
pCB221 (Prib-1::rib-1::Venus), Pttx-
3::mCherry, pRF4.  Line #1 
This study 
VQ684 rib-1(qm32) IV; zdIs5 I; 
qvEx148 
pCB221 (Prib-1::rib-1::Venus), Pttx-
3::mCherry, pRF4.  Line #2 
This study 
VQ502 rib-2(qm46) III; zdIs5 I; 
qmEx329  
PCR product of bases 604..6196 of 
cosmid K01G5, pRF4.  Line #1 
This study 
VQ503 rib-2(qm46) III; zdIs5 I; 
qmEx330  
PCR product of bases 604..6196 of 
cosmid K01G5, pRF4.  Line #2 
This study 
VQ381 rib-1(qm32) IV; hdIs29 V; 
qvEx86  
pCB221 (Prib-1::rib-1 ::Venus), Pttx-




VQ673 rib-1(qm32) IV; hdIs29 V; 
qvEx140  
pCB221 (Prib-1::rib-1::Venus), Pttx-
3::mCherry, pRF4.  Line #2 
This study 
VQ504 rib-2(qm46) III; hdIs29 V; 
qmEx329 
PCR product of bases 604…6196 of 
cosmid K01G5, pRF4.  Line #1 
This study 
VQ505 rib-2(qm46) III; hdIs29 V; 
qmEx330  
PCR product of bases 604…6196 of 
cosmid K01G5, pRF4.  Line #2 
This study 
VQ663 rib-1(qm32) IV; zdIs5 I; 
qvEx131  
pCB225 (Prib-1::rib-1), Pttx-
3::mCherry, pRF4.  Line #1 
This study 
VQ376 rib-1(qm32) IV; zdIs5 I; 
qvEx81  
pCB225 (Prib-1::rib-1), Pttx-
3::mCherry, pRF4.  Line #2 
This study 
VQ664 rib-1(qm32) IV; zdIs5 I; 
qvEx132  
pCB225 (Prib-1::rib-1), Pttx-
3::mCherry, pRF4.  Line #3 
This study 
VQ665 rib-1(qm32) IV; zdIs5 I; 
qvEx133  
pCB204 (Pmec-7::rib-1), Pceh-
22::gfp, pRF4.  Line #1 
This study 
VQ334 rib-1(qm32) IV; zdIs5 I;  
qvEx85 
pCB204 (Pmec-7::rib-1), Pceh-
22::gfp, pRF4.  Line #2 
This study 
VQ508 rib-1(qm32) IV; zdIs5 I; 
qvEx101 
pCB204 (Pmec-7::rib-1), pRF4, 
Prgef-1::DsRed2. Line #3 
This study 
VQ509 rib-1(qm32) IV; zdIs5 I; 
qvEx102 
pCB204 (Pmec-7::rib-1), pRF4, 
Prgef-1::DsRed2. Line #4 
This study  
VQ667 rib-1(qm32) IV; zdIs5 I; 
qvEx134  
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4.  Line #1 
This study 
VQ666 rib-1(qm32) IV; zdIs5 I; 
qvEx141 
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4.  Line #2 
This study 
VQ668 rib-1(qm32) IV; zdIs5 I; 
qvEx135 
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4.  Line #3 
This study 
VQ487 rib-1(qm32) IV; zdIs5 I;  
qvEx94 
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4.  Line #4 
This study 
VQ488 rib-1(qm32) IV; zdIs5 I; 
 qvEx95  
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4.  Line #1 
This study 
VQ669 rib-1(qm32) IV; zdIs5 I; 
qvEx136 
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4.  Line #2 
This study 
VQ670 rib-1(qm32) IV; zdIs5 I; 
qvEx137 
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4.  Line #3 
This study 
VQ672 rib-1(qm32) IV; zdIs5 I; 
qvEx139 
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4.  Line #4 
This study 
VQ391 +; qvEx90  pCB78 (Prib-1::gfp), pRF4.  Line #1 This study 
VQ204 +; qvEx36  
 
pCB78 (Prib-1::gfp), Pttx-
3::mCherry, pBSK+.   Line #2 
This study 
VQ205 +; qvEx37 
 
pCB78 (Prib-1::gfp), Pttx-
3::mCherry, pBSK+.   Line #3 
This study 
VQ356 +; qvEx79  
 
pCB221 (Prib-1::rib-1 ::Venus), 
pRF4, Punc-122::rfp. Line #1 
This study 
VQ379 +; qvEx84  pCB221 (Prib-1::rib-1 ::Venus), 
pRF4.    
Line #2 
This study 
VQ694 rib-1(qm32) IV; hdIs29 V; 
qvEx153 
pCB199 (Prgef-1::rib-1), Pttx-
3::mCherry, pRF4. Line #1 
This study 
VQ695 rib-1(qm32) IV; hdIs29 V; 
qvEx154 
pCB199 (Prgef-1::rib-1), Pttx-
3::mCherry, pRF4. Line #2 
This study 
VQ696 rib-1(qm32) IV; hdIs29 V; 
qvEx155 
pCB199 (Prgef-1::rib-1), Pttx-









VQ253 rib-1(qm32) IV; hdIs29 V; 
qvEx43 
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4. Line #1 
This study 
VQ698 rib-1(qm32) IV; hdIs29 V; 
qvEx157 
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4. Line #2 
This study 
VQ699 rib-1(qm32) IV; hdIs29 V; 
qvEx158 
pCB186 (Pdpy-7::rib-1), Pttx-
3::mCherry, pRF4. Line #3 
This study 
VQ260 rib-1(qm32) IV; hdIs29 V; 
qvEx47 
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4. Line #1 
This study 
VQ261 rib-1(qm32) IV; hdIs29 V; 
qvEx48 
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4. Line #2 
This study 
VQ702 rib-1(qm32) IV; hdIs29 V; 
qvEx161 
pCB196 (Pmyo-3::rib-1), Pttx-
3::mCherry, pRF4. Line #3 
This study 
VQ703 rib-1(qm32) IV; hdIs29 V; 
qvEx162 
pCB199 (Prgef-1::rib-1), pCB186 
(Pdpy-7::rib-1), pCB196 (Pmyo-
3::rib-1), Pttx-3::mCherry, pRF4. 
Line #1 
This study 
VQ704 rib-1(qm32) IV; hdIs29 V; 
qvEx163 
pCB199 (Prgef-1::rib-1), pCB186 
(Pdpy-7::rib-1), pCB196 (Pmyo-
3::rib-1), Pttx-3::mCherry, pRF4. 
Line #2 
This study 
VQ705 rib-1(qm32) IV; hdIs29 V; 
qvEx164 
pCB199 (Prgef-1::rib-1), pCB186 
(Pdpy-7::rib-1), pCB196 (Pmyo-
3::rib-1), Pttx-3::mCherry, pRF4. 
Line #3 
This study 
evIs25 strains and controls 
VQ396 unc-6(ev400) X; zdIs5 I  (Blanchette et al 2015) 
VQ470 unc-40(e271) zdIs5 I  (Blanchette et al 2015) 
VQ473 sax-3(k123) X; zdIs5 I  (Blanchette et al 2015) 
VQ423 sdn-1(zh20) X; zdIs5 I  (Blanchette et al 2015) 
VQ536 evIs25 X; zdIs5 I  (Blanchette et al 2015) 
VQ538 unc-6(ev400) evIs25 X; zdIs5 I  (Blanchette et al 2015) 
VQ540 unc-40(e271) zdIs5 I; evIs25 X  (Blanchette et al 2015) 
VQ556 slt-1(eh15) evIs25 X; zdIs5 I  (Blanchette et al 2015) 
VQ557 sax-3(ky123) evIs25 X; zdIs5 I  (Blanchette et al 2015) 
VQ572 sdn-1(zh20) evIs25 X; zdIs5 I  (Blanchette et al 2015) 
VQ554 rib-1(qm32) IV; evIs25 X; zdIs5 I  This study  
VQ539 rib-2(qm46) III; evIs25 X; zdIs5 I  This study  
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Gene Allele Nature of allele Reference 
rib-1 qm32 Stop codon converted into a Lys codon, likely 
extending the open reading frame into the 3’UTR 
This study 
 




tm472 1249 bp deletion and addition of an adenosine, 
which deletes most of exons 4 – 7 and generates 
a frame shift after exon 4 




ok595 1336 bp deletion, deleting from exon 4 to part of 
exon 7 




ok273 1064 bp deletion, with the addition of nucleotides 
CTTT, which deletes exons 4 and 5 and 
generates a frameshift after exon 3 
(Bülow & Hobert 
2004) 
unc-6 ev400 Early stop Q78*. Null. (Wadsworth et al 
1996) 
unc-6 e78 C410Y. Partial loss of function. (Lim & 
Wadsworth 2002) 
slt-1 eh15 Duplication and deletions. First copy contains a 
1900 bp deletion. Both duplicated copies have a 
100 bp deletion. First copy produces no mRNA 
while second copy produces mRNA with a 
frameshift.  
(Hao et al 2001) 




ky123 Deletion of signal peptide and first exon.  (Zallen et al 
1998) 




Table 2.3 Primers used for strain building 





rib-1(qm32) sequencing   
 oCB1026 gggtgcgtaaggagatgagg 456 
 oCB1027 ggcaaccagccatcacagcc  
rib-2(qm46) sequencing   
 oCB1028 caacttatcggatcttcaacc 437 
 oCB1029 ttccagcggtccaaggagg  
slt-1(eh15)    
Mutant specific  oCB919 tatgacgtgttccggaaacc 467 
 oCB920 atttctctaatacgggtagc  
Wild-type specific  oCB922 tctcaattctaacatccatgtc 339 
 oCB920 atttctctaatacgggtagc  
sax-3(ky123)    
Mutant specific  oCB1038 agaatgtggctctctagtcc ~330 
 oCB1039 tcgtttccgcgcattcagtc  
Wild-type specific  oCB1038 agaatgtggctctctagtcc 527 
 oCB1042 agcttcggattactgcttgc  
sdn-1(zh20)    
Mutant specific  oCB837 aaagagatgccggtcaggtg 410 
 oCB842 aatggacgggatgagtgtcc  
Wild-type specific  oCB837 aaagagatgccggtcaggtg 293 
 oCB876 cttcagattcgagcctgctttgc  
evIs25:  Detection of insertion Pmec-7::unc-5 
 oCB933 ttgtcagtcgagcctcaagg ~631 
 oCB966 tccactgtctgataatctgg  
kyIs209:  Detection of insertion Pmyo-3::slt-1 
 oCB945 tcattcgggatattttgtgg 592 
 oCB950 aagaagaagcatgcttctgg  
hse-5(tm472)    
Mutant specific  oCB1055 atcgtgtacgatgtgtcagc 546 
 oCB1056 attcgcctcatacggtttcc  
Wild-type specific  oCB1055 atcgtgtacgatgtgtcagc 779 
 oCB1057 aactttctctcggcaattg  
hst-2(ok595)    
Mutant specific  oCB1052 tattacaacatggacggagc 692 
 oCB1054 aacattatgcgcatgaacgc  
    
   Wild-type specific  oCB1052 tattacaacatggacggagc 486 
 oCB1053 ttagcagtgattcaattacg  
hst-6(ok273)    
   Mutant specific  oCB1049 ttagacgtggctgttctcac 723 
 oCB1051 tgtgagtctgttaagggtgg  
   Wild-type specific  oCB1049 ttagacgtggctgttctcac 804 
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Netrin is a key axon guidance cue that orients axon growth during neural circuit 
formation. However, the mechanisms regulating netrin and its receptors in the 
extracellular milieu are largely unknown. Here we demonstrate that in C. elegans, 
LON-2/glypican, a heparan sulfate proteoglycan, modulates UNC-6/netrin 
signaling, and may do this through interactions with the UNC-40/DCC receptor. 
We show that developing axons misorient in the absence of LON-2/glypican 
when the SLT-1/slit guidance pathway is compromised, and that LON-2/glypican 
functions in both the attractive and repulsive UNC-6/netrin pathways. We find 
that the core LON-2/glypican protein, lacking its heparan sulfate chains, and 
secreted forms of LON-2/glypican, are functional in axon guidance. We also find 
that LON-2/glypican functions from the epidermal substrate cells to guide axons, 
and provide evidence that LON-2/glypican associates with UNC-40/DCC 
receptor-expressing cells. We propose that LON-2/glypican acts as a modulator 
of UNC-40/DCC-mediated guidance to fine-tune axonal responses to UNC-
6/netrin signals during migration. 
 
INTRODUCTION 
Directed migrations of developing axons are essential for the proper wiring of the 
nervous system. A host of guidance cues and their receptors instruct axon 
guidance decisions. However, how these cues and the growth cone’s responses 
to them are spatially and temporally regulated in vivo remains largely unknown. 
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Answering this question is central to our understanding of how growing axons 
navigate in complex environments to reach their targets during development and 
regeneration. 
 
UNC-6/netrin is a highly conserved secreted guidance cue with structural 
similarity to the extracellular matrix protein laminin (Ishii et al 1992, Kennedy et al 
1994, Serafini et al 1994). UNC-6/netrin directs attractive guidance through 
receptors of the UNC-40/DCC family, and repulsive guidance through both UNC-
40/DCC and UNC-5/UNC5 receptors (Chan et al 1996, Hedgecock et al 1990, 
Leung-Hagesteijn et al 1992). Notably, whereas netrin receptors and 
downstream transduction pathways have been well characterized, how netrin 
signals are regulated extracellularly remains largely unknown. UNC-6/netrin was 
identified through genetic analysis in C. elegans (Ishii et al 1992), and 
biochemically purified and cloned from vertebrate embryos (Serafini et al 1994). 
A second biochemical component that synergized with netrin to elicit axon 
outgrowth was termed “netrin synergizing activity” (NSA) (Kennedy et al 1994) 
and remains unidentified. Vertebrate netrin-1 and its receptor DCC can bind 
heparin, a fully sulfated version of heparan sulfate (HS), in vitro (Bennett et al 
1997, Geisbrecht et al 2003, Kennedy et al 1994), and a general disruption of HS 
chain synthesis is detrimental to netrin-1-mediated axon outgrowth in vitro 
(Matsumoto et al 2007, Ogata-Iwao et al 2011). While heparan sulfate 
proteoglycans (HSPGs) might be intriguing candidates for NSA, it is not yet 
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known whether a specific HSPG is required for netrin signaling, nor how 
interactions with HSPGs might regulate netrin signals to direct axons during 
nervous system development. 
 
We addressed these questions using the nematode Caenorhabditis elegans, 
which has been instrumental for discovering major conserved axon guidance 
pathways. During larval development, the axon of the mechanosensory neuron 
AVM migrates ventrally as its growth cone integrates signals from two 
complementary guidance cues (Fig. 3.1a) (Chan et al 1996, Hao et al 2001, 
Hedgecock et al 1990, Hedgecock et al 1987, Ishii et al 1992, Leung-Hagesteijn 
et al 1992, Zallen et al 1998): (1) UNC-6/netrin is secreted at the ventral midline 
and attracts the growth cone ventrally via the receptor UNC-40/DCC (Chan et al 
1996, Wadsworth et al 1996), and (2) SLT-1/Slit is secreted by the dorsal 
muscles and repels the growth cone away from the dorsal side via the receptor 
SAX-3/Robo (Hao et al 2001, Zallen et al 1998). Animals null for the guidance 
cues unc-6/netrin or slt-1/Slit exhibit partial AVM ventral axon guidance defects, 
and loss of both cues in unc-6 slt-1 double mutants results in fully penetrant 
guidance defects ((Hao et al 2001), Fig. 3.2). AVM axons defective in guidance 
fail to extend ventrally and instead migrate laterally in the anterior direction (Fig. 
3.1). In this study, we use the AVM axon as a model to elucidate mechanisms 
that regulate UNC-6/netrin signaling. 
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Here we provide a missing link in understanding the modulation of UNC-6/netrin 
signaling in the extracellular milieu. We demonstrate that LON-2/glypican, a 
HSPG secreted from epidermal cells, acts as a modulator of the UNC-6/netrin 
signaling pathways to guide migrating cells and axons. We show that LON-
2/glypican modulates UNC-6/netrin signaling in both attractive guidance 
mediated by the UNC-40/DCC receptor, and repulsive guidance mediated by the 
UNC-40/DCC and UNC-5/UNC5 receptors. We provide evidence that LON-
2/glypican associates with UNC-40/DCC-receptor-expressing cells. We show that 
the N-terminal globular region of LON-2/glypican, lacking the three HS chain 
attachment sites, is functional in UNC-6/netrin-mediated guidance. Our studies 
unravel a novel mechanism by which LON-2/glypican is produced by substrate 
epidermal cells and released from the membrane to likely associate with UNC-
40/DCC-expressing neurons, enabling the modulation of their responses to UNC-





lon-2/glypican and sdn-1/syndecan cooperate to guide unc-6/netrin- and 
slt-1/Slit-mediated axon migration 
To address whether a specific HSPG interacts with the netrin signaling system to 
guide axons, we first examined axon guidance in mutants lacking core HSPGs. 
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HSPGs are composed of a core protein with covalently attached long 
unbranched heparan sulfate (HS) chains (Bülow & Hobert 2006). HSPGs can be 
associated with the plasma membrane through either a transmembrane domain 
(e.g., syndecans) or a glycerophosphatidylinositide (GPI)-anchor (e.g., 
glypicans), or be secreted into the extracellular milieu (e.g., perlecans, agrins). 
We examined the axon morphology of AVM in single, double, and triple mutants 
for several core HSPG proteins (see Table 3.1 for alleles). These included the 
sole C. elegans syndecan (sdn-1), the two glypicans (lon-2, gpn-1), perlecan 
(unc-52), and agrin (agr-1). We found that the mild AVM axon guidance defects 
of sdn-1/syndecan mutants, including a null, (Rhiner et al 2005) were enhanced 
by the complete loss of lon-2/glypican in double mutants lon-2 sdn-1 (Fig. 3.1b), 
revealing a role for lon-2/glypican in AVM axon guidance. Similarly, loss of lon-
2/glypican enhances sdn-1/syndecan mutants in motorneuron guidance (Gysi et 
al 2013). Although the C. elegans genome encodes two glypicans, loss of 
function of the second glypican, gpn-1, using two likely null mutant alleles (see 
Fig. 3.3), did not enhance the defects of lon-2/glypican or sdn-1/syndecan null 
mutants, in double or triple mutants (Fig. 3.1b). Moreover, we did not observe 
abnormal phenotypes in the single mutants for agr-1/agrin or unc-52/perlecan. 
These observations highlight the specificity of lon-2/glypican function in this axon 
guidance process, and raise the possibility that lon-2/glypican might be a 







lon-2/glypican acts in the attractive and repulsive unc-6/netrin guidance 
pathways 
Considering that AVM axon guidance occurs via the unc-6/netrin and slt-1/Slit 
pathways, mutations in genes such as lon-2/glypican and sdn-1/syndecan that 
affect AVM axon guidance may point towards interactions with either of these two 
guidance systems. Since the AVM axon guidance defects in lon-2 sdn-1 double 
mutants are qualitatively similar to those of mutants lacking unc-6/netrin or slt-
1/Slit, we determined how lon-2/glypican and sdn-1/syndecan impact unc-6/netrin 
and slt-1/Slit signaling. In animals that completely lack slt-1/Slit function, the 
complete loss of a gene functioning independently of slt-1/Slit is expected to 
enhance the AVM guidance defects, such as in the double null mutants unc-
Figure 3.1. lon-2/glypican functions in the attractive unc-6/netrin guidance pathway. 
(a) During the first larval stage of C. elegans, the pioneer neuron AVM extends ventrally along 
the body wall until it reaches the ventral nerve cord. Its migration results from the combined 
attractive response to UNC-6/netrin (secreted at the ventral midline) via the UNC-40/DCC 
receptor, and the repulsive response to SLT-1/Slit (secreted by the dorsal muscles) via its 
SAX-3/Robo receptor. We visualized the morphology of the AVM axon using the transgene 
Pmec-4::gfp. (b) The heparan sulfate proteoglycans lon-2/glypican and sdn-1/syndecan 
cooperate to guide the axon of AVM, as their simultaneous loss enhances guidance defects. 
The role of lon-2/glypican in axon guidance is specific as the loss of lon-2/glypican, but not the 
loss of the other C. elegans glypican, gpn-1, enhances the defects of sdn-1/syndecan 
mutants. (c) Complete loss of lon-2/glypican enhances the axon guidance defects resulting 
from disrupted slt-1/Slit signaling in mutants for slt-1/Slit or its receptor sax-3/Robo, as well as 
in animals misexpressing slt-1 in all body wall muscles (using a Pmyo-3::slt-1 transgene). 
Data for wild type and lon-2 are the same as in (b). (d) Complete loss of lon-2/glypican does 
not enhance the AVM guidance defects of unc-6/netrin mutants, nor of mutants for its receptor 
unc-40/DCC, suggesting that lon-2/glypican functions in the same genetic pathway as unc-
6/netrin. Data for wild type, and lon-2 are the same as in (b). (e) Loss of sdn-1/syndecan 
function does not enhance the defects of slt-1/Slit or sax-3/Robo mutants, but enhances the 
defects of unc-40/DCC mutants. Data for wild type, sdn-1, slt-1, sax-3, and unc-40 same as in 
(b-d). Error bars are standard error of the proportion. Asterisks denote significant difference: 
*** P ≤ 0.001,** P ≤ 0.01, and * P ≤ 0.05 (z-tests, P values were corrected by multiplying by 




6/netrin slt-1/Slit (see Fig. 3.2). We tested the interactions of lon-2/glypican with 
the slt-1/Slit pathway in AVM axon guidance, and found that the complete loss of  
 
 
lon-2/glypican enhanced a presumptive null allele of slt-1/Slit in lon-2 slt-1 double 
mutants (Fig. 3.1c), suggesting that lon-2/glypican functions in a pathway 
separate from slt-1/Slit. Loss of lon-2/glypican also enhanced guidance defects 
when signaling through sax-3/Robo, the slt-1/Slit receptor, was disrupted in lon-2 
sax-3 double null mutants, providing further evidence that lon-2/glypican 
functions in a pathway separate from that of slt-1/Slit (Fig. 3.1c). As an additional 
method to investigate the impact of lacking lon-2/glypican function when slt-1/Slit 
signaling is perturbed, we used a transgene that ectopically expresses slt-1/Slit 
from both ventral and dorsal body wall muscles (using Pmyo-3::slt-1), and 
Figure 3.2. Ventral guidance of the 
AVM axon. Mutations in unc-6/netrin 
and slt-1/slit pathways result in partially 
redundant defects, as previously 
established by the Culotti and 
Bargmann labs (Hao et al 2001). 
Mutants displayed here never exhibit a 
dorsally migrated AVM axon. Error bars 
are standard error of the proportion. 
Asterisks denote significant difference: 
*** P ≤ 0.001 (z-tests, P values were 
corrected by multiplying by the number 







Figure 3.3. gpn-1(ok377) and gpn-1(tm595) are likely null alleles. (a) gpn-1(ok377) and 
gpn-1(tm595) are deletions (brackets) in the gpn-1 locus. (b) RT-PCR using primers oCB834 
and oCB1321 yields truncated products in gpn-1(ok377) and gpn-1(tm595). Y45F10D.4 is a 
housekeeping gene used as an RT-PCR control (Hoogewijs et al 2008). Sequencing of the 
gpn-1 RT-PCR products for ok377 (blue) reveals that the transcript lacks most of exon 3 and 
has several in-frame Stop codons (*), as intronic sequence (hatch pattern) gets incorporated 
into the mature transcript. Sequencing of the gpn-1 RT-PCR product for tm595 (red) reveals 
that the transcript lacks exons 2 and 3, and has several in-frame Stop codons (*), as intronic 
sequence (hatch pattern) gets incorporated into the mature transcript. No alternatively spliced 
products were detected in the mutants ok377 and tm595. (c) gpn-1(ok377) and gpn-1(tm595) 
are strong loss-of-function mutations, likely nulls, in which, at most, small truncated proteins 




misguides the axon of AVM (Yu et al 2002). Loss of lon-2/glypican enhanced  
the defects caused by slt-1/Slit misexpression (Fig. 3.1c), consistent with the 
above findings that lon-2/glypican mediates its axon guidance effects 
independently of slt-1/Slit.  
 
The unc-6/netrin pathway functions independently of slt-1/Slit to guide AVM. To 
address whether lon-2/glypican functions in the unc-6/netrin axon guidance 
pathway, we examined the AVM axon in double mutants of lon-2/glypican and 
unc-6/netrin. In animals that completely lack unc-6/netrin function, the complete 
loss of a gene functioning in the same unc-6/netrin pathway is expected to not 
enhance the AVM guidance defects, such as in the double null mutants unc-6; 
unc-40 (see Fig. 3.2). We found that the complete loss of lon-2/glypican did not 
enhance the guidance defects displayed by unc-6/netrin null mutants ev400 (Fig. 
3.1d). Given that loss of lon-2 enhances the defects of other guidance mutants 
(see doubles with sdn-1, slt-1, sax-3, Pmyo-3::slt-1, in Fig. 3.1b,c and sqv-5 in 
Fig. 3.4), the lack of enhancement when combined with the unc-6 null mutation 
suggests that lon-2/glypican functions in the same pathway as unc-6/netrin.  
 
Consistent with this idea, we also found that complete loss of lon-2/glypican did 
not enhance the AVM guidance defects of two null mutant alleles of the netrin 
receptor unc-40/DCC in the double mutants unc-40; lon-2 (Fig. 3.1d), suggesting 




guidance. These observations raise the interesting possibility that lon-2/glypican 
may be the HSPG dedicated to modulate unc-6/netrin signaling through unc-
40/DCC during axon guidance. 
 
Since lon-2/glypican functions independently of slt-1/Slit (Fig. 3.1c) and partly 
separate from sdn-1/syndecan (Fig. 3.1b), we tested whether sdn-1/syndecan 
and slt-1/Slit function together to guide the axon of AVM. We found that defects 
in slt-1 sdn-1 double null mutants were not enhanced compared to the single 
mutants (Fig. 3.1e), consistent with findings in Drosophila (Johnson et al 2004, 
Steigemann et al 2004) and C. elegans (Rhiner et al 2005). We also found that 
double null mutants for sdn-1/syndecan and the slt-1/Slit receptor sax-3/Robo 
were not enhanced compared to the single mutants (Fig. 3.1e). Our results 
Figure 3.4. Loss of lon-2 enhances 
AVM guidance defects of sqv-5. Loss of 
function of sqv-5, the gene coding for the 
chondroitin sulfate polymerase (Hwang et 
al., 2003), leads to defective AVM ventral 
axon guidance, which is significantly 
enhanced by loss of lon-2 function. Error 
bars are standard error of the proportion. 
Asterisks denote significance: *** P ≤ 
0.001 (z-tests, P values were corrected 
by multiplying by the number of 




support the notion that sdn-1/syndecan acts in the same genetic pathway as slt-
1/Slit to guide AVM. Consistent with this, we found that the double null mutants 
for sdn-1/syndecan and the netrin receptor unc-40/DCC were enhanced, 
indicating that sdn-1/syndecan functions in a pathway separate from unc-6/netrin. 
The analysis of axon guidance in double mutants of unc-6/netrin and sdn-
1/syndecan was precluded by their lethality (data not shown). Our results are 
consistent with the notion that unc-6/netrin and sdn-1/syndecan act in different 
pathways of axon guidance. 
 
In addition to unc-6/netrin acting as an attractive cue for cells expressing the unc-
40/DCC receptor in ventral guidance, unc-6/netrin also acts as a repulsive cue 
for cells expressing both the unc-5/UNC5 and unc-40/DCC receptors, which 
together mediate dorsal guidance away from unc-6/netrin (Chan et al 1996, 
Hedgecock et al 1990, Leung-Hagesteijn et al 1992). To address whether lon-
2/glypican functions in unc-6/netrin-mediated repulsive guidance as well, we 
examined the dorsal migration of the distal tip cells (DTCs) and of the GABAergic 
motorneuron axons (Hedgecock et al 1990, Hedgecock et al 1987). We found  







(Fig. 3.5a,b), and that the complete loss of lon-2/glypican did not enhance the 
dorsal DTC migration defects of unc-6/netrin, unc-40/DCC or unc-5/UNC5 null 
mutants (Fig. 3.5b, Table 3.2), indicating that lon-2/glypican functions in the unc-
6/netrin-repulsive-guidance pathway as well. Similarly, complete loss of lon-
2/glypican did not enhance the defects of unc-40/DCC mutants in the dorsal 
guidance of motorneuron axons (Fig. 3.5c, Table 3.3). Given that loss of lon-
2/glypican enhances the motorneuron axon guidance defects of sdn-1 mutants 
as shown in (Gysi et al 2013), lon-2/glypican plays a role in the dorsal guidance 
of motorneuron axons. The lack of enhancement of the defects in the dorsal 
guidance of motorneuron axons of unc-40/DCC mutants by loss of lon-2/glypican 
further supports that lon-2/glypican functions in the unc-6/netrin pathway 
Figure 3.5. lon-2/glypican functions in the repulsive unc-6/netrin guidance pathway. (a) 
Schematics of the migration path of the DTCs in the wild type, and examples of defective DTC 
migration in lon-2/glypican mutants (the anterior and the posterior DTCs exhibit similar 
defects). In wild-type animals, the DTCs migrate away from the vulva along the antero-
posterior axis (1), then turn dorsally (2), and turn again to migrate towards the midbody region 
(3). Loss of lon-2/glypican leads to defective DTC guidance, including a failure to migrate 
dorsally, premature dorsal turning, or a failure to remain dorsal. (b) Quantification of the DTC 
migration defects in lon-2/glypican mutants and rescue by lon-2(+) (see Table 3.7). For each 
transgenic line, transgenic animals were compared to non-transgenic sibling controls. 
Complete loss of lon-2/glypican does not enhance the defects of the unc-6/netrin null mutants, 
nor of the null mutants for unc-5/UNC5 and unc-40/DCC, suggesting that lon-2/glypican 
functions in the same guidance pathway as unc-5/UNC5, unc-40/DCC and unc-6/netrin (see 
Table 3.2). (c) The axons of the GABAergic motorneurons project dorsally from the ventral 
midline towards the dorsal nerve cord. unc-6/netrin, unc-5/UNC5, and unc-40/DCC are 
required for this dorsal guidance of GABAergic axons. Complete loss of lon-2/glypican does 
not enhance the partially penetrant defects of unc-40/DCC null mutants, suggesting that lon-
2/glypican functions in the same pathway as unc-40/DCC and unc-6/netrin to guide axons 
dorsally (see Table 3.3). Error bars are standard error of the proportion. Asterisks denote 
significant difference: *** P ≤ 0.001 and * P ≤ 0.05 (z-tests, P values were corrected by 




mediating dorsal guidance. Thus, lon-2/glypican may modulate unc-6/netrin 
signaling not only during attractive guidance, but also during repulsive guidance. 
 
unc-6/netrin signaling via the unc-5/UNC5 receptor requires lon-2/glypican 
To complement the above loss-of-function approach, we next used a gain-of-
function strategy to test the model that lon-2/glypican functions in the unc-6/netrin 
signaling pathway. We focused on the axon of the PVM neuron instead of AVM, 
because it could reliably be identified (AVM cannot be distinguished from ALMR 
in these experiments). In wild-type animals, PVM, like AVM, expresses the 
receptor unc-40/DCC and its axon grows ventrally towards unc-6/netrin (Fig. 





ventrally, instead extend anteriorly (never dorsally, see Table 3.4). The PVM 
axon normally does not express the receptor unc-5/UNC5 that mediates 
repulsive guidance away from ventral unc-6/netrin (Leung-Hagesteijn et al 1992), 
but misexpression of the receptor unc-5/UNC5 (using transgene Pmec-7::unc-5 
(Hamelin et al 1993)) in PVM forces its axon to extend dorsally in an unc-
6/netrin- and unc-40/DCC-dependent manner (Hamelin et al 1993), Fig. 3.6a,b). 
We used this unc-6/netrin-dependent unc-5/UNC5-mediated abnormal dorsal 
migration to further investigate the function of lon-2/glypican in netrin signaling. 
By analyzing lon-2/glypican mutants carrying Pmec-7::unc-5, we found that 
compete loss of lon-2/glypican function significantly suppressed the unc-6/netrin-
dependent unc-5-mediated abnormal dorsal migration of the PVM axon, 
indicating that unc-6/netrin signaling is lon-2/glypican-dependent (Fig. 3.6b). In 
contrast, the complete loss of sdn-1/syndecan, of slt-1/Slit, or of sax-3/Robo 
function did not suppress these PVM abnormal dorsal migrations (Fig. 3.6b, see 
Table 3.4), highlighting the specificity of lon-2/glypican action on unc-6/netrin 
Figure 3.6. unc-6/netrin signaling via the unc-5/UNC5 receptor requires lon-2/glypican.  
(a) The axon of PVM normally migrates ventrally in the wild type, but it can be forced to 
migrate dorsally by misexpressing the repulsive receptor unc-5/UNC5. We quantified PVM 
since AVM could not be reliably identified (both AVM and neighboring ALMR axons project 
dorsally in Pmec-7::unc-5 transgenic animals.) (b) Upon misexpression of unc-5/UNC5 in 
PVM, using the transgene Pmec-7::unc-5, the axon of PVM projects dorsally in an unc-
6/netrin-, unc-40/DCC-, and unc-34/enabled-dependent manner. Loss of lon-2/glypican 
partially suppresses this forced dorsal migration, indicating that unc-6/netrin signaling 
depends on lon-2/glypican. Scale bar, 5 μm. Error bars are standard error of the proportion. 
Asterisks denote significant difference: *** P ≤ 0.001 (z-tests, P values were corrected by 
multiplying by the number of comparisons). ns, not significant. (see Table 3.4). Wild type 




signaling. As expected, lon-2 sdn-1 double mutants lacking both lon-2/glypican 
and sdn-1/syndecan and expressing unc-5/UNC5 in PVM did not further 
suppress the abnormal unc-5/UNC-5-mediated dorsal migration of PVM as 
compared to lon-2 single mutants, further supporting the specificity of lon-
2/glypican on unc-6/netrin signaling. 
 
To investigate whether lon-2/glypican functions in the same genetic pathway as 
known downstream mediators of unc-6/netrin signaling, we tested for genetic 
interactions between lon-2/glypican and unc-34/enabled. unc-34/enabled is a 
regulator of actin polymerization for axonal filopodia outgrowth (Chang et al 
2006, Fleming et al 2010, Gertler et al 1995, Gertler et al 1990, Gitai et al 2003, 
Yu et al 2002), and its role in both unc-6/netrin and slt-1/Slit guidance pathways 
renders the analysis of genetic interactions in the context of normal AVM axon 
guidance challenging. Therefore, we used the unc-6/netrin-specific gain-of-
function approach as above, where the dorsal migration of the PVM axon upon 
ectopic expression of unc-5/UNC5 is unc-34/enabled-dependent ((Colavita & 
Culotti 1998, Hamelin et al 1993); Fig. 3.6b). We asked whether loss of lon-
2/glypican could enhance the extent of suppression of PVM dorsal migration 
induced by loss of unc-34/enabled. We found that the PVM dorsal migration was 
suppressed to the same degree in the double null mutants lon-2; unc-34 and the 
single mutant unc-34/enabled upon expression of unc-5/UNC5 in PVM (Pmec-
101 
 
7::unc-5, Fig. 3.6b). These results support that lon-2/glypican functions with unc-
6/netrin and unc-34/enabled during axon guidance. 
 
Epidermal lon-2/glypican functions in axon guidance  
The AVM growth cone extends along a basement membrane, located between 
the epidermis, referred to as hypodermis, and body wall muscles (Hedgecock et 
al 1987). lon-2/glypican is expressed in the hypodermis and the intestine 
(Gumienny et al 2007). We asked in which cell type lon-2/glypican needs to be 
produced to guide AVM. We found that wild-type lon-2(+) transgenes expressed 
under the heterologous epidermal promoters Pdpy-7 and Pelt-3 (that drive 
expression in the hypodermis underlying the AVM growth cone, hyp7), rescued 
lon-2 slt-1 double mutants back to slt-1 single mutant levels, as efficiently as 
when expressed under the endogenous promoter Plon-2 (Fig. 3.7a, Table 3.5). 
Rescue was not observed when we expressed lon-2/glypican in other epidermal 
cells (seam cells, Pgrd-10), in the migrating neuron itself (Pmec-7), in the 
intestine (Pelt-2), or in body wall muscles (Pmyo-3) (Fig. 3.7a, Table 3.5). Our 
results suggest that lon-2/glypican is produced by the hypodermis underlying the 
growth cone of AVM to function in axon guidance.  
 
sdn-1/syndecan functions cell autonomously 
We found that expressing wild-type copies of sdn-1(+) in the AVM neuron (using 











mutants (Fig. 3.7b, Table 3.6).  Accordingly, our examination of a transgene 
reporting sdn-1/syndecan expression (sdn-1::gfp ((Rhiner et al 2005)) revealed 
that sdn-1/syndecan is indeed expressed in the AVM neuron (Fig. 3.8), at the 
time of its ventral migration during the first larval stage. Thus, sdn-1/syndecan 
appears to function in the migrating neuron in the slt-1/Slit-sax-3/Robo guidance 
pathway, whereas lon-2/glypican appears to function non-autonomously, as it is 
produced by the hypodermis underlying the migrating neuron to modulate the 
unc-6/netrin guidance pathway. Consistent with this, we found that sdn-1(+)  
Figure 3.7. lon-2/glypican functions in the epidermal cells underlying the developing 
axon. (a) Epidermal expression of lon-2/glypican is sufficient for function. Providing wild-type 
lon-2(+) in the hypodermis (under the heterologous hypodermal promoters Pdpy-7 and Pelt-3) 
rescues the function of lon-2 in the double mutants lon-2 slt-1, as it brings the defects down to 
the level of slt-1 single mutants. In contrast, expression of lon-2(+) in other epidermal cells 
(seam cells), the migrating neuron AVM, the intestine, or the body wall muscles, fails to 
rescue the function of lon-2. For each rescued transgenic line, transgenic animals were 
compared to non-transgenic sibling controls (see Tables 3.6 and 3.5). Data for wild type, lon-
2, slt-1, and lon-2 slt-1 are the same as in Fig. 3.1b,c. (b) Expression of sdn-1/syndecan in the 
migrating neuron is sufficient for function. Providing wild-type copies of sdn-1(+) in AVM 
(expressed under the heterologous promoter Pmec-7) rescues the axon guidance function of 
sdn-1 in a lon-2 sdn-1 double mutant. We assayed rescue of sdn-1 function using the double 
mutant lon-2 sdn-1 since it is easier to rescue defects that are 33% penetrant (as in the 
double lon-2(e678) sdn-1(zh20)) than to rescue defects that are 12% penetrant (as in the 
single mutant sdn-1(zh20)). For each transgenic line, transgenic animals were compared to 
non-transgenic sibling controls (see Table 3.6). Data for wild type, lon-2, sdn-1, and lon-2 sdn-
1 the same as in Fig. 3.1b-d. Scale bar, 5 μm. Error bars are standard error of the proportion. 
Asterisks denote significant difference: *** P ≤ 0.001, ** P ≤ 0.01 and * P ≤ 0.05 (z-tests, P 






cannot replace the function of lon-2/glypican; expressing sdn-1/syndecan in 
either the cells that normally express lon-2/glypican (using Plon-2::sdn-1) or the 
migrating neuron itself (Pmec-7::sdn-1) did not rescue the loss of lon-2/glypican 
(Fig. 3.9), supporting that lon-2/glypican and sdn-1/syndecan have specific roles 





Figure 3.8. SDN-1::GFP expression in the neuron AVM. Using the translational fusion sdn-
1::gfp (opIs171), we found that SDN-1::GFP is expressed in hypodermal cells and neurons, as 
previously reported (Rhiner et al 2005). Importantly, we observed expression in the AVM 
neuron, including during the L1 stage, when the AVM growth cone migrates ventrally. This 
expression pattern is consistent with our finding that sdn-1/syndecan expression in AVM 
(Pmec-7::sdn-1) rescues the defects of sdn-1 mutants (Fig. 3.7c), supporting a cell-






LON-2/glypican lacking its heparan sulfate chain attachment sites  
functions in axon guidance  
Glypicans are composed of a core protein moiety with covalently linked heparan 
sulfate (HS) chains attached via a tetrasaccharide linker at specific Ser residues  
 
 
Figure 3.9. lon-2/glypican cannot be replaced by sdn-1/syndecan. lon-2 slt-1 double 
mutants exhibit enhanced AVM guidance defects as compared to slt-1 single mutants. The 
defects of the double mutants can be rescued back down to slt-1 single mutant levels with 
expression of wild-type Plon-2::lon-2(+). In contrast, expression of sdn-1(+) where lon-
2/glypican is normally expressed (using the Plon-2 promoter) or in the AVM neuron (using the 
heterologous promoter Pmec-7), cannot rescue the axon guidance defects of lon-2 slt-1 
double mutants. Data for wild type, lon-2, slt-1, lon-2 slt-1, and Plon-2::lon-2 in lon-2 slt-1 are 
as in Fig. 3.1b-c, and Fig. 3.7a. *** P ≤ 0.001, * P ≤ 0.05. (z-tests, P values were corrected by 




(Bülow & Hobert 2006); Fig. 3.10a). Prior studies on the role of HSPGs in other 
developmental pathways indicate that both the identity of the HSPG core proteins 
and the heterogeneity of their HS chains modified by epimerization and sulfations 
(Bülow & Hobert 2006) contribute to the specificity of the interactions between 
particular HSPGs and the proteins that they bind (Bülow & Hobert 2006, Van 
Vactor et al 2006, Xu & Esko 2014).  
 
To address the importance of the HS chains linked to LON-2/glypican during 
axon guidance, we tested whether a mutated form of LON-2/glypican lacking its 
HS chains could still function in axon guidance. For this experiment, the three 
Ser residues serving as HS chain attachment sites were mutated to Ala residues, 
generating the mutant LON-2ΔGAG (Taneja-Bageshwar & Gumienny 2012). 
Western blot analysis confirmed that LON-2ΔGAG severely reduced HS chains 
associated with LON-2, in both worms and S2 cells (Fig. 3.10b and Fig. 3.11). 
We then expressed LON-2ΔGAG under the Plon-2 endogenous promoter, and 
found that the AVM guidance defects of lon-2 slt-1 double mutants were rescued 
back to the level of slt-1 single mutants (Fig. 3.10c). Similarly, the DTC migration 
defects of lon-2/glypican mutants were rescued by LON-2ΔGAG expression (Fig. 
3.10d, Table 3.7). Our results indicate that LON-2/glypican devoid of its HS-
chain attachment sites can function in unc-6/netrin-mediated guidance, 
suggesting that the core protein is the critical part of LON-2/glypican for its 



















Figure 3.10. A secreted form of LON-2/glypican that lacks the heparan sulfate chain 
attachments is functional in axon guidance. (a) The HSPG LON-2/glypican is composed of 
a core protein and three HS chains. The core protein is predicted to fold into a globular 
domain on its N-terminal region and to be GPI-anchored. (b) Schematics of the engineered 
forms of LON-2 that we used: LON-2ΔGAG, where the HS chain attachment sites are 
mutated; LON-2ΔGPI, where the GPI anchor is deleted; N-LON-2, where the C-terminus is 
deleted; and C-LON-2, where the N-terminal globular domain is deleted. Western blot analysis 
of protein extracts of worms expressing LON-2::GFP or LON-2ΔGAG::GFP confirms that 
deleting the HS attachment sites on LON-2 affects HS addition on LON-2. Protein extracts 
from wild type (N2) and an unrelated GFP strain (lqIs4) are negative controls. (c) A form of 
LON-2/glypican lacking HS chain attachment sites (LON-2ΔGAG) functions in axon guidance. 
LON-2ΔGAG rescues the AVM guidance defects of double mutants lon-2 slt-1 back to the 
level of slt-1 single mutants. Secreted globular LON-2/glypican is functional in axon guidance. 
LON-2/glypican was engineered to be secreted by deleting its GPI anchor (LON-2ΔGPI), or by 
deleting the C-terminus, thus lacking the GPI anchor and the HS attachment sites (N-LON-2). 
Both LON-2ΔGPI and N-LON-2 function in axon guidance, as assayed by their ability to 
rescue axon guidance defects of lon-2 slt-1 back down to the level of slt-1 single mutants. In 
contrast, a form of LON-2/glypican containing its C-terminus including the three HS 
attachment sites, but lacking its N-terminal globular domain (C-LON-2), is not functional (see 
Tables 3.6 and 3.5), indicating that the N-terminal globular domain of the core protein is key 
to the function of LON-2/glypican in axon guidance. For each rescued transgenic line, 
transgenic animals were compared to non-transgenic sibling controls (see Tables 3.6 and 
3.5). Data for wild type, lon-2, slt-1, and lon-2 slt-1 are the same as in Fig. 3.1b,c. (d) A form 
of LON-2/glypican lacking HS chain attachment sites is functional in DTC guidance. The DTC 
migration of lon-2 mutants carrying the transgene Plon-2::LON-2ΔGAG is rescued back to 
wild-type levels. Secreted N-terminus globular LON-2/glypican (N-LON-2) is functional in DTC 
guidance, as DTC guidance defects of lon-2 mutants are rescued by N-LON-2. Transgenic 
animals were compared to non-transgenic sibling controls (see Table 3.7). Data for wild type 
and lon-2 the same as in Fig. 3.5b. Error bars are standard error of the proportion. Asterisks 
denote significant difference: *** P ≤ 0.001, ** P ≤ 0.01 (z-tests, P values were corrected by 













LON-2/glypican associates with cells expressing UNC-40/DCC 
Our above observations provide evidence that the HSPG lon-2/glypican functions 
in the same genetic pathway as unc-6/netrin to guide migrating axons. It has 
been shown in several models that HSPGs play multifaceted roles across various 
signaling pathways, such as facilitating ligand-receptor interactions, transporting 
morphogens, as well as localizing and stabilizing ligands (Lander & Selleck 2000, 
Yan & Lin 2009). We asked if the LON-2/glypican molecules might interact with 
either UNC-6/netrin or its receptor UNC-40/DCC, suggesting a potential 
mechanism of action for LON-2/glypican in unc-6/netrin-mediated guidance. To 
test these interactions, we generated epitope-tagged versions of LON-2/glypican, 
UNC-6/netrin, and UNC-40/DCC proteins, with HA, superfolder-GFP (SfGFP), 
and FLAG, respectively (Fig. 3.12a) and used cell-mixing experiments. We  
Figure 3.11. Detection of LON-2 and LON-2ΔGAG in the supernatant and cell extracts of 
S2 cell cultures by western blot analysis. (a) Diagram of LON-2/glypican variants 
expressed in S2 cells, HA::LON-2::myc and HA::LON-2ΔGAG::myc, in which the three HS 
attachment sites were mutated from Ser to Ala residues. The core protein of LON-2/glypican 
is red, and the heparan sulfate chains (HS) are yellow. (b) In the supernatant of cells 
expressing HA::LON-2::myc, high molecular weight species were detected with the anti-myc 
antibody, which likely corresponds to full length HA::LON-2::myc with HS chains attached. In 
contrast, the species detected in the supernatant of HA::LON-2ΔGAG::myc-expressing cells 
are smaller and fainter, indicating that HA::LON-2ΔGAG::myc indeed affects the synthesis of 
HS chains onto the LON-2/glypican core protein. No signal was detected with the anti-HA 
antibody in the supernatants, likely due to technical limitations. In the cell extracts from 
HA::LON-2::myc-expressing cells, the main species runs at ~90 kDa, and it is detected with 
both the anti-myc and anti-HA antibodies, suggesting that it is full length. This signal likely 
corresponds to the LON-2/glypican core protein devoid of HS chains, as it runs as a tight 
band. The slight mobility shift in cell extracts of HA::LON-2ΔGAG::myc-expressing cells 
compared to HA::LON-2::myc might correspond to a difference of mass and isoelectric point 
between HA::LON-2::myc and HA::LON-2ΔGAG::myc. Anti-actin and anti-HSP90 antibodies 











Figure 3.12. LON-2/glypican associates with UNC-40/DCC-expressing cells. 
(a) Experimental design. Each construct was individually and transiently transfected in S2 
cells. After 2 days, cells from independent single transfections were mixed and incubated 
overnight, and then immunostained for the corresponding tags. HA::LON-2-conditioned 
medium was mixed with UNC-40::FLAG expressing cells. (b) HA::LON-2 is released from 
cells that produce it and associates with UNC-40-expressing cells. HA::LON-2 fills the 
cytoplasm of the cells that produce it (indicated by an asterisk, see also Fig. 3.14). Notably, 
HA::LON-2 is observed decorating the outline of UNC-40::FLAG expressing cells 
(experiments 1,6,7,8). HA::LON-2ΔGAG also associates with UNC-40::FLAG expressing cells 
(experiment 2). Cells expressing UNC-40ΔNt::FLAG that lacks the extracellular domain do not 
have HA::LON-2 signal, indicating that the association of LON-2 with UNC-40-expressing cells 
requires the extracellular domain of UNC-40 (experiment 3). HA::LON-2 conditioned medium 
contains HA::LON-2 that associates with UNC-40::FLAG expressing cells, indicating that 
HA::LON-2 is released from the cells that produce into a diffusible form that interacts with 
UNC-40::FLAG cells (experiment 8). HA::LON-2 does not associate with cells expressing 
SfGFP::UNC-6 (experiments 4,6,7), or with untransfected cells. UNC-40-FLAG expressing 
cells can simultaneously associate with HA::LON-2 and SfGFP::UNC-6 (experiment 6). 
HA::LON-2 associates with cells expressing a mutant form of UNC-40/DCC that is unable bind 
SfGFP::UNC-6, as it lacks the Fn4/5 UNC-6 binding domains (UNC-40ΔFn4/5::FLAG; 
experiment 7). Scale bars, 10 μm. (c) Quantification of the association of HA::LON-2 (from 
expressing cells, from medium of expressing cells, or from cells expressing HA::LON-2ΔGAG) 
with cells expressing UNC-40::FLAG, UNC-40ΔNt::FLAG, SfGFP::UNC-6, or UNC-
40ΔFn4/5::FLAG, and untransfected. Ten different optical fields containing ~300 cells from 
three independent experiments were quantified and averaged. (d) Cells expressing UNC-
40::FLAG can display irregular morphology, which is enhanced by the presence of HA::LON-
2. Images of the different morphologies displayed by UNC-40::FLAG-expressing cells: with a 
smooth edge, with an irregular edge, or with membrane extensions. The morphology of S2 
cells expressing mCherry alone or co-expressing UNC-40::FLAG and mCherry, that were 
mixed with control untransfected cells or with HA::LON-2-expressing cells, were quantified for 
irregular edges (grey bars) or membrane extensions (black bars). A higher percentage of 
UNC-40::FLAG expressing cells show membrane extensions or irregular edges when mixed 
with HA::LON-2-expressing cells,  as compared to when they are mixed with control mCherry 
cells.  
Error bars are standard error of the mean. Asterisks denote significant difference: *** P ≤ 
0.001, * P ≤ 0.05. ns, not significant. In (d), significant differences in irregular cell shape are 
indicated by grey asterisks, and significant difference in membrane extensions is indicated by 





independently expressed each of these labeled proteins in separate populations 
of Drosophila S2 cells for 2 days, then co-cultured them overnight, and detected 
the tagged proteins by western blot analysis (see Figure 3.13) and by 
immunostaining (Fig. 3.12a).  
 
We observed that the HA::LON-2 signal filled the cytoplasm of HA::LON-2 
producing cells (indicated by white asterisks in Fig. 3.12b experiment 1 and Fig. 
3.14). Notably, HA::LON-2 was also found decorating the outline of UNC-
40::FLAG expressing cells (Fig. 3.12b,c experiments 1,6,7,8). This observation 
suggests that LON-2/glypican is released from the cells that produce it, diffuses 
in the extracellular medium, and associates with UNC-40/DCC expressing cells. 
In contrast, HA::LON-2/glypican did not bind to cells expressing SfGFP::UNC-6 
(Fig. 3.12b,c experiments 4,6,7), nor to cells expressing an unrelated type I 
transmembrane receptor, Evi (see Fig. 3.15), nor to untransfected cells (Fig. 
3.12b,c experiments 1-8). Furthermore, we found that another HSPG, SDN-
1/syndecan, did not bind UNC-40-expressing cells (see Fig. 3.15). These 
findings provide evidence for a specific interaction between LON-2/glypican and 







Figure 3.13. Detection of LON-2, UNC-40 and UNC-6 expression in S2 cells by Western 
blot analysis. (a) Diagram of constructs used to express these proteins in S2 cells, showing 
the tags used to detect them. (b) Western blots for detection of HA::LON-2::myc, UNC-
40::FLAG and SfGFP::UNC-6. Constructs were individually and transiently transfected in S2 
cells. Two days later, cells from single transfections were mixed and incubated overnight. 
Cells were harvested and combined with their corresponding supernatant from each of these 
cell mixes. Samples of each cell mix were split into 3 to run 3 parallel western blots and detect 
the proteins. As shown in Figure 3.11, a main species (~90 kDa, bottom arrow) and high 
molecular weight species (top arrows) are detected with the anti-myc antibody against 
HA::LON-2::myc. UNC-40::FLAG and SfGFP::UNC-6 run at ~156 kDa and ~99 kDa as 











Figure 3.14. HA::LON-2 is released from cells 
(co-transfected with GFP) and associates with 
cells expressing UNC-40::FLAG. In order to 
distinguish HA::LON-2-producing cells from 
HA::LON-2-acquiring cells, two separate 
populations of cells were transfected. One 
population of S2 cells was transfected with UNC-
40::FLAG. A second population of S2 cells was 
simultaneously transfected with both GFP and 
HA::LON-2. Two days later, the two populations of 
cells were mixed, incubated overnight, and 
immunostained with anti-HA and anti-FLAG 
antibodies, as described for Fig. 3.12. In GFP 
expressing cells (indicated by white asterisks), 
which had also been transfected with HA::LON-2, 
the HA::LON-2 signal was observed filling the 
cytoplasm. HA::LON-2 was also observed 
decorating the outline of UNC-40-expressing cells 
(indicated by white triangles, see Fig. 3.12), 
supporting that LON-2/glypican associates with 
UNC-40-expressing cells. Occasionally, HA::LON-
2 was observed on cells in which no UNC-
40::FLAG was detected (indicated by the empty 




We tested whether the HS chains of LON-2/glypican were necessary for its 
association with UNC-40-expressing cells. We used a mutated form of LON-
2/glypican lacking its three HS chain attachment sites, HA::LON-2ΔGAG (Taneja-
Bageshwar & Gumienny 2012), see Fig. 3.11). Western blot analysis confirmed 
that LON-2ΔGAG severely reduced HS chains associated with LON-2/glypican 
(Fig. 3.11). We found that LON-2ΔGAG associated with UNC-40/DCC-
expressing cells (Fig. 3.12b,c experiment 2), suggesting that the association of 
LON-2/glypican with UNC-40/DCC-expressing cells is HS-chains independent. 
 
The HA::LON-2 signal outlined the UNC-40/DCC expressing cells (Fig. 3.12b, 
experiments 1,6,7,8) suggesting a potential interaction at the cell surface. To 
further support this idea, we asked whether LON-2/glypican would associate with 
cells expressing a mutated form of UNC-40/DCC that lacks the extracellular 
domain, and contains only the intracellular and transmembrane domains (UNC-
40ΔNt::FLAG). We found that HA::LON-2 did not associate with cells expressing 
the UNC-40ΔNt::FLAG (Fig. 3.12b,c experiment 3), indicating that the 







as would be predicted if LON-2/glypican and UNC-40/DCC interact, directly or 
indirectly, at the cell surface. 
 
Interestingly, HA::LON-2 was absent from cells expressing SfGFP::UNC-6 (Fig. 
3.12b,c experiments 4,6,7), indicating that while LON-2/glypican interacts with 
cells expressing UNC-40/DCC, it does not bind to UNC-6/netrin-expressing cells 
in this assay. Moreover, the presence of SfGFP::UNC-6 did not reduce the ability 
of HA::LON-2 to associate with UNC-40/DCC-expressing cells in experiments 
where the three singly-transfected cell populations were mixed (Fig. 3.12b,c 
experiment 6). These results suggest that if LON-2/glypican interacted directly or 
indirectly with UNC-40/DCC, then the interactions of LON-2/glypican and UNC-
6/netrin would occur with different regions of UNC-40/DCC. Consistent with this 
Figure 3.15. Controls for the specificity of the association of LON-2/glypican with UNC-
40-expressing cells. (a) Experiments 1 and 2 show that HA::LON-2 does not associate with 
cells expressing the unrelated Drosophila type I transmembrane receptor Evi. Evi-expressing 
cells were mixed with cells expressing LON-2/glypican and/or UNC-40/DCC. As shown in 
experiment 2 and Fig. 3.12b,c, while LON-2/glypican associates with cells expressing UNC-
40/DCC, LON-2/glypican does not associate with cells expressing Evi::GFP (experiments 1,2). 
Experiment 3 shows that SDN-1::myc/syndecan, another heparan sulfate proteoglycan, does 
not associate with UNC-40/DCC expressing cells. This SDN-1::myc was engineered to be 
secreted as it lacks its transmembrane and intracellular C-terminal domains. These results 
indicate that the association of LON-2/glypican with UNC-40/DCC expressing cells is specific, 
and not a general feature of any HSPG. (b) Quantification of the association of HA::LON-2 
with cells expressing UNC-40::FLAG, Evi::GFP, and untransfected cells. Ten different optical 
fields containing ~300 cells from three independent experiments were quantified and 
averaged. Error bars are standard error of the mean. Asterisks denote significant difference: 
*** P ≤ 0.001 (t-test versus untransfected cells). ns, not significant. (c) Quantification of the 
association of SDN-1::myc with cells expressing UNC-40::FLAG, HA::LON-2, and 
untransfected cells. Ten different optical fields containing ~300 cells from three independent 




possibility, we found that LON-2/glypican still associated with cells expressing 
UNC-40ΔFn4/5::FLAG, a mutated form of UNC-40/DCC that lacks the UNC-
6/netrin-binding sites (FnIII domains 4 and 5) ((Wang et al 2014, Xu et al 2014); 
Fig. 3.12b,c experiment 7). Our results indicate that for LON-2/glypican to 
associate with UNC-40/DCC-expressing cells, the FnIII domains 4 and 5 of UNC-
40/DCC are dispensable and UNC-6/netrin does not need to be bound to UNC-
40/DCC. 
 
LON-2/glypican increases membrane outgrowths triggered by UNC-40/DCC 
Previous work has suggested that overexpression of DCC in cells overactivates 
DCC downstream signaling pathways, leading to cytoskeletal rearrangements 
that result in increased membrane extensions and cell surface area (Shekarabi & 
Kennedy 2002). Similarly, expression of UNC-40/DCC leads to changes in 
cellular morphology in our cell assays (Fig. 3.12d). To test whether the 
association of LON-2/glypican with UNC-40/DCC-expressing cells results in an 
activation of signaling downstream of UNC-40/DCC, we examined the impact of 
LON-2/glypican on the morphology of UNC-40/DCC-expressing cells. For these 
experiments, we mixed mCherry expressing cells with either untransfected 
control cells or LON-2/glypican-expressing cells, and we also mixed UNC-
40/mCherry-expressing cells with either untransfected control cells or LON-
2/glypican-expressing cells. Examination of the morphology of these cells one 
day after mixing revealed that UNC-40/mCherry-expressing cells mixed with 
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LON-2/glypican exhibited an increased frequency of irregular shapes and 
membrane extensions, compared to UNC-40/mCherry cells mixed with control 
cells (Fig. 3.12d). Thus, consistent with a model in which LON-2/glypican 
functions in the UNC-6/netrin signaling pathway to guide developing axons, the 
association of LON-2/glypican with UNC-40/DCC-expressing cells leads to 
increased membrane extensions, suggestive of increased signaling downstream 
of the UNC-40/DCC receptor. 
 
LON-2/glypican is released extracellularly and its N-terminal domain is 
functional 
While LON-2/glypican possesses a signature GPI anchor that mediates its 
attachment to plasma membranes (Fig. 3.10a), our experiments indicate that 
LON-2/glypican is released into the extracellular milieu through cleavage where it 
can diffuse to associate with UNC-40/DCC-expressing cells. This is consistent 
with prior work demonstrating that many glypicans are shed or cleaved into a 
soluble form (Bernfield et al 1999). To verify that LON-2/glypican is indeed 
released into the extracellular medium, we collected cell-free media from 
HA::LON-2 cultures (HA::LON-2-conditioned medium) and added it to cells 
expressing UNC-40::FLAG. We found that HA::LON-2-conditioned medium 
contained HA::LON-2 that associated with UNC-40::FLAG-expressing cells. As 
above, this interaction was specific, as no HA::LON-2 signal was found on 
adjacent untransfected cells (Fig. 3.12b,c experiment 8). This result provides 
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compelling evidence that LON-2/glypican can be released from the membrane of 
LON-2/glypican-expressing cells, diffuses, and associates with UNC-40/DCC-
expressing cells. We propose that using a similar mechanism, LON-2/glypican 
may be shed from epidermal cells and may interact with migrating axons that 
express UNC-40/DCC. This is consistent with our finding that LON-2/glypican is 
produced by the hypodermis to function non-autonomously in unc-6/netrin-
mediated AVM axon guidance. 
 
To provide evidence for the model that LON-2/glypican can function in axon 
guidance when detached from the plasma membrane, we used a form of LON-
2/glypican lacking the GPI anchor, LON-2ΔGPI, which should be directly 
secreted into the extracellular milieu (Taneja-Bageshwar & Gumienny 2012). 
LON-2ΔGPI rescued the AVM guidance defects of lon-2 slt-1 double mutants 
back to the level of slt-1 single mutants (Fig. 3.10c). We also used a truncated 
form of LON-2/glypican (N-LON-2) containing the N-terminal globular domain, but 
lacking the C-terminal region, thus removing the three HS attachment sites and 
the GPI membrane anchor. N-LON-2 also rescued the AVM guidance defects of 
lon-2 slt-1 double mutants back to the level of slt-1 single mutants (Fig. 3.10c). In 
contrast, a reciprocal construct containing only the C-terminus with the three HS 
attachment sites and the GPI anchor (C-LON-2) did not rescue the AVM axon 
guidance defects of lon-2 slt-1, consistent with the model that the N-terminal 
globular domain of LON-2/glypican is the key functional domain during guidance 
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(Fig. 3.10c). A secreted form of LON-2/glypican is also functional in DTC 
guidance, as we found that DTC guidance defects of lon-2/glypican mutants 
could be rescued by expression of N-LON-2, containing only the N-terminal 
globular domain (Fig. 3.10d). These findings also support the hypothesis that 
LON-2/glypican may normally be released from the hypodermis to interact with 







Growth cone responses to guidance cues require precise regulation as 
developing axons traverse complex extracellular environments in order to reach 
their targets. The mechanisms by which guidance cue signals are regulated in 
the extracellular milieu are still poorly understood (Lai Wing Sun et al 2011). 
Here, we demonstrate that the unc-6/netrin-unc-40/DCC guidance system is 
modulated by the HSPG lon-2/glypican. 
 
lon-2/glypican is a component of the unc-6/netrin signaling pathways 
Our studies identify the HSPG LON-2/glypican as a component of the unc-
6/netrin attractive and repulsive signaling pathways that guide axons during 
development. We show that LON-2/glypican specifically acts on unc-6/netrin 
signaling independently of slt-1/Slit. We demonstrate that lon-2/glypican functions 
from the hypodermis, the epidermal cells that secrete the substrate along which 
growth cones extend (Hedgecock et al 1987), and that a secreted form of LON-
2/glypican, containing only its N-terminal globular region and lacking its HS 
chains, guides cells and axons in vivo. In addition, we provide evidence that 
Figure 3.16. A model for the role of LON-2/glypican in UNC-6/netrin-UNC-40/DCC-
mediated axon guidance. HSPG LON-2/glypican (red) is expressed from the hyp7 epidermal 
cells (pink) underlying the migrating growth cone of the AVM neuron (tan). LON-2/glypican is 
released from the hypodermal cell surface and may associate with the developing axon 
expressing the receptor UNC-40/DCC (blue), directly or indirectly interacting with UNC-
40/DCC, to modulate UNC-6/netrin (green) signaling. A second HSPG, SDN-1/syndecan 




LON-2/glypican is released from cells producing it and associates with cells 
expressing UNC-40/DCC receptors. Taken together, our observations support a 
hypothetical model where GPI-linked LON-2/glypican is produced by substrate 
epidermal cells, is released into the extracellular milieu, and binds growth cones 
expressing UNC-40/DCC receptors to regulate attractive and repulsive 
responses of the growth cone to UNC-6/netrin. 
 
The impact of lon-2/glypican on the unc-6/netrin signaling pathway is highly 
specific. First, loss of lon-2/glypican, but not of sdn-1/syndecan, suppresses the 
guidance phenotypes elicited by the gain-of-function condition in which unc-
5/UNC5 was misexpressed. Second, the complete loss of lon-2/glypican does 
not enhance the guidance defects observed in null mutants for unc-6/netrin or its 
receptors unc-40/DCC and unc-5/UNC5, whereas it does enhance the defects of 
several other axon guidance mutants, including sdn-1/syndecan, slt-1/Slit, 
misexpressed slt-1/Slit (Pmyo-3::slt-1), sax-3/Robo, and sqv-5, suggesting that 
lon-2/glypican functions specifically in the unc-6/netrin pathway. Third, sdn-
1/syndecan, cannot replace lon-2/glypican function, highlighting a requirement for 
lon-2/glypican that cannot be achieved by any HSPG. Given that the core protein 
of LON-2/glypican, devoid of its HS chains, is fully functional in guidance, the 
specificity of action of LON-2/glypican in netrin-mediated guidance appears to 
reside in the core protein itself. As a note, whereas lon-2/glypican mutants are 
defective in DTC migration, the lon-2/glypican mutant by itself does not show 
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drastic alterations in AVM axon guidance as is observed with other modulators 
(Lander & Selleck 2000). It is possible that in the absence of lon-2/glypican, 
another HSPG may provide compensation, or that our scoring of strong 
alterations in pathfinding did not include more subtle phenotypes, as could be 
expected from a modulator of the signal (Lander & Selleck 2000).  
 
The core protein of LON-2/glypican is functional in UNC-6/netrin-mediated 
guidance 
We show that the LON-2/glypican core protein, devoid of HS attachment sites, is 
able to associate with UNC-40-expressing cells and is functional in unc-6/netrin-
mediated guidance. Thus, the core protein is the critical region of LON-2/glypican 
for netrin-mediated axon guidance. This is in line with previous studies showing a 
contextual dependence of HS chains for glypican function. For instance, the core 
protein of C. elegans LON-2/glypican and of Drosophila glypican Dally do not 
require HS chains to function in the TGFβ pathway (Kirkpatrick et al 2006, 
Taneja-Bageshwar & Gumienny 2012). Similarly, Drosophila glypican Dally-like 
interacts with Wg and Hh through their protein core in a HS-independent manner 
(Williams et al 2010, Yan & Lin 2009, Yan et al 2010), and mammalian Glypican-
3 does not require HS chains for its role in Wnt and Hh signaling (Capurro et al 
2005, Capurro et al 2008, Gonzalez et al 1998, Song et al 2005). While the HS 
chains are not critical for the role of LON-2/glypican in guidance, a contribution of 
HS chains to modulate functionality, as observed for other glypicans in the 
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context of BMP4, Wnt3, Wg, and Hh signaling (Capurro et al 2005, Kirkpatrick et 
al 2006, Yan & Lin 2009, Yan et al 2010) cannot be ruled out. For instance, it is 
conceivable that the normal endogenous HS chains of LON-2/glypican may 
impact its trafficking, levels, release from the membrane, recruitment of binding 
partners, or recycling. 
 
LON-2/glypican is released from the cell surface to guide axons 
LON-2/glypican is predicted to localize at the cell surface via its GPI anchor 
(Taneja-Bageshwar & Gumienny 2012). However, in our cell culture studies we 
demonstrate that LON-2/glypican can be released as a soluble molecule from 
producing cells. We also show that two truncated forms of LON-2/glypican, LON-
2ΔGPI and N-LON-2, which are no longer associated with the plasma membrane 
and are secreted into the extracellular milieu, can function to guide axons in vivo. 
This indicates that LON-2/glypican is likely released from the epidermal cells to 
reach the growth cone to modulate its guidance. This finding raises the question 
of how LON-2/glypican is released from the cell membrane and how this process 
might be regulated during development. The release of LON-2/glypican from the 
surface of cells could involve phospholipases that cleave the GPI anchor and/or 
proteases that cleave its extracellular domain, such as at a predicted furin-





Glypican cleavage by lipases and proteases has been demonstrated to occur 
and to be functionally important in other contexts, such as in regulating FGF and 
Wnt signaling during morphogenesis (Bernfield et al 1999, Matsuo & Kimura-
Yoshida 2013). For instance, the Drosophila glypican Dally-like protein is cleaved 
at the GPI anchor by the lipase Notum, to negatively regulate Wnts (Giraldez et 
al 2002). Similarly, several mammalian glypicans, including glypican-3, are 
cleaved by Notum (Traister et al 2008). The functional importance of glypican 
proteolytic cleavage is illustrated by the processing of glypican-3 by a furin-like 
convertase to modulate Wnt signaling in zebrafish (De Cat et al 2003). In 
addition, glypican-1 and glypican-4 are proteolytically cleaved to stimulate long-
range FGF signaling in the Xenopus embryo (Hou et al 2007), and increase the 
efficiency of myogenic differentiation in the presence of FGF in mammalian cells 
(Velleman et al 2013), respectively. Our studies show that glypican processing 
also functions during axon guidance. 
 
LON-2/glypican associates with the surface of UNC-40/DCC-expressing 
cells  
We demonstrate that LON-2/glypican is secreted into the extracellular medium 
and decorates the outline of UNC-40/DCC-expressing cells. Deleting the 
extracellular domain of UNC-40 (UNC-40ΔNt) abrogated the association of LON-
2/glypican with UNC-40/DCC expressing cells, indicating that LON-2/glypican 
may interact with UNC-40/DCC at the cell surface. The association of LON-
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2/glypican with UNC-40/DCC may be direct, or indirect through interactions with 
other molecules (Fig. 3.16). Our experiments demonstrate that UNC-6/netrin 
binding to UNC-40/DCC was undisturbed by the association of UNC-40/DCC 
with LON-2/glypican, suggesting that the possible interaction of LON-2/glypican 
with UNC-40/DCC likely involves a region of UNC-40/DCC other than the netrin 
binding sites. Indeed, we found that LON-2/glypican associates with UNC-
40/DCC-expressing cells even when the UNC-40/DCC receptors lack the UNC-
6/netrin binding domains. 
 
We found that LON-2/glypican leads to increased irregular morphology of UNC-
40/DCC-expressing cells. Ectopic expression of DCC in mammalian cells 
activates downstream signaling via Cdc42 and Rac1, producing cytoskeletal 
rearrangements that lead to filopodia outgrowth and cell surface extensions 
(Shekarabi & Kennedy 2002). Our finding that the presence of LON-2/glypican 
enhances the UNC-40/DCC-induced irregular cell morphology and filopodia-like 
extensions, suggests that the association of LON-2/glypican with UNC-40/DCC-
expressing cells may increase signaling downstream of UNC-40/DCC. 
Consistent with this notion, we show that lon-2/glypican functions in the same 
signaling pathway as the UNC-40/DCC downstream mediator unc-34/enabled 




Our results suggest a possible regulatory mechanism in the extracellular space in 
which secreted LON-2/glypican modulates the activity of the receptor UNC-
40/DCC. LON-2/glypican may directly bind UNC-40/DCC, or alternatively, LON-
2/glypican may instead interact with other molecules to impact UNC-40/DCC to 
modulate its stability, distribution, or activity. Alternatively, LON-2/glypican could 
potentially function as a co-receptor for UNC-6/netrin, where it may facilitate the 
formation of UNC-6/netrin-UNC-40/DCC-LON-2/glypican signaling complexes, 
similar to the situation in FGF signaling (Bülow & Hobert 2006). It is also 
conceivable that LON-2/glypican could bind UNC-6/netrin directly as well, even if 
undetected in our assays, as netrin has been found to bind heparin in vitro 
(Kappler et al 2000, Kennedy et al 1994, Shipp & Hsieh-Wilson 2007). Previous 
studies have also documented the binding of DCC to heparin in vitro (Bennett et 
al 1997, Geisbrecht et al 2003), and while we have found that the core protein is 
the critical portion of LON-2/glypican in netrin-mediated axon guidance, it 
remains possible that the endogenous HS chains contribute to the function of 
LON-2/glypican in axon guidance.  
 
In summary, our studies uncover a novel mechanism by which UNC-6/netrin 
signaling through its UNC-40/DCC receptor is modulated by the HSPG LON-
2/glypican during axon pathfinding. Given the evolutionary conservation of the 
UNC-6/netrin pathway components (UNC-6/netrin and its receptors UNC-
40/DCC and UNC-5/UNC5), and of glypicans (LON-2 is most similar to 
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mammalian glypican-3), and that synthesis of HS chains is required for 
mammalian axons to respond to netrin-1 in vitro (Matsumoto et al 2007, Ogata-
Iwao et al 2011), glypicans are likely to play a role in netrin-mediated axon 
pathfinding in mammals as well. Our findings provide a general mechanism for 
the extracellular regulation of growth cone responses to netrin during the 
development of nervous systems. 
 
MATERIALS AND METHODS 
 
Nematode strains and genetics 
Nematode cultures were maintained at 20oC on NGM plates seeded with OP50 
bacteria as described (Brenner 1974). Strains were constructed using standard 
genetic procedures and are all listed in Table 3.8. Genotypes were confirmed by 
genotyping PCR or by sequencing when needed, using primers listed in Table 
3.9.  
 
S2 cell culture, transfection, mixing, and immunostaining 
S2 cells were maintained in SFX Insect Media (HyClone) containing 10% Fetal 
Bovine Serum (HyClone) and Penicillin-Streptomycin (50 units-50 μg/mL) 
(Sigma). 70-90% confluent S2 cells were transfected with 500 ng of each 
construct using Effectene® (Qiagen) according to manufacturer’s protocol. 48 hr 
after transfection, old culture media was removed and new media was added to 
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resuspend the cells. Equal volumes of resuspended cells that had been 
transfected with individual constructs were plated onto coverslips and co-cultured 
overnight. Cells were then fixed with 4% paraformaldehyde and immunostained 
with rabbit anti-HA (Life Technologies #715500) and mouse anti-FLAG (Sigma 
#F3165) primary antibodies, and Alexa594 donkey anti-rabbit (Life Technologies 
#R37119) and Alexa647 goat anti-mouse (Life Technologies #A21235) 
secondary antibodies. Confocal analysis was performed on a Zeiss LSM 5 
Pascal confocal microscope. Confocal images were processed using ImageJ. 
Each experiment was repeated at least three times.  
     For the experiment in which we use HA::LON-2-conditioned medium 
(supernatant) of cells expressing HA::LON-2, the culture media was also 
changed 48 hr after transfection, fresh media was added, and the cells were 
incubated for another 48 hr. This media was collected and centrifuged at 1500 
rpm to remove cells and debris. This supernatant was added onto cells 
expressing UNC-40::FLAG, incubated overnight, and as above, fixed, stained, 
and imaged. 
 
RT-PCR for gpn-1 alleles 
Total RNA was extracted from worm samples using Trizol (Invitrogen) according 
to manufacturer’s instructions. 500 ng RNA was used to reverse transcribe using 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and 
random primers. PCR reactions were carried out with 1st strand cDNA template 
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and primers oCB834 (ATCAAGACCGAGTGATAGTG) and oCB1321 
(TGGCGAGTATTCCCGTTTAG) were used for gpn-1 cDNA amplification, and 
primers oCB992 (TCGCTTCAAATCAGTTCAGC) and oCB993 
(GCGAGCATTGAACAGTGAAG) were used for the control gene Y45F10D.4 
(Hoogewijs et al 2008) cDNA amplification. 
 
Neuroanatomical and distal tip cell observations 
Animals were mounted on agarose pads, anaesthetized with 100 mM sodium 
azide, and examined under a Zeiss Axio Scope.A1 or a Zeiss Axioskop 2 Plus. 
AVM and PVM axon guidance analysis. Axons of neurons AVM and PVM were 
examined in L4 larvae and adult animals using zdIs5, an integrated Pmec-4::gfp 
reporter (Clark & Chiu 2003). Animals with the cell body of AVM posterior to the 
vulva (cell migration defect) were excluded from axon guidance analysis.  
AVM analysis: Worms were counted as mutant for AVM ventral axon guidance if: 
a) AVM failed to send an axon ventrally and instead projected laterally to the 
anterior; or b) the AVM axon projected laterally, in the anterior or the posterior 
direction, for at least ~15 μm (>3 AVM cell body lengths) before projecting to the 
ventral side. The angle between the anterior/posterior axon projection and the 
ventral axon projection had to be >45° to be counted as mutant therefore 
excluding animals with a slight curve in the ventral axon of AVM from the mutant 
count. Values reported in Table 3.6.  
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PVM analysis criteria: Worms were counted as having their PVM axon 
misoriented dorsally if the axon of PVM was projecting to the dorsal side of the 
animal. The vulva was used as a reference for the ventral side. Worms whose 
zdIs5 labeled neurons were too misplaced to be identified were excluded from 
analysis. 
Distal tip cell guidance analysis: The path of migration of the distal tip cells (DTC) 
brings about the shape of the mature gonad arms (Fig. 3.5a, (Hedgecock et al, 
1987)). In the wild type, the DTC migrates away from the vulva location along the 
antero-posterior axis of the animal. The DTC then turns dorsally to reach the 
dorsal side of the animal, where it then migrates towards the vulva along the 
antero-posterior axis of the animal. To infer the path of DTC migration, gonad 
arms were examined in late L4 and young adult animals using DIC microscopy. 
Animals were counted as having abnormal gonad arm shapes when a) the distal 
arm of the gonad was located ventrally instead of dorsally, indicating a failure of 
the DTC to migrate dorsally; b) the proximal gonad arm was too short, resulting 
from a premature turn of the DTC towards the dorsal side; or c) the gonad arm 
was twisted over itself. 
GABAergic motorneuron axon analysis: Commissures of the GABAergic 
motorneurons were analyzed in L4 larvae and adults using ufIs34, an integrated 
Punc-47::mCherry reporter (Petrash et al 2013). For each animal, all GABAergic 
commissures (except DD1 and VD2) were counted and categorized as either 
reaching the dorsal cord, or failing to reach the dorsal cord. The fraction of 
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commissures failing to reach the dorsal cord among all the commissures 
extending from the ventral cord was determined for each animal, averaged for 
the genotype, and expressed as percentage.  
 
C. elegans constructs and microinjections to generate transgenic animals 
All inserts of finalized clones were verified by sequencing.  
 Plon-2::lon-2 (PCR product): Primers oCB1070 
(CATGATAAGCTTTTCAAATTGGCGGTTAACTG) and oCB1124 
(ATCATGGGGCCCTAAGCTGAATTCCCATAAC) were used to amplify a PCR 
product out of N2 genomic DNA containing bases 13,104 of cosmid C39E6 to 
26,408 of cosmid F55D10 of the lon-2 locus.  
 Pdpy-7::lon-2 (pCB268): Vector Pdpy-7 was cut with XmaI and ApaI and 
ligated with insert of lon-2 cDNA digested out of pCB251 (Pmec-7::lon-2) with 
XmaI and ApaI. 
 Pelt-3::lon-2 (pCB304): Vector Pdpy-7::lon-2 (pCB268) was digested with 
HindIII and XmaI to release Pdpy-7 and ligated with insert of Pelt-3 2-kb 
promoter (coordinates on cosmid K02B9: 16,117 to 18,081) amplified out of N2 
genomic DNA (modeled after (Maduzia et al., 2002)) using primers oCB1063 
(CATGATAAGCTTTGTGACACGTTGTTTCACG) and oCB1064 




 Pgrd-10::lon-2 (pCB266): Vector Pgrd-10::GFP (in pPD95.75 backbone) 
was digested with KpnI and EcoRI to release GFP and ligated with insert of lon-2 
cDNA (yk1346g07) amplified with primers oCB1034 
(CATGATGGTACCATGGTCTTCCGGTGGCTCATTC) and oCB1035 
(ATCATGGAATTCTCAAAAAAGTTTAATAACTGC) to add on KpnI and EcoRI 
sites. 
 Pmec-7::lon-2 (pCB251): Vector pPD96.41 was digested with XmaI and 
NheI and ligated with insert of lon-2 cDNA (yk1346g07) amplified by primers 
oCB963 (CATGATCCCGGGATGGTCTTCCGGTGGCTCATTC) and oCB964 
(ATCATGGCTAGCTCAAAAAAGTTTAATAACTGC) to add on XmaI and NheI 
sites. 
 Pelt-2::lon-2 (pCB218): Vector Pdpy-7::lon-2 (pCB268) was digested with 
HindIII and XmaI to release Pdpy-7 and ligated with insert of Pelt-2 1-kb 
promoter (coordinates on cosmid C33D3: 2933 - 3875) amplified out of N2 
genomic DNA (modeled after (Maduzia et al 2002)) using primers oCB1059 
(CATGATAAGCTTTTGATTTTGTTTCACTCTGTG) and oCB1060 
(ATCATGCCCGGGTATAATCTATTTTCTAGTTTC) to add on HindIII and XmaI 
sites. 
 Pmyo-3::lon-2 (pCB332): Vector pCB268 (Pdpy-7::lon-2) was digested 
with HindIII and XbaI to release Pdpy-7, and was ligated with insert of Pmyo-3 
digested out of vector pPD95.86 with HindIII and XbaI.  
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 Plon-2::lon-2 (pCB246): Vector Pdpy-7::lon-2 (pCB268) was digested 
with HindIII and XmaI to release Pdpy-7 and ligated with insert of lon-2 3-kb 
promoter (coordinates on cosmid C39E6: 13,104 - 10,105) amplified out of N2 
genomic DNA (modeled after (Gumienny et al 2007)) using primers oCB1070 
(CATGATAAGCTTTTCAAATTGGCGGTTAACTG) and oCB1069 
(ATCATGCCCGGGTCTGAAATTTTGAATATGTAAGC) to add on HindIII and 
XmaI sites. 
 Plon-2::LON-2ΔGPI (pCB269): Vector pCB246 (Plon-2::lon-2) was 
digested with XmaI and EcoRI to release the lon-2 cDNA and ligated with insert 
of lon-2 cDNA (yk1346g07) amplified with primers oCB963 
(CATGATCCCGGGATGGTCTTCCGGTGGCTCATTC) and oCB1074 
(ATCATGCTCGAGTCAATCCGGCTGAATTTCTTTTTCC) to add on XmaI and 
EcoRI sites and generate a truncated form of LON-2 after amino acid 488 to 
remove the GPI anchor (modeled after (Taneja-Bageshwar & Gumienny 2012)). 
 Plon-2::N-LON-2 (pCB270): Vector pCB268 (Pdpy-7::lon-2) was digested 
with XmaI and EcoRI to release the lon-2 cDNA and was ligated with insert of 
lon-2 cDNA (yk1346g07) amplified by primers oCB963 
(CATGATCCCGGGATGGTCTTCCGGTGGCTCATTC) and oCB1075 
(ATCATGGAATTCTCACCTTCCGAGTCGGTCCCACG), to add on XmaI and 
EcoRI sites and generate a truncated form of LON-2 after amino acid 368, ie, 
containing amino acids 1-368 (modeled after (Gumienny et al 2007)). 
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 Plon-2::C-LON-2 (pCB311): Vector pCB246 (Plon-2::lon-2) was digested 
with XmaI and NheI to release lon-2 cDNA and was ligated with insert of lon-2 
cDNA amplified by primers oCB964 
(ATCATGGCTAGCTCAAAAAAGTTTAATAACTGC) and 1) oCB1253 
(TCCGTCCTACCTGCAGAAGAAGTGAAAATCTGTGATCACTCG) 2) oCB1254 
(ATTCTTTTTGTATTGCTCTACCGGTCCGTCCTACCTGCAGAAG) and 3) 
oCB1255 
(CATGATCCCGGGATGGTCTTCCGGTGGCTCATTCTTTTTGTATTGCTCTACC
) to add on XmaI and NheI sites, to add on the 22 amino acid lon-2 signal peptide 
sequence, and to truncate LON-2 to begin at amino acid 369. Thus, this 
construct codes for 22 amino acid residues of the signal peptide of LON-2, 
followed by residues 369 – 508. 
 Pmec-7::sdn-1 (pCB242): Vector pPD96.41 was digested with XmaI and 
XhoI, and ligated with insert of sdn-1 cDNA (yk139f3) amplified with primers 
oCB903 (CATGATCCCGGGATGATTCTGAAACTCAATTTC) and oCB904 
(ATCATGCTCGAGTTACGCGTAAAATTCTTTTG) to add on XmaI and XhoI 
sites. 
 Plon-2::sdn-1 (pCB312): Vector pCB246 (Plon-2::lon-2) was digested 
with XmaI and EcoRI to release lon-2, and was ligated with an insert of sdn-1 




Transgenic animals were generated by standard microinjection techniques (Mello 
& Fire 1995). Each construct or PCR amplicon was injected at 1, 5, 10, or 25 
ng/μL with one or two coinjection markers which included pRF4 (125-150 ng/µL), 
Pttx-3::mCherry (50 ng/µL), Pceh-22::gfp (50-75 ng/µL), and/or Punc-122::rfp 
(50-75 ng/µL). pBSK+ (90-100 ng/µL) used to increase total DNA concentration if 
needed. For details on specific coinjection marker(s) used for each rescued 
transgenic line, see Table 3.8.  
 
Western blot analysis of LON-2::GFP and LON-2ΔGAG::GFP expressed in 
worms 
Mixed-stage wild-type (N2), GFP control (lqIs4), LON-2::GFP (TLG257), and 
LON-2ΔGAG::GFP (TLG199) worms were collected in buffer and protease 
inhibitors (Roche). Worm pellets were subjected to repeated freeze-thaw cycles. 
Protein concentration was measured using the Pierce 660 nm Protein Assay on a 
Nanodrop. 70 µg of samples mixed with 2x Laemmli sample buffer (Bio-Rad) 
were boiled, separated by SDS-PAGE on a 4-20% Mini-Protean TGX gel (Bio-
Rad), and transferred to PVDF membrane. Membranes were incubated in 1:3000 
anti-GFP primary antibody (Millipore #AB3080) and 1:9000 goat anti-rabbit HRP 
secondary antibody (Bio-Rad #166-2408EDU). For the loading control, 
membranes were incubated in 1:5000 anti-HSP90 antibody (CST #4874) and 
1:10000 goat anti-rabbit HRP secondary antibody (Bio-Rad #166-2408EDU). 
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Signal was revealed using Clarity Western ECL Substrate (Bio-Rad), and imaged 
using film (LabScientific). 
 
Constructs to express variants of LON-2, UNC-40, UNC-6, SDN-1 and Evi in 
S2 cells 
All inserts of finalized clones were verified by sequencing. 
 HA::LON-2 (pCB285): The C. elegans lon-2 full length cDNA (yk1346g07) 
was amplified by PCR with primers adding the EcoRI and ApaI restriction 
enzyme sites and cloned into pBlueScript II (Life Technologies). HA::LON-2 was 
made by synthesizing a DNA fragment, carrying the restriction sites EcoRI and 
HincII, and containing the 5’ end of the lon-2 cDNA with the HA tag added after 
the signal peptide sequence (at cDNA position 61) and cloned into 
pBlueScript/lon-2. The HA::LON-2 EcoRI/ApaI fragment was then cloned into the 
pActin5.1/V5-His vector (Life Technologies).  
 HA::LON-2::myc (pCB313): The HA::LON-2::myc construct was made by 
synthesizing the 3’ end of the lon-2 cDNA (bases 739-1527) with the myc tag 
DNA sequence before the GPI anchor domain sequence (at cDNA position 1375) 
and an ApaI restriction site at the 3’ end. The PmlI/ApaI synthesized fragment 
was then cloned into the pActin5.1/HA::LON-2 (pCB285) construct cut with the 
same restriction enzymes. 
 HA::LON-2ΔGAG (pCB295): The LON-2ΔGAG construct was made by 
replacing the XhoI/BsmI fragment (bases 803-1340 of the lon-2 cDNA) in the 
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pBlueScript/HA::lon-2 plasmid with synthesized fragment where the lon-2 
sequence is mutated at the three predicted heparan sulfate chain attachment 
sites (S374A, S442A and S444A) modeled after (Taneja-Bageshwar & Gumienny 
2012). Similar to the wild type version of lon-2, the HA::LON-2ΔGAG EcoRI/ApaI 
fragment was then cloned into the pActin5.1/V5-His vector (Life Technologies). 
 HA::LON-2ΔGAG::myc (pCB330): The double tagged HA::LON-
2ΔGAG::myc construct was made by replacing the BsmI/ApaI fragment (bases 
1340-1527 of the lon-2 cDNA) in the pBlueScript/HA::LON-2ΔGAG plasmid with 
a synthesized fragment containing the myc tag DNA sequence before the GPI 
anchor domain sequence (at cDNA position 1375) and an ApaI restriction site at 
the 3’ end. The HA::LON-2ΔGAG::myc EcoRI/ApaI fragment was then cloned 
into the pActin5.1/V5-His vector (Life Technologies). 
 SfGFP::UNC-6 (pCB292): The C. elegans unc-6 full length cDNA 
(yk603d12) was amplified by PCR with primers adding the EcoRI and ApaI 
restriction enzyme sites and cloned into pBlueScript II. The superfolder-
GFP::UNC-6 construct was made by synthesizing a DNA fragment, carrying the 
restriction sites EcoRI and HincII, and containing the 5’ end of the unc-6 cDNA 
with the superfolder-GFP sequence after the signal peptide sequence (cDNA 
position 70) and cloned into pBlueScript/unc-6. The superfolder-GFP::UNC-6 
EcoRI/ApaI fragment was then cloned into the pActin5.1/V5-His vector. 
 UNC-40::FLAG (pCB301): The C. elegans full length unc-40 cDNA 
(yk449d8) was amplified by two sequential PCR reactions that added the XhoI 
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and ApaI restriction enzyme sites, as well as the FLAG tag at the 3’ end before 
the stop codon (adding the FLAG tag at the C-terminus of UNC-40 after the 
intracellular domain). This UNC-40::FLAG cDNA was then cloned into the 
pActin5.1/V5-His vector. 
 UNC-40ΔNt::FLAG (pCB310): The unc-40 intracellular fragment (cDNA 
bases 3022-4245 that include the coding sequence for the transmembrane and 
intracellular domains of UNC-40), along with the FLAG tag, was amplified by 
PCR using the UNC-40::FLAG cDNA as template and primers carrying the EcoRI 
and ApaI sites. A start codon (ATG) was added to the forward primer. The UNC-
40ΔNt::FLAG fragment was then cloned into the pActin5.1/V5-His vector. 
 UNC-40ΔFn4/5::FLAG (pCB334): The UNC-40ΔFn4/5 construct was 
made by PCR amplifying a 2-kb DNA fragment from genomic DNA from the 
strain NK821 qyIs155 containing a deletion of fibronectin III domains 4 and 5 of 
the unc-40 cDNA using nested primers ((Wang et al., 2014)). The nested PCR 
added the FLAG tag to the 3’ end of the UNC-40ΔFn4/5 cDNA fragment. This 
final fragment was cloned into the pActin5.1/unc-40 vector using DraIII and ApaI 
restriction enzymes, thus generating an unc-40 full length cDNA with a deletion 
of the fibronectin III domains 4 and 5. 
 SDN-1::myc (pCB336): The C. elegans sdn-1 cDNA, excluding the 
coding region for the transmembrane and intracellular C-terminal tail (cDNA 
bases 1-678), was amplified by two sequential PCR reactions adding the EcoRI 
and ApaI restriction sites and the myc tag sequence at the 3’ end before the stop 
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codon. The sdn-1::myc EcoRI/ApaI fragment was then cloned into the 
pActin5.1/V5-His vector (Life Technologies). 
 The pAc/Evi::EGFP (Bartscherer et al., 2006) and pAc/GFP constructs 
were a gift from V. Budnik (University of Massachusetts Medical School). 
 
Western blot analysis of HA::LON-2::myc and HA::LON-2ΔGAG::myc 
expressed in S2 cells 
S2 cells were transfected with HA::LON-2::myc (pCB313) and HA::LON-
2ΔGAG::myc (pCB330) constructs. Cells were washed once with 1X Phosphate 
Buffered Saline and lysed for 30 min at 4°C in 1X Phosphate Buffered Saline, 
0.5% Triton X-100 and 1X Protease Inhibitor Cocktail (Roche). Samples of 
supernatant and cell lysates were each mixed with 2X Laemmli sample buffer 
(BioRad). Proteins were separated by SDS-PAGE and transferred to PVDF 
membrane. Membranes were incubated with rabbit anti-HA (Life Technologies 
#715500) and rabbit anti-myc (Santa Cruz #sc-789) primary antibodies and HRP-
linked goat anti-rabbit (Bio-Rad #166-2408EDU) secondary antibody. Signals 
were revealed by chemiluminescence with Clarity™ Western ECL Substrate 
(BioRad) and imaged using the ChemiDocTM System (BioRad). 
 
Western blot analysis of HA::LON-2::myc, UNC-40::FLAG and SfGFP::UNC-
6 expressed in S2 cells 
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S2 cells were independently transfected with HA::LON-2::myc (pCB313), UNC-
40::FLAG (pCB301) or SfGFP::UNC-6 (pCB292) constructs. 48 hr after 
transfection, old culture media was removed and new media was added to 
resuspend the cells. Equal volumes of resuspended cells that had been 
transfected with individual constructs were mixed and co-cultured overnight. 
Cells were harvested, centrifuged, and combined with their corresponding 
supernatant from each of these cell mixes. 100 μL of supernatant of each mixture 
was saved and kept on ice. Cell pellets were washed once with 1X Phosphate 
Buffered Saline and lysed for 30 min at 4°C in 100 μL of ice-cold RIPA buffer (50 
mM Tris HCl pH 7.5, 150 mM NaCl, 1% Triton-X100, 0.5% sodium deoxycholate, 
0.1% SDS, 1mM EDTA pH 8.0) supplemented with Protease Inhibitor Cocktail 
(Roche) and PMSF. Cell lysates were combined with their corresponding 
supernatant and mixed with 2X Laemmli sample buffer (BioRad). Each sample 
was split into 3 to run 3 protein gels in parallel. Proteins were separated by SDS-
PAGE and transferred to PVDF membrane. Membranes were incubated with 
rabbit anti-myc (Santa Cruz #sc-789), mouse anti-FLAG (Sigma #F3165) and 
rabbit anti-GFP (Millipore AB3080) primary antibodies as well as HRP-linked goat 
anti-rabbit (Bio-Rad #166-2408EDU) and HRP-linked horse anti-mouse (Vector 
Labs PI-2000) secondary antibodies. Signals were revealed by 
chemiluminescence with Clarity™ Western ECL Substrate (BioRad) and imaged 




Analysis of the shape of UNC-40-expressing cells 
Independent populations of S2 cells were transfected with (1) 450 ng of 
pActin5.1::mCherry alone, (2) 50 ng of the UNC-40::FLAG construct plus 450 ng 
of the co-transfection marker pActin5.1::mCherry, or (3) 500 ng of HA::LON-2. 
The media was changed and cells were mixed 48 hr after transfection. Control 
mCherry expressing cells were mixed with untransfected cells, or with HA::LON-2 
expressing cells. Similarly, UNC-40::FLAG/mCherry expressing cells were mixed 
with untransfected cells or with HA::LON-2 expressing cells. To maintain the total 
number of cells constant in our different mixes, one volume of UNC-
40::FLAG/mCherry cells was mixed with either (a) one volume of 
control/untransfected cells, or (b) one volume of LON-2-transfected cells. Cell 
mixes were co-cultured overnight. Cells were then fixed with 4% 
paraformaldehyde and examined under a Zeiss LSM 5 Pascal confocal 
microscope. Control mCherry expressing cells or UNC-40::FLAG/mCherry 
expressing cells were identified by the co-transfection marker mCherry. 20 fields 
of ~300 cells each per mix per were photographed for each of 3 independent 
experiments. Cells were categorized as having the typical S2 cell round and 
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Gene Allele Nature of allele Reference 
unc-52 e444 Early stop in exon 18. Partial loss of 
function. 
(Rogalski et al 1995) 
agr-1 tm2051 423 bp deletion, deleting exons 26 and 27 
resulting in an in frame loss of 42 amino 
acids. 
(Hrus et al 2007) 
gpn-1 ok377 1194 bp deletion, deletes most of exon 3, 
and introduces early Stop codons. Likely 
null. (see Figure S2) 
(Hudson et al 2006) 
This study 
gpn-1 tm595 1411 bp deletion, deletes part of exon 2, 
exon 3, and introduces early Stop 
codons. Likely null. (see Figure S2) 
(Hudson et al 2006) 
This study 
lon-2 e678 ~9 kb deletion. Null. (Gumienny et al 2007) 
sdn-1 zh20 1258 bp deletion. Null. (Rhiner et al 2005) 
sdn-1 ok449 483 bp in-frame deletion. Produces 
truncated SDN-1. 
(Minniti et al 2004) 
unc-6 ev400 Early stop Q78*. Null. (Wadsworth et al 1996) 
unc-6 e78 C410Y. Partial loss of function. (Lim & Wadsworth 
2002) 
unc-40 e271 Early stop R824*. Null. (Stavoe et al 2012) 
unc-40 e1430 Early stop R157*. Likely null. (Colon-Ramos et al 
2007) 
slt-1 eh15 Duplication of locus and deletions. First 
copy contains a 1900 bp deletion. Both 
copies have a 100 bp deletion. First copy 
produces no mRNA while second copy 
produces mRNA with a frameshift. 
(Hao et al 2001) 
sax-3 ky123 Deletion of signal peptide and first exon. (Zallen et al 1998) 
unc-34 e566 A likely null mutation. (Bloom 1993) (Fleming 
et al 2010) 
sqv-5 k172 G663E. Partial loss of function. (Suzuki et al 2006) 
147 
 
Table 3.2. Distal tip cell guidance defects in strains examined. 
Genotype N % Defective distal 
tip cell guidance 
s.e.p. 
ufIs34; vsIs48 140 4 1.7 
lon-2(e678); ufIs34 251 17 2.4 
unc-6(ev400); zdIs5 172 62 3.7 
lon-2(e678) unc-6(ev400); zdIs5 160 65 3.8 
unc-40(e271); ufIs34; vsIs48 122 25 3.9 
lon-2(e678); unc-40(e271); ufIs34 136 22 3.6 
unc-5(e53); vsIs48; ufIs34 134 46 4.3 
lon-2(e678); unc-5(e53); ufIs34 138 49 4.3 
 
Table 3.3. Motorneuron axon dorsal guidance defects in strains examined. 
Genotype N % GABA 
commissures failing 
to reach dorsal cord 
s.e.p. 
ufIs34; vsIs48 104 0.1 0.3 
lon-2(e678); ufIs34 86 0.2 0.5 
unc-40(e271); ufIs34; vsIs48 73 55 5.8 
















Table 3.4. PVM dorsal guidance defects quantified in wild-type and mutant 
strains with or without misexpression of unc-5 in the PVM neuron using 
transgene evIs25 Pmec-7::unc-5.  
 




zdIs5 52 0 0.0 
unc-6(ev400); zdIs5 44 0 0.0 
unc-40(e271) zdIs5 30 0 0.0 
unc-34(e566); zdIs5 73 0 0.0 
lon-2(e678) unc-6(ev400); zdIs5 65 0 0.0 
slt-1(eh15); zdIs5 60 0 0.0 
sax-3(ky123); zdIs5 41 0 0.0 
lon-2(e678); zdIs5 54 0 0.0 
sdn-1(zh20); zdIs5 58 0 0.0 
lon-2(e678) sdn-1(zh20); zdIs5 44 0 0.0 
Strains with evIs25 Pmec-7::unc-5 
evIs25; zdIs5 228 66 3.1 
unc-6(ev400) evIs25; zdIs5 41 0 0.0 
unc-40(e271) zdIs5; evIs25 191 18 2.8 
unc-34(e566); evIs25; zdIs5 159 13 2.7 
unc-6(ev400) lon-2(e678) evIs25; 
zdIs5 
62 0 0.0 
unc-40(e271) zdIs5; lon-2(e678) 
evIs25 
249 25 2.7 
slt-1(eh15) evIs25; zdIs5 212 63 3.3 
unc-34(e566); lon-2(e678) evIs25; 
zdIs5 
207 8 1.9 
sax-3(ky123) evIs25; zdIs5 201 66 3.3 
lon-2(e678) evIs25; zdIs5 330 48 2.8 
sdn-1(zh20) evIs25; zdIs5 259 64 3.0 
lon-2(e678) sdn-1(zh20) evIs25; 
zdIs5 
343 42 2.7 
N, number of AVM axons examined. s.e.p., standard error of the proportion. 
^  PVM axons normally never extend dorsally, not even in the complete absence of the slt-1/slit 
and the unc-6/netrin guidance pathways in unc-6 slt-1 double null mutants, where axons defective 
in guidance extend anteriorly. Dorsal axon extension is only observed with unc-5/UNC5 ectopic 
expression, which overpowers the endogenous signaling mechanism within PVM and thus forces 
its axon to extend dorsally. This highlights the power of this ectopic-unc-5-expression system to 
uncover molecules specifically involved in unc-6/netrin signaling through the unc-5/UNC5 




Table 3.5. Transgenic rescue of lon-2 function in AVM guidance.  
We assayed rescue of the AVM guidance defects in lon-2 slt-1 double mutants 
back to slt-1 single mutant levels. Underlined indicates “rescued”. Non-transgenic 
sibling controls of rescued transgenic lines were examined to ascertain that the 
rescue was transgene-dependent. 
 
Genotype Transgene  Transgenic  Non-transgenic controls 
   N % 
Mut. 
















































































































55 62 6.5  n.d.  
lon-2 slt-1; Pelt-2::lon- line 49 67 6.7  n.d.  
150 
 
















































































































































39 69 7.4  n.d.  






Table 3.6. AVM ventral guidance defects in strains examined, including 
transgenic lines to rescue sdn-1. 
 
Genotype  N % Defective s.e.p. 
zdIs5  391   0 0.0 
HSPG mutants 
lon-2(e678); zdIs5  238 2 0.9 
sdn-1(zh20); zdIs5  506 12 1.4 
sdn-1(ok449); zdIs5  205 13 2.3 
gpn-1(ok377); zdIs5  58 0 0.0 
gpn-1(tm595); zdIs5  129 0 0.0 
unc-52(e444); zdIs5  190 2 1.0 
agr-1(tm2051); zdIs5  107 1 1.0 
lon-2(e678) gpn-1(ok377); zdIs5  110 1 0.9 
lon-2(e678) gpn-1(tm595); zdIs5  181 2 1.0 
sdn-1(zh20) gpn-1(ok377); zdIs5  222 13 2.3 
sdn-1(zh20) gpn-1(tm595); zdIs5  197 16 2.6 
lon-2(e678) sdn-1(zh20); zdIs5  283 33 2.8 
lon-2(e678) sdn-1(ok449); zdIs5  264 25 2.7 
unc-52(e444); sdn-1(zh20); zdIs5  131 12 2.8 
unc-52(e444) agr-1(tm2051); zdIs5  97 1 1.0 
lon-2(e678) gpn-1(ok377) sdn-1(zh20); zdIs5  218 41 3.3 
lon-2(e678) gpn-1(tm595) sdn-1(zh20); zdIs5  271 29 2.8 
Strains with unc-6 and unc-40 
unc-6(ev400); zdIs5  199 43 3.5 
unc-6(e78); zdIs5  199 32 3.3 
unc-40(e1430) zdIs5  237 15 2.3 
unc-40(e271) zdIs5  190 18 2.8 
unc-40(e271) zdIs5; unc-6(ev400)  290 36 2.8 
lon-2(e678) unc-6(ev400); zdIs5  205 45 3.5 
lon-2(e678) unc-6(e78); zdIs5  262 28 2.8 
unc-40(e271) zdIs5; lon-2(e678)  246 18 2.4 
unc-40(e1430) zdIs5; lon-2(e678)  205 18 2.7 
unc-40(e271) zdIs5; sdn-1(zh20)  94 84 3.8 
unc-6(ev400) slt-1(eh15); zdIs5  188 91 2.1 
Strains with slt-1 and sax-3 
slt-1(eh15); zdIs5  465 50 2.3 
sax-3(ky123); zdIs5  380 44 2.5 
sax-3(ky123) slt-1(eh15); zdIs5  220 51 3.4 
lon-2(e678) slt-1(eh15); zdIs5  233 67 3.1 
sax-3(ky123) lon-2(e678); zdIs5  493 53 2.2 
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sdn-1(zh20) slt-1(eh15); zdIs5  378 41 2.5 
sax-3(ky123) sdn-1(zh20); zdIs5  137 45 4.3 
kyIs209; zdIs5  835 19 1.4 
lon-2(e678) kyIs209; zdIs5  783 25 1.5 
Strains with sqv-5     
sqv-5(k172)  235 9 1.9 
lon-2(e678); sqv-5(k172)  189 23 3.1 
Transgenic strains used to rescue sdn-1 function in AVM guidance in lon-2 sdn-1; 
zdIs5^ 
 Transgene    
lon-2(e678) sdn-
1(zh20); zdIs5; qvEx114 
Pmec-7::sdn-1(+) line #1 129 14 3.1 
lon-2(e678) sdn-
1(zh20); zdIs5; qvEx115 
Pmec-7::sdn-1(+) line #2 136 15 3.1 
lon-2(e678) sdn-
1(zh20); zdIs5; qvEx100 
Pmec-7::sdn-1(+) line #3 99 14 3.5 
N, number of AVM axons examined. s.e.p., standard error of the proportion. 
^ We assayed rescue of sdn-1 function using the double mutants lon-2 sdn-1 since it is easier to 
rescue defects that are 33% penetrant (as in the double lon-2(e678) sdn-1(zh20)) than to rescue 









Genotype Transgene Transgenic  Non-transgenic sibling 
controls 
  N % 
Defective 

























124 5 2.0 126 16 3.3 
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Table 3.8. List of strains used. 
 
Strain  Genotype Transgene Reference 
Inserted transgenes 
N2   (Brenner 1974) 
MT4005 zdIs5 I Pmec-4::gfp; lin-15(+) (Clark & Chiu 2003)  
VQ412 kyIs209 X derived from 
CX5374 
Pmyo-3::slt-1 (Yu et al 2002) 
NW767 evIs25 X Pmec-7::unc-5; Pmec-
7::lac-Z 
(Hamelin et al 1993)  
WS3404 opIs171 Psdn-1::sdn-1::gfp; lin-
15(+) 
(Rhiner et al 2005) 
LE311 lqIs4 Pceh-10::gfp (Tsalik et al 2003) 
  VQ84 vsIs48 X; ufIs34 derived 
from LX949 and IZ829 
Punc-17::gfp; Punc-
47::mCherry 
(Chase et al 2004) 
(Petrash et al 2013) 
HSPG mutants 
VQ398 lon-2(e678) X; zdIs5 I  This study 
VQ423 sdn-1(zh20) X; zdIs5 I  This study 
VQ584 sdn-1(ok449) X; zdIs5 I  This study 
VQ400 gpn-1(ok377) X; zdIs5 I  This study 
VQ728 gpn-1(tm595) X; zdIs5 I  This study 
VQ411 unc-52(e444) II; zdIs5 I  This study 
VQ419 agr-1(tm2051) II; zdIs5 I  This study 
VQ458 lon-2(e678) gpn-1(ok377) 
X; zdIs5 I 
 This study 
VQ730 lon-2(e678) gpn-1(tm595) 
X; zdIs5 I 
 This study 
VQ460 sdn-1(zh20) gpn-1(ok377) 
X; zdIs5 I 
 This study 
VQ737 sdn-1(zh20) gpn-1(tm595) 
X; zdIs5 I 
 This study 
VQ461 lon-2(e678) sdn-1(zh20) 
X; zdIs5 I 
 This study 
VQ587 lon-2(e678) sdn-1(ok449) 
X; zdIs5 I 
 This study 
VQ474 unc-52(e444) II; sdn-
1(zh20) X; zdIs5 I 
 This study 
VQ483 unc-52(e444) agr-
1(tm2051) II; zdIs5 I 
 This study 
VQ486 lon-2(e678) gpn-1(ok377) 
sdn-1(zh20) X; zdIs5 I 
 This study 
VQ740 lon-2(e678) gpn-1(tm595) 
sdn-1(zh20) X; zdIs5 I 
 This study 
VQ693 lon-2(e678) X; ufIs34  This study 
Strains with unc-6, unc-40, unc-34, and unc-5 
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VQ396 unc-6(ev400) X; zdIs5 I  This study 
VQ395 unc-6(e78) X; zdIs5 I  This study 
VQ470 unc-40(e271) zdIs5 I  This study 
VQ565 unc-40(e1430) zdIs5 I  This study 
VQ529 unc-40(e271) zdIs5 I; unc-
6(ev400) X 
 This study 
VQ469 lon-2(e678) unc-6(ev400) 
X; zdIs5 I 
 This study 
VQ567 lon-2(e678) unc-6(e78) X; 
zdIs5 I 
 This study 
VQ522 unc-40(e271) zdIs5 I; lon-
2(e678) X 
 This study 
VQ581 unc-40(e1430) zdIs5 I; 
lon-2(e678) X 
 This study 
VQ738 unc-40(e271) zdIs5 I; sdn-
1(zh20) X 
 This study 
VQ481 unc-6(ev400) slt-1(eh15) 
X; zdIs5 I 
 This study 
VQ686 unc-40(e271) I; vsIs48 X; 
ufIs34 
 This study 
VQ727 unc-40(e271) I; lon-
2(e678) X; ufIs34 
 This study 
VQ722 unc-34(e566) V; zdIs5 I  This study 
VQ724 unc-5(e53) IV; vsIs48 X; 
ufIs34 
 This study 
VQ723 unc-5(e53) IV; lon-2(e678) 
X; ufIs34 
 This study 
Strains with slt-1 and sax-3 
VQ401 slt-1(eh15) X; zdIs5 I  This study 
VQ473 sax-3(ky123) X; zdIs5 I  This study 
VQ578 sax-3(ky123) slt-1(eh15) 
X; zdIs5 I 
 This study 
VQ482 lon-2(e678) slt-1(eh15) X; 
zdIs5 I 
 This study 
VQ501 sax-3(ky123) lon-2(e678) 
X; zdIs5 I 
 This study 
VQ432 sdn-1(zh20) slt-1(eh15) X; 
zdIs5 I 
 This study 
VQ526 sax-3(ky123) sdn-1(zh20) 
X; zdIs5 I 
 This study 
VQ427 kyIs209 X; zdIs5 I  This study 
VQ582 lon-2(e678) kyIs209 X; 
zdIs5 I 
 This study 
Strains with evIs25 
VQ536 evIs25 X; zdIs5 I  This study 
VQ538 unc-6(ev400) evIs25 X; 
zdIs5 I 
 This study 
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VQ540 unc-40(e271) zdIs5 I; 
evIs25 X 
 This study 
VQ555 unc-6(ev400) lon-2(e678) 
evIs25 X; zdIs5 I 
 This study 
VQ645 unc-40(e271) zdIs5 I; lon-
2(e678) evIs25 X 
 This study 
VQ556 slt-1(eh15) evIs25 X; 
zdIs5 I 
 This study 
VQ557 sax-3(ky123) evIs25 X; 
zdIs5 I 
 This study 
VQ541 lon-2(e678) evIs25 X; 
zdIs5 I 
 This study 
VQ572 sdn-1(zh20) evIs25 X; 
zdIs5 I 
 This study 
VQ772 unc-34(e566) V; evIs25 X; 
zdIs5 I 
 This study 
VQ773 unc-34(e566) V; evIs25 
lon-2(e678) X; zdIs5 I 
 This study 
VQ542 lon-2(e678) sdn-1(zh20) 
evIs25 X; zdIs5 I 
 This study 
Strains with sqv-5 
VQ523 sqv-5(k172) zdIs5 I  This study 
VQ530 lon-2(e678) X; sqv-
5(k172) zdIs5 I 
 This study 
Transgenic Lines 






TLG257 lon-2(e678) X; 
texEx164 
Plasmid HW483 (Plon-2::lon-
2::gfp), Pttx-3::mCherry. Line 
#2 
This study 




3::mCherry. Line #1 
This study 




Punc122::rfp. Line #1 
This study 
VQ596 lon-2(e678) slt-
1(eh15) X; zdIs5 I; 
qvEx107 
PCR product of bases 13,104 
of cosmid C39E6 to 26,408 of 
F55D10, Pceh-22::gfp, Punc-
122::rfp. Line #1 
This study 
VQ612 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ597 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ615 lon-2(e678) slt-








VQ623 lon-2(e678) slt-1(eh15) 
X; zdIs5 I; qvEx116 
pCB218 (Pelt-3::lon-2), Pceh-
22::gfp, Punc-122::rfp, 
pBSK+. Line #2 
This study 
VQ614 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ624 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ625 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ746 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ747 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ748 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ749 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ750 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ751 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ752 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ753 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ754 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ755 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ756 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ757 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ621 lon-2(e678) sdn-
1(zh20) X; zdIs5 I; 
qvEx114 
pCB242 (Pmec-7::sdn-1), 
pRF4, Pttx-3::mCherry. Line 
#1 
This study 
VQ622 lon-2(e678) sdn- pCB242 (Pmec-7::sdn-1), This study 
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1(zh20) X; zdIs5 I; 
qvEx115 
pRF4, Pttx-3::mCherry. Line 
#2 
VQ507 lon-2(e678) sdn-
1(zh20); zdIs5 I; 
qvEx100 
pCB242 (Pmec-7::sdn-1), 








pBSK+. Line #1 
This study 
VQ782 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ783 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ784 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ785 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ786 lon-2(e678) slt-




pBSK+. Line #3 
This study 
VQ646 lon-2(e678) slt-




























122::rfp, pBSK+. Line #1 
This study 
VQ761 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ762 lon-2(e678) slt-




pBSK+. Line #2 
This study 
VQ763 lon-2(e678) slt-
1(eh15) X; zdIs5 I; 
qvEx174 
pCB270 (Plon-2::N-LON-2),  
Pceh-22::gfp, Punc-122::rfp, 
pBSK+. Line #3 
This study 
VQ766 lon-2(e678) slt-




pBSK+. Line #1 
This study 
VQ767 lon-2(e678) slt-






qvEx177 pBSK+. Line #2 
VQ768 lon-2(e678) slt-




pBSK+. Line #3 
This study 
Note: Plasmid pSBL3SG006 (Plon-2::lon-2(ΔGAG)) is from (Taneja-Bageshwar & Gumienny 







Table 3.9. List of primers used for building strains. 
 
Gene Primer Sequence PCR product 
(bp) 
 
sdn-1(zh20)     
Mutant oCB837 aaagagatgccggtcaggtg 410  
 oCB842 aatggacgggatgagtgtcc   
Wild-type oCB837 aaagagatgccggtcaggtg 293  
 oCB876 cttcagattcgagcctgctttgc   
sdn-1(ok449)     
Mutant oCB1114 ttctgcctgtcgacttactc 297  
 oCB1125 aagattgcggtaaaacacatc   
Wild-type oCB1114 ttctgcctgtcgacttactc 478  
 oCB1115 ttcgtcgtcggttgggtagc   
gpn-1(ok377)      
Mutant oCB834 atcaagaccgagtgatagtg 501  
 oCB843 aatcatcagcatcgggaggg   
Wild-type oCB834 atcaagaccgagtgatagtg 412  
 oCB832 ttttttgagggatatcatcg   
gpn-1(tm595)      
Mutant oCB1309 agtcgattgcaaacgaatacg 468  
 oCB1310 tcacacagtacgcttggcacg   
Wild-type  oCB1309 agtcgattgcaaacgaatacg 393  
 oCB1311 aagctttccatgcatactcgc   
agr-1(tm2051)     
Mutant  oCB891 cgaaaaatcgagagcaaaagg 362  
 oCB893 tcagattcttgacacatccc   
Wild-type  oCB890 tttgaactcttggacgaacc 1210  
 oCB891 cgaaaaatcgagagcaaaagg   
 slt-1(eh15)     
Mutant  oCB919 tatgacgtgttccggaaacc 467  
 oCB920 atttctctaatacgggtagc   
Wild-type  oCB922 tctcaattctaacatccatgtc 339  
 oCB920 atttctctaatacgggtagc   
kyIs209: Detection of insertion Pmyo-3::slt-1   
 oCB945 tcattcgggatattttgtgg 592  
 oCB950 aagaagaagcatgcttctgg   
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sax-3(ky123)     
Mutant  oCB1038 agaatgtggctctctagtcc ~330  
 oCB1039 tcgtttccgcgcattcagtc   
Wild-type  oCB1038 agaatgtggctctctagtcc 527  
 oCB1042 agcttcggattactgcttgc   
evIs25: Detection of insertion Pmec-7::unc-5 
 oCB933 ttgtcagtcgagcctcaagg ~631  
 oCB966 tccactgtctgataatctgg   
unc-40(e271) sequencing 
 oCB1077 aattcgtgtaactgcttcc 577  
 oCB1076 ttgaatatttcggaggttgc   
unc-40(e1430) sequencing 
 oCB1079 atcaatgcgctgtacatgtg 366  




















LON-1, a conserved CAP superfamily protein and TGF-β pathway target, 
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After embryonic development of the nervous system, neuronal architecture 
needs to be maintained in the face of further growth, maturation, and the physical 
stress of body movements. sax-7/L1CAM is a key neuronal maintenance 
molecule that functions to maintain neuronal architecture after its initial 
establishment. Through a forward genetic screen using C. elegans, we have 
identified lon-1 as a novel suppressor of the sax-7/L1CAM mutant defects in the 
maintenance of nervous system architecture. Although lon-1 has been 
characterized as a downstream target of the TGF-β pathway to regulate body 
length, our results indicate that the lon-1-mediated suppression of sax-7 mutant 
defects is independent of both body length and the TGF-β signaling pathway. We 
find that an interaction with sax-7/L1CAM is not a general feature of other CAP 
superfamily molecules, highlighting its specificity of action. We found that to 
function with sax-7 in maintaining head ganglia organization, lon-1 acts in 
neurons and the hypodermis. Using a heat shock-inducible expression system as 
well as temporally controlled RNAi knockdown, we found that both lon-1 and sax-
7 function post-embryonically to maintain the architecture of the nervous system. 
We show that lon-1-mediated suppression of sax-7 defects is context dependent, 
as loss of lon-1 does not lead to the suppression all of sax-7 defects. Our 
findings reveal a novel interaction between lon-1 and sax-7, and provide insight 





A critical but poorly understood aspect of neurobiology is how the integrity and 
function of an embryonically-established nervous system is protected throughout 
life, despite post-embryonic body growth, movement, and the incorporation of 
new neurons into existing neural circuits (Benard & Hobert 2009). Dedicated 
mechanisms must be in place to actively protect the nervous system in spite of 
these stresses. Research in C. elegans has identified a handful of molecules that 
function to maintain specific structures of the nervous system after their initial 
establishment, such as the precise positioning of axons within fascicles, the 
organization of neuronal soma and axons within ganglia, and the distribution and 
density of synapses. (Aurelio et al 2002, Barsi-Rhyne et al 2013, Benard et al 
2009, Benard et al 2006, Bülow et al 2004, Cherra & Jin 2016, Hammarlund et al 
2007, Johnson & Kramer 2012, Pocock et al 2008, Sasakura et al 2005, Shao et 
al 2013, Wang et al 2005, Woo et al 2008, Zallen et al 1999).    
 
One of these molecules, SAX-7, is the conserved C. elegans homologue of the 
L1 cell adhesion molecule (L1CAM) family, and functions in neurons to maintain 
the position of neuronal soma and axons (Chen et al 2001, Pocock et al 2008, 
Sasakura et al 2005, Wang et al 2005, Zallen et al 1999). SAX-7/L1CAM is a 
transmembrane protein of the immunoglobulin superfamily with roles as a cell 
adhesion molecule (Chen et al 2001, Pocock et al 2008, Sasakura et al 2005, 
Wang et al 2005). Both long (SAX-7L) and short (SAX-7S) isoforms of SAX-7 are 
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expressed in C. elegans. SAX-7L contains six extracellular Ig-like domains while 
SAX-7S contains four, and both contain five extracellular fibronectin type III 
domains, a transmembrane domain, and a cytoplasmic tail containing FERM, 
ankyrin, and PDZ binding motifs (Chen et al 2001, Pocock et al 2008, Sasakura 
et al 2005, Wang et al 2005, Zhou et al 2008); Fig. 4.1). Despite their normal 
initial development, a subset of embryonically developed axons of the ventral 
nerve cord become defasciculated during the first larval stage in sax-7 mutant 
animals, and specific neuronal soma and axons within ganglia become 
progressively disorganized in later larval and adult stages of sax-7 mutant 
animals (Pocock et al 2008, Sasakura et al 2005, Wang et al 2005, Zallen et al 
1999).  
 
In vertebrates, L1CAM carries out developmental roles in migration and 
fasciculation, and in humans, mutations in L1CAM lead to neurodevelopmental 
disorders (reviewed in (Hortsch et al 2014)). Moreover, mammalian L1 family 
members L1CAM, CHL1, NrCAM, and Neurofascin (Hortsch 2000) play roles in 
the adult vertebrate brain, as conditional knockouts in the adult nervous system 
lead to changes in synaptic transmission, alterations to the axon initial segment, 
and behavioral deficits (Amor et al 2014, Kolata et al 2008, Kriebel et al 2011, 
Law et al 2003, Zonta et al 2011). These results highlight that both C. elegans 
SAX-7 and vertebrate L1 family members have continued importance in the adult 
nervous system to actively promote its integrity and functionality.  
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Despite the identification of molecules that function to maintain the architecture of 
the nervous system, our mechanistic understanding of how these molecules 
carry out these functions remains limited. To elucidate the molecular 
mechanisms by which SAX-7 functions to maintain the nervous system, and 
identify conserved neuronal protection molecules, we have carried out a forward 
genetic screen for suppressors of the sax-7 defective maintenance of head 
ganglia organization. Through this screen, we have identified lon-1 as a potent 
suppressor of the sax-7 defect in the maintenance of the relative positioning 
between the ASH/ASI soma and the nerve ring. We show that lon-1-mediated 
suppression of sax-7 defects is both independent of the TGF-β signaling pathway 
and also separate from body length. We find that lon-1, rather than being a 
general suppressor of sax-7 defects, acts in a context-dependent manner, as 
sax-7 defects in ventral cord maintenance and in dendritic arbor development are 
not altered by loss of lon-1. We demonstrate that lon-1 functions in the nervous 
system and hypodermis to maintain nervous system architecture, and provide 
evidence that both lon-1 and sax-7 function post-embryonically to maintain head 
ganglia organization. Our results point to a novel, post-embryonic interaction 
between sax-7 and lon-1, which highlights a newly uncovered role for lon-1 







Identification of qv24, a new allele of sax-7/L1CAM 
While studying two members of the ZIG family of two-Ig domain proteins and 
their role in the maintenance of neuronal architecture (Benard et al 2012), we 
uncovered a novel and spontaneous sax-7 background mutation in one of our 
strains, which we named sax-7(qv24). Following PCR amplification and Sanger 
sequencing of all sax-7 exons and splice sites we identified that sax-7(qv24) is a 
G to A mutation that changes the splice donor site at intron four of the short 
isoform and at intron seven of the long isoform of sax-7, potentially affecting both 
the long and short isoforms of sax-7 (Fig. 4.1A). sax-7(qv24) does not appear to 
be a null allele, as our RT-PCR analysis reveals that sax-7 transcripts are 
present in sax-7(qv24) (Fig. 4.1B). Similarly, sax-7(nj48) is a strong loss-of-
function deletion mutant that affects both the long and short isoforms of sax-7 
(Sasakura et al 2005), but sax-7 transcripts are detected in our RT-PCR analysis 
(Fig. 4.1A,B). These results, along with previous work, indicate that no null 
mutant of sax-7 currently exists (Wang et al 2005, Zhou et al 2008) (Fig. 4.1B), 
and those available are instead, strong loss-of-function alleles.  
 
Prior work has shown that sax-7 mutants exhibit a post-developmental failure to 
maintain the organization of neuronal structures including head ganglia and 
axonal fascicles (Pocock et al 2008, Sasakura et al 2005, Wang et al 2005, 





mutants using the integrated oyIs14 (Psra-6::gfp) transgene (Sarafi-Reinach et al 
2001) which labels the ASH, ASI, and PVQ neurons and compared it to the 
phenotype of sax-7(nj48) mutants. We analyzed the maintenance of the relative 
positioning between the ASH/ASI soma and the nerve ring in wild type, sax-
7(nj48), and sax-7(qv24) animals across the first through fourth larval stages and 
Figure 4.1. sax-7(nj48) and sax-7(qv24) are not null alleles. 
A. Diagram of the sax-7 locus depicting the gene structure of both the short (C18F3.2a) 
and long (C18F3.2b) sax-7 isoforms. Exons (black boxes), introns (black lines), and UTRs 
(gray boxes) are to scale. nj48 (Sasakura et al 2005) and qv24 alleles used in this study 
are deletion and splice donor mutation alleles, respectively. Scale bar, 1 kb. Corresponding 
protein structure of SAX-7L and SAX-7S below.  
B. RT-PCR using primers oCB985 and oCB987 to detect all sax-7 isoforms yields products 
similar in size to N2 in both the sax-7(nj48) deletion mutant and the sax-7(qv24) splice 
donor site mutant worms. Y45F10D.4 is a housekeeping gene used as an RT-PCR control 
(Hoogewijs et al 2008). Primers used for RT-PCR of sax-7 depicted in 4.1A. Neither sax-
7(nj48) or sax-7(qv24) appear to be null.  
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into adulthood. Initially, in the first larval stage, both sax-7(nj48) and sax-7(qv24) 
appear identical to wild type with regards to the relative positioning between the 
ASH/ASI soma and the nerve ring (Fig. 4.2). However, by the third larval stage, 
both sax-7(nj48) and sax-7(qv24) mutants begin to display defects in this relative 
positioning between the ASH/ASI soma and the nerve ring, and this 
progressively worsens as the animals go through the fourth larval stage and 
reach adulthood (Fig. 4.2). This suggests that the positioning of the ASH/ASI 
neurons and the nerve ring is initially properly established in sax-7 mutants, but 
that they subsequently fail to maintain the relative positioning between the 
ASH/ASI soma and the nerve ring (Benard et al 2012, Pocock et al 2008). 
Despite the molecular differences between the sax-7(nj48) deletion and the sax-
7(qv24) splice donor mutation, these mutants exhibit a very similar onset and 
severity in their failure to maintain the relative positioning between the ASH/ASI 
soma and the nerve ring.   
 
We confirmed that the defects displayed by sax-7(qv24) mutants are indeed the 
result of the loss of sax-7 function, by introducing wild-type copies of sax-7(+) in 
sax-7(qv24) mutants and assaying for rescue. Previous work has shown that 
sax-7S is the adhesive isoform and the active form in the maintenance of head 
ganglia organization (Pocock et al 2008, Sasakura et al 2005) and that sax-7 
functions in the nervous system to maintain the relative positioning between the 





Figure 4.2. sax-7 mutants exhibit a progressive decline in the maintenance of 
head ganglia organization.  
A. Images of the ASH/ASI soma and the nerve ring visualized using oyIs14 (Psra-
6::gfp) in wild type, sax-7(nj48), and sax-7(qv24) mutants in the first (L1), second (L2), 
and fourth (L4) larval stages, and adulthood (Adult). In wild-type animals through 
adulthood, and sax- 7 mutants until L2, the ASH/ASI soma (closed white arrowhead) 
are maintained posterior relative to the position of the nerve ring (open white 
arrowhead). In sax-7 mutants, this relative positioning is disrupted (closed red arrow) 
in later larval stages and adults. Scale bar, 10 µm.  
B. Quantification of animals defective for the relative positioning between the ASH/ASI 
soma and the nerve ring in wild type, sax-7(nj48) mutants, and sax-7(qv24) mutants 
from L1 through adulthood. Error bars are standard error of the proportion. ** P ≤ 
0.01, *** P ≤ 0.001. (z-tests, P values were corrected by multiplying by the number of 
comparisons). ns, not significant. 
169 
 
7S(+) pan-neuronally under the control of the heterologous promoter Punc-14 
and found that expression of sax-7S(+) in the nervous system was sufficient to 
fully rescue the sax-7(qv24) defects (Fig. 4.3). This result indicates that 
disruption of the function of sax-7 by the qv24 mutation results in post-
developmental defects in head ganglia organization. Our identification and 
analysis of the sax-7(qv24) mutation further confirms the functional importance of 
sax-7 in maintaining neuronal architecture during post-embryonic development.  
 
 
Expression of sax-7S(+) after establishment of head ganglia organization is 
sufficient for function  
sax-7 mutants display defects in the organization of the ASH/ASI neurons with 
respect to the nerve ring starting at the third larval stage and progressively 
worsening into adulthood. The appearance of these defects could be the result of 
either (1) an active role for sax-7 during larval and adult stages, or (2) a 
Figure 4.3. sax-7(qv24) mutants are rescued 
by neuronal sax-7S(+) expression.  
sax-7(qv24) mutant defects are rescued by 
expression of sax-7S(+) in the nervous system 
using the heterologous promoter Punc-14. Error 
bars are standard error of the proportion. 
Asterisks denote significant difference: *** P ≤ 
0.001. (z-tests, P values were corrected by 
multiplying by the number of comparisons). 
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secondary consequence of undetectable developmental defects during 
embryogenesis that get amplified as the animal grows and moves. To distinguish 
between these possibilities, we induced transgenic expression of sax-7S(+) in 
sax-7(nj48) mutants at different time points and assayed for rescue of the sax-7 
mutants’ defects. For this, we expressed the rescuing sax-7S(+) cDNA under the 
control of Phsp-16.2, a heat shock inducible promoter that expresses in neurons 
and other tissues (Fire et al 1990, Jones et al 1986, Stringham et al 1992), in 
sax-7(nj48) mutant worms. As a control, sax-7(nj48) transgenic animals carrying 
Phsp-16.2::sax-7S were not rescued for the head ganglia defects when grown at 
15°C and without heat shock. They were as defective as our reference sax-
7(nj48) mutant strain and as their non-transgenic siblings under the same 
conditions (Fig. 4.4). These controls indicate that in the absence of heat shock, 
SAX-7S is not expressed from Phsp-16.2::sax-7S(+).  
 
We heat shocked sax-7(nj48) mutants carrying Phsp-16.2::sax-7S as freshly 
hatched first larval stage animals, kept the animals at 15°C at all times except 
during heat shock, and examined them as 1-day old adults. The sax-7(nj48) 
transgenic worms that were heat shocked in the first larval stage showed a 
significant rescue of the relative positioning between the ASH/ASI soma and the 
nerve ring compared to their non-transgenic control siblings that were also heat 
shocked (Fig. 4.4). Thus, sax-7(nj48) mutants can undergo embryogenesis and 





wild-type copies of sax-7S(+) post-hatch, indicating that post-embryonic sax-7S 
is sufficient for the maintenance of neuronal organization.  
 
To determine when during larval development sax-7 function is required for the 
maintenance of neuronal organization, we heat shocked transgenic sax-7(nj48) 
mutants carrying Phsp-16.2::sax-7S at the second and third larval stages. 
Figure 4.4. Onset of sax-7S(+) expression in larval stages is sufficient for rescue of 
sax-7(nj48) mutants’ defects.  
The top four lanes on the histogram correspond to non-heat shock controls of wild type, sax-
7(nj48) mutants, transgenic sax-7(nj48) mutants carrying Phsp-16.2::sax-7S(+) (hatched 
bar), and non-transgenic controls (black bar). All were grown at 15°C and analyzed. The six 
bottom bars of the histogram correspond to heat-shocked animals, Phsp-16.2::sax-7S(+) 
transgenic (hatched bars), and non-transgenic controls (black bars). These heat-shocked 
animals were maintained at 15°C at all times except during heat shock at 37°C (pink box), 
which was done at the first, second, or third larval stage. All conditions tested showed a 
significant rescue of the sax-7(nj48) mutant defects with larval heat-shock induced sax-
7S(+) expression, as compared to non-transgenic controls. Error bars are standard error of 
the proportion. Asterisks denote significant difference: *** P ≤ 0.001. (z-tests, P values were 
corrected by multiplying by the number of comparisons). ns, not significant.  
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Transgenic Phsp-16.2::sax-7S animals heat shocked in either the second or third 
larval stages showed a partial but significant rescue of the relative positioning 
between the ASH/ASI soma and the nerve ring compared to heat-shocked non-
transgenic sibling controls (Fig. 4.4). By the third larval stage these sax-7 mutant 
animals have been moving and growing for up to 42 hours without normal sax-7 
function, and roughly 40% already exhibit defects in head ganglia organization 
(Fig. 4.2). Despite these factors, sax-7S expression starting in the third larval 
stage can rescue, which suggests these structures have not been irreparably 
damaged by the stresses they’ve encountered, and can still be protected by the 
presence of sax-7S.  
 
lon-1 identified as a novel suppressor of sax-7 maintenance defects 
To gain understanding of the mechanism of action of sax-7 we set out to identify 
molecules that function with sax-7 to maintain the architecture of the nervous 
system. For this, we carried out an F2 clonal forward genetic screen to find 
suppressors of the sax-7 mutant defect in the maintenance of head ganglia 
organization. We mutagenized P0 sax-7(qv24); oyIs14 worms with EMS and 
screened F3s to find broods of adults that maintained the ASH/ASI soma 
posterior to the nerve ring, despite harboring the sax-7(qv24) mutation (Fig. 4.5). 
Potential suppressors with impaired locomotion were not analyzed further, as 
paralysis is known to suppress sax-7 defects in head ganglia organization 





suppressors, including qv10 which displays profound suppression of the sax-7 
defects. We outcrossed this suppressor four times. 
 
Next we set out to determine the molecular identity of the qv10 suppressor 
mutation. Over the course of four outcrosses, we observed that the qv10 worms 
were also longer than wild-type worms, and this Lon phenotype could not be 
segregated away from the suppression of the sax-7 mutant phenotype. This 
Figure 4.5. A forward genetic screen to find suppressors of sax-7.  
Schematic of the EMS forward genetic screen carried out to find suppressors of the sax-7 
mutant defect in the maintenance of head ganglia organization. P
0 
sax-7(qv24) worms were 
mutagenized with EMS. F1 progeny of the mutagenized P
0
s were singled, those containing a 
suppressor mutation would be heterozygous. Seven F2s were singled from each F1 brood. If 
F1 was heterozygous for a suppressor mutation, expect one quarter of F2 broods to be 
homozygous for suppressor mutation (green worms). Adult F3s were screened to find broods 
of adults with properly maintained head ganglia organization.  
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suggested that either the suppression was due to a lon mutation, or the 
suppressor mutation was tightly linked to one of the lon loci. We tested whether a 
mutation in one of the lon genes could suppress the sax-7 neuronal maintenance 
defect. We built strains mutant for both sax-7(nj48) and lon mutants lon-1(e185) 
(Maduzia et al 2002, Morita et al 2002), lon-2(e678) (Gumienny et al 2007), lon-
3(e2175) (Nystrom et al 2002, Suzuki et al 2002), and lon-8(hu187) (Soete et al 
2007) and analyzed the relative positioning between the ASH/ASI soma and the 
nerve ring. We found that loss of function of lon-1 in the sax-7(nj48) background 
suppressed the failure to maintain neuronal organization to a similar degree as 
our qv10 suppressor. The other lon mutants showed either minimal or no 
suppression of the sax-7 neuronal maintenance phenotype (Fig. 4.6). This 
finding suggested that qv10 is an allele of lon-1. To directly test whether qv10 
harbors a mutation in the gene lon-1, we PCR amplified and Sanger sequenced 
all exons and splice sites of the lon-1 locus in our qv10 suppressor strain. We 
found that the qv10 worms contain a G to A mutation at position 33,209 on 
cosmid F48E8, which converts a tryptophan residue to an early STOP at position 
197 within the protein LON-1 (Fig. 4.7). To determine the impact of this allele on 
lon-1 expression, we carried out RT-PCR which revealed that neither qv10 nor 
e185 are null, as lon-1 transcripts are present in both mutant alleles (Fig. 4.7), 







To test whether the suppression of the sax-7(qv24) neuronal maintenance 
defects by loss of lon-1(qv10) was allele-specific, we built and analyzed double 
mutants between two alleles of lon-1 (qv10 and e185) with two alleles of sax-7 
(qv24 and nj48). We found that all four combinations of these alleles as double 
mutants between lon-1 and sax-7 produced a similar suppression of the sax-7 
mutant defects in maintaining the positioning of ASH/ASI soma with respect to 
the nerve ring (Fig. 4.8).  
 
Figure 4.6. Investigation of Lon mutants and their effect on the sax-7 mutant 
phenotype.  
Isolated suppressor qv10 was Lon. Analysis of head ganglia organization of double 
mutants between lon-1,-2,-3,-8 with sax-7(nj48) revealed lon-1 as the candidate with the 
highest degree of suppression. Gray dashed line indicates degree of suppression of sax-
7 mutant defects by loss of lon-1. Error bars are standard error of the proportion. 
Asterisks denote significant difference: *** P ≤ 0.001. (z-tests, P values were corrected 







Figure 4.7. qv10 and e185 are partial loss-of-function lon-1 alleles.  
A. Diagram of the lon-1 locus depicting the lon-1a and lon-1b isoforms. Exons (black 
boxes), introns (black lines), and UTRs (gray boxes) are to scale. qv10 creates an early 
stop (*) at W197. e185 is a missense mutation converting a cysteine residue at position 
185 to a tyrosine residue (C185Y) (Maduzia et al 2002, Morita et al 2002). Scale bar, 
500 bp. 
B. RT-PCR using primers oCB977 and oCB979 to detect all lon-1 isoforms yields a 
similar size product in N2, lon-1(qv10), and lon-1(e185). Primers specific to lon-1a 
(primers oCB977 and oCB980) and lon-1b (primers oCB977 and oCB981) also yield 
products of similar size in N2, lon-1(qv10), and lon-1(e185). Y45F10D.4 is a 
housekeeping gene used as an RT-PCR control (Hoogewijs et al 2008). Primers used 
for RT-PCR of lon-1 depicted in 4.7A on top of gene diagram. Neither lon-1(qv10) nor 





To directly determine if the suppression of the sax-7 neuronal maintenance 
defects is due to loss of lon-1 function, we carried out rescue assays for lon-1. 
We introduced wild-type copies of lon-1(+) driven by its endogenous promoter 
including Plon-1::lon-1(+) genomic in the lon-1; sax-7 double mutant background, 
and reasoned that if the suppression of sax-7 defects was dependent on the loss 
of lon-1 function, then the sax-7 mutant phenotype would resurface in transgenic 
animals rescued for lon-1. Indeed, upon introduction of wild-type copies lon-1(+) 
Figure 4.8.  Loss of lon-1 suppresses the sax-7 mutant defects in maintenance of 
head ganglia organization. 
Images of wild type, lon-1(qv10), sax-7(qv24), and lon-1(qv10); sax-7(qv24) double 
mutants expressing oyIs14 (Psra-6::gfp) to label head neurons ASH/ASI and the nerve 
ring. The nerve ring (closed white arrowhead) is maintained anterior to the ASH/ASI 
soma (open white arrowhead) in wild type, lon-1, and lon-1; sax-7 double mutants, while 
sax-7 mutants exhibit a failure to maintain this relative positioning (closed red arrow). 
Quantification (on the right) of animals defective in the maintenance of this relative 
positioning indicates that loss of lon-1(qv10) or lon-1(e185) is able to suppress the sax-
7(qv24) or sax-7(nj48) mutant defects in the maintenance of head ganglia organization. 
Error bars are standard error of the proportion.  
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DNA in the lon-1; sax-7 double mutant background, we found that the sax-7 
mutant phenotype reappeared (Fig. 4.9A). This indicates that loss of lon-1 
indeed suppresses the maintenance defects of sax-7 mutants and identifies lon-1 
as a novel suppressor of the sax-7 mutant defects in maintenance of neuronal 
architecture. As a control, we also overexpressed the same Plon-1::lon-1(+) 
genomic rescuing construct in the lon-1 single mutants (without a sax-7 mutation) 
and analyzed the relative positioning between the ASH/ASI soma and the nerve 
ring. We found that overexpression of lon-1(+) in the lon-1 mutant background 
did not lead to neuronal defects (Fig. 4.9B), further confirming that the 
reappearance of neuronal maintenance defects in the lon-1; sax-7 double 
mutants expressing lon-1(+) was indeed due to rescue of lon-1  and not 
overexpression-induced defects. Taken together, these results indicate that loss 
of function of lon-1 is able to suppress the sax-7 mutant defect in the 
maintenance of the relative positioning between the ASH/ASI soma and the 
nerve ring.  
 
LON-1 comes as two major isoforms, the a (313 aa) and b (302 aa) isoforms 
(Fig. 4.7). To determine which isoform is functional in maintaining neuronal 
architecture, we carried out lon-1 rescue assays with each isoform individually. 
We found that expression of either lon-1a(+) cDNA or lon-1b(+) cDNA under the 










lon-1 function and bring back the sax-7 mutant defects.  Additionally, we found 
that overexpression of either lon-1a(+) or lon-1b(+) in the lon-1 mutant 
background did not lead to neuronal defects (Fig. 4.9B). These results indicate 
that both isoforms, LON-1a and LON-1b, are active in the maintenance of 
neuronal architecture.  
 
Loss of lon-1 specifically suppresses head ganglia maintenance defects of 
sax-7  
Having identified lon-1 as a novel suppressor of the head ganglia maintenance 
defects of sax-7, we wondered if lon-1 also participates in other functions of sax-
7, such as in the maintenance of neuronal architecture in other areas of the 
nervous system or during neuronal development. For instance, sax-7 mutants fail 
to maintain the precise positioning of axons along the ventral nerve cord, 
including the PVQ axons (Pocock et al 2008). In wild-type animals, the axon of 
the PVQ neurons is located ipsilaterally along the left or the right fascicle of the 
ventral nerve cord. However, in sax-7 mutants, although in early first larval stage 
Figure 4.9. Rescue of lon-1-mediated suppression of sax-7 by lon-1(+) expression. 
A. Loss of lon-1 in the sax-7 mutant background suppresses the sax-7 defects in 
maintaining head ganglia organization. Expression of wild type copies of lon-1(+) under its 
endogenous promoter in lon-1(e185); sax-7(nj48) double mutants brings back the sax-7 
mutant phenotype and therefore rescues this lon-1-mediated suppression. Transgenic 
animals were compared to non-transgenic sibling controls.  
B. Wild type copies of lon-1(+) under its endogenous promoter were expressed in lon-
1(qv10) mutants. These animals exhibited no defects in the maintenance of the 
organization of the head ganglia. Therefore, the rescue observed in 4.9A is not due to the 
creation of an overexpression-induced phenotype.  
Error bars are standard error of the proportion. Asterisks denote significant difference: *** P 
≤ 0.001. (z-tests, P values were corrected by multiplying by the number of comparisons). 
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worms the PVQ axons appear indistinguishable from wild type, by the late first 
larval stage the PVQ axons are not maintained within their specific fascicle along 
the ventral nerve cord and instead flip over to the opposite side (Pocock et al 
2008). To determine whether loss of lon-1 could suppress this sax-7 defect in 
maintaining the PVQ axons within their appropriate fascicle, we analyzed the 
maintenance of the positioning of the PVQ axons in lon-1; sax-7 double mutants 
compared to the single mutants. We found that the PVQ axons of lon-1 appeared 
identical to wild type, and that lon-1; sax-7 double mutants had a similar 
penetrance of PVQ axon flipover defects as sax-7 single mutants (Fig. 4.10A). 
This result indicates that loss of lon-1 did not suppress the sax-7 defects in the 
maintenance of the axon positioning within their proper fascicle in the ventral 
nerve cord. This specificity suggests that loss of lon-1 suppressing sax-7 defects 
in the maintenance of neuronal architecture is context-dependent rather than lon-
1 acting as a general suppressor of sax-7 maintenance defects.  
 
In addition to defects in the maintenance of neuronal architecture, sax-7 mutants 
also exhibit other neuronal phenotypes that are developmental in origin, including 
a defect in the development of the dendritic branches of the PVD neurons (Dong 
et al 2013, Salzberg et al 2013). In wild-type animals the PVD neurons are born 
postembryonically in the second larval stage (Sulston & Horvitz 1977) and  
extend their primary, secondary, tertiary, and quaternary dendritic branches that 
together have a menorah-like appearance during the second through fourth larval 
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stages (Oren-Suissa et al 2010, Smith et al 2010). sax-7 mutants fail to develop 
this structure properly, as their PVD dendrites are highly disorganized (Dong et al 
2013, Salzberg et al 2013). To address whether loss of lon-1 could suppress 
developmental sax-7 mutant phenotypes, we analyzed the development of the 
PVD dendrites in lon-1; sax-7 double mutants compared to the single mutants, 
using the integrated transgene wdIs52 (Smith et al 2010, Watson et al 2008). 
Whereas the dendritic structures between the secondary and tertiary PVD 
branches in lon-1 mutants were indistinguishable from the wild type (T-shaped), 
we observed that they were severely disrupted in sax-7 mutants, as previously 
reported (Dong et al 2013, Salzberg et al 2013) (Fig. 4.10B).  We found that the 
PVD dendritic defects in lon-1; sax-7 double mutants were as severely defective 
as in sax-7 single mutants (Fig. 4.10B), indicating sax-7 mutant defects in PVD 
dendrite development could not be suppressed by loss of lon-1. This observation 
supports the notion that lon-1, rather than functioning as a general suppressor of 








Suppression of sax-7 defects by loss of lon-1 is independent of the TGF-β 
signaling pathway 
lon-1 is a downstream target of the Sma/Mab TGF-β signaling pathway and 
regulates body length in a dose-dependent manner (Fig. 4.11). To gain 
mechanistic insight into how loss of function of lon-1 might suppress the sax-7 
mutant defects in the maintenance of head ganglia organization, we investigated 
the role of the TGF-β signaling pathway and the impact of body length on the 
maintenance of neuronal architecture. We first determined the importance of 
TGF-β signaling in the maintenance of the neuronal architecture by analyzing the 
relative positioning between the ASH/ASI soma and the nerve ring in null or 
severe loss-of-function mutants for genes functioning in the TGF-β signaling 
pathway. This included mutants for a TGF-β ligand dbl-1(nk3) (Morita et al 1999), 
a type I TGF-β receptor sma-6(wk7) (Krishna et al 1999), the R-Smads sma-
2(e502) and sma-3(e491), the Co-Smad sma-4(e729) (Savage et al 1996), the 
extracellular TGF-β regulators lon-2(e678) (Gumienny et al 2007), sma-
10(ok2224) (Gumienny et al 2010), crm-1(tm2218) (Fung et al 2007), adt-
Figure 4.10. Loss of lon-1 does not suppress other sax-7 mutant defects.  
A. The positioning of the PVQ axons along the ventral nerve cord is maintained in wild 
type animals and lon-1(e185) mutants, but is not in sax-7(nj48) mutants. Similar to sax-
7(nj48) mutants alone, lon-1(e185); sax-7(nj48) double mutants exhibit defects in PVQ 
axon maintenance. 
B. Wild type and lon-1(e185) mutants exhibit normal PVD dendritic branch development, 
whereas sax-7(nj48) mutants and lon-1(e185); sax-7(nj48) double mutants exhibit defects 
in the development of the PVD dendritic branches.  
Error bars are standard error of the proportion. Asterisks denote significant difference: *** 
P ≤ 0.001. (z-tests, P values were corrected by multiplying by the number of 
comparisons). ns, not significant. 
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2(wk156) (Fernando et al 2011), and drag-1(tm3773) (Tian et al 2010), and other 
associated genes related by homology, namely unc-129(tm5461) (Colavita et al 
1998) and tig-2(ok3416) (Patterson & Padgett 2000). We found that loss of any 
of these TGF-β pathway components did not affect the maintenance of the 
relative positioning between the ASH/ASI soma and the nerve ring (Fig. 4.12A).  
Although loss of these TGF-β pathway components alone, including loss of lon-1, 
did not disrupt the maintenance of head ganglia organization, we addressed 
whether loss of these TGF-β pathway components could affect the sax-7 mutant 
phenotype, as the loss of lon-1 does. For this, we created double mutants 
between sax-7(nj48) and null/severe mutants for each of these TGF-β pathway 
components. Loss of four TGF-β pathway components other than lon-1, namely 
lon-2, sma-10, sma-2, and adt-2, reduced the penetrance of the sax-7(nj48) 
mutant defects but to a much lesser extent than the suppression elicited by loss 
of lon-1 (Fig. 4.12B). Importantly, loss of the other eight TGF-β pathway 
components tested did not suppress the sax-7(nj48) neuronal maintenance 
mutant defects at all (Fig. 4.12B). Taken together, our results indicate that 
suppression of sax-7 defects by loss of lon-1 is independent of the TGF-β 
signaling pathway.  
 
Other than loss of lon-1, the next best suppression of the sax-7(nj48) mutant 









Figure 4.11. Sma/Mab branch of the TGF-β signaling pathway. One function of the 
Sma/Mab branch of the TGF-β signaling pathway is to regulate body length. TGF- β ligand 
(DBL-1) signals through a heteromeric complex of two type I (SMA-6) and two type II (DAF-
4) receptor subunits. This is regulated by extracellular modulators including LON-2, CRM-1, 
DRAG-1, and SMA-10. Smads (SMA-2, SMA-3, and SMA-4) along with transcription factors 
regulate downstream targets, such as LON-1, to control body length. Diagram modeled 








transcription factor to regulate gene expression in a pathway that normally 
inhibits lon-1 expression (Savage et al 1996), perhaps the suppression of sax-7 
by sma-2 is due to an upregulation of lon-1 in the absence of sma-2. To test this, 
we overexpressed the lon-1(+) genomic sequence under its endogenous 
promoter (using Plon-1::lon-1(+) genomic) in the sax-7(nj48) mutant background. 
We analyzed the relative positioning between the ASH/ASI soma and the nerve 
ring in our transgenic animals compared to sax-7(nj48) single mutants at the 
fourth larval stage, and found that overexpression of lon-1 in the sax-7(nj48) 
background did not significantly alter the sax-7 mutant phenotype (Fig. 4.13). 
This suggests that loss of sma-2 suppressing the sax-7 mutant defects is unlikely 
simply due to increase in expression of lon-1. Alternatively, loss of sma-2 may 
result in changes in the expression of other target genes, which could in turn 
Figure 4.12. Maintenance of head ganglia organization is independent of TGF-β 
signaling.  
A. Loss of TGF-β signaling does not affect maintenance of head ganglia organization. 
ASH/ASI were visualized using oyIs14 (Psra-6::gfp) in mutants for TGF-β pathway 
components including TGF-β ligand dbl-1(nk3), type I TGF-β receptor sma-6(wk7), the R-
smads sma-2(e502) and sma-3(e491), the Co-Smad sma-4(e729), the extracellular TGF-β 
regulators lon-2(e678), sma-10(ok2224), crm-1(tm2218), adt-2(wk156), and drag-1(tm3773), 
and genes related by homology including unc-129(tm5461) and tig-2(ok3416). Animals mutant 
for these TGF-β signaling pathway components are able to maintain the relative positioning 
between the ASH/ASI soma and the nerve ring, similar to wild type. 
B. Loss of TGF-β signaling in sax-7 mutants does not suppress defects in head ganglia 
organization to the same degree as loss of lon-1. ASH/ASI were visualized using oyIs14 
(Psra-6::gfp) in double mutants between sax-7(nj48) and the TGF-β components listed in A. 
Gray dashed line indicates level of suppression of sax-7 defects elicited by loss of lon-1.  
Error bars are standard error of the proportion. Asterisks denote significant difference: ** P ≤ 
0.01, *** P ≤ 0.001. (z-tests, P values were corrected by multiplying by the number of 
comparisons). ns, not significant. 
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affect the sax-7 mutant phenotype. Overall these results suggest that the TGF-β 
pathway per se does not regulate the maintenance of neuronal architecture.  
 
  
lon-1-mediated suppression of the neuronal maintenance defects of sax-7 
mutants is independent of body length  
While our results suggest that the lon-1-mediated suppression of the sax-7 
defects is independent of TGF-β signaling, the possibility remained that the 
mechanism of lon-1-mediated suppression of sax-7 defects was dependent upon 
body length. Therefore, we investigated whether the suppression of sax-7 mutant 
defects by loss of lon-1 is due to the increased body length of the animals. As 
previously mentioned, our results show that loss of lon-2(e678), lon-3(e2175), 
and lon-8(hu187) did not suppress the sax-7 defects to the same degree as lon-
1, which suggests that this lon-1–mediated suppression is independent of body 
Figure 4.13. Overexpression of lon-
1(+) does not alter the sax-7 mutant 
phenotype.  
sax-7(nj48) mutants overexpressing 
lon-1(+) show no significant difference 
compared to sax-7(nj48) alone in the 
maintenance of head ganglia 
organization. Animals were analyzed in 
the fourth larval stage when sax-7(nj48) 
mutant defects are not yet fully 
penetrant, to allow the detection of a 
potential enhancement of the defects. 
Error bars are standard error of the 
proportion. (z-tests, P values were 
corrected by multiplying by the number 
of comparisons). ns, not significant. 
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length (Fig. 4.6). One caveat is that lon-2, lon-3, and lon-8 mutants, while also 
Lon, are not as long as lon-1(e185) or lon-1(qv10) mutants (Nystrom et al 2002, 
Soete et al 2007). To directly test whether the Lon phenotype suppresses the 
sax-7 mutant defects, we used an alternative approach to increase body length. 
Overexpression of the TGF-β ligand dbl-1 using the integrated transgene ctIs40 
(Suzuki et al 1999) increases body length due to a downregulation of lon-1 
(Morita et al 1999, Suzuki et al 1999). Overexpression of dbl-1 reduces lon-1 
expression but does not eliminate it completely (Maduzia et al 2002, Morita et al 
2002) and also increases body length to a similar degree as lon-1 mutants 
(Morita et al 1999). Therefore, we wondered if an increase in body length due to 
the overexpression of dbl-1 in sax-7(nj48) mutants would lead to a suppression 
of the defects in the maintenance of the relative positioning between the 
ASH/ASI soma and the nerve ring. We found that sax-7(nj48) mutants 
overexpressing dbl-1 in the sax-7; ctIs40 strain did not exhibit a difference in 
phenotype compared to sax-7(nj48) mutants alone (Fig. 4.14A). This result 
suggests that an increase in body length is not responsible for the suppression, 
and that a greater reduction in lon-1 expression than that triggered by 
overexpression of dbl-1 is required to suppress the sax-7 mutant defects.  
To further address the relationship between body length and the lon-1-mediated 
suppression of defective maintenance of head ganglia organization, we 
examined whether loss of lon-1 could suppress the defects of dig-1, another 
neuronal maintenance mutant unrelated to sax-7. dig-1 encodes a large, 
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secreted protein required for proper basement membrane structure and 
maintenance of neuronal architecture (Benard et al 2006). Loss of function of dig-
1 leads to a failure to maintain head ganglia organization, similar to sax-7(nj48) 
mutants (Fig. 4.14B) (Benard et al 2006). We analyzed the relative positioning 
between the ASH/ASI soma and the nerve ring in dig-1(ky188) single mutants as 
compared to lon-1(e185) dig-1(ky188) double mutants and found that loss of lon-
1 did not suppress the dig-1(ky188) mutant defects (Fig. 4.14B). This finding 
indicates that the suppression of the head ganglia maintenance defect in sax-7 
mutants by loss of lon-1 is highly specific, as the same defect in another mutant, 
dig-1, cannot be suppressed by loss of lon-1. Moreover, this result further 
corroborates that the increase in body size does not suppress defects in the 
maintenance of the relative positioning between the ASH/ASI soma and the 
nerve ring. Taken together, our results indicate that the mechanism by which lon-
1 impacts the sax-7-mediated maintenance of head ganglia organization is not 







Figure 4.14. lon-1-mediated suppression of sax-7 defects is independent of body 
length.  
A. Increased body length cannot suppress sax-7(nj48) mutant defects. Animals 
overexpressing TGF-β ligand dbl-1 (transgene ctIs40) are longer than wild type due to a 
decrease in lon-1 expression (Morita et al 1999, Suzuki et al 1999), and maintain head 
ganglia organization similar to wild type. sax-7(nj48); ctIs40 animals that overexpress dbl-1 
are long, yet do not display a significant difference compared to sax-7(nj48) mutants alone 
in the maintenance of head ganglia organization. This indicates increased body length 
alone cannot suppress sax-7(nj48) mutant defects. 
B. dig-1(ky188) mutants, like sax-7 mutants, exhibit a defective maintenance of the relative 
positioning between the ASH/ASI soma and the nerve ring (Bénard et al., 2006). Double 
mutant lon-1(e185) dig-1(ky188) exhibits defects in the maintenance of head ganglia 
organization that are not significantly different than dig-1(ky188) mutants alone. This 
suggests specificity of loss of lon-1 in suppressing head ganglia organization defects 
resulting from loss of sax-7.  Analysis done with two-day adults.  
Error bars are standard error of the proportion. (z-tests, P values were corrected by 
multiplying by the number of comparisons). ns, not significant. 
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Suppression of sax-7 unlikely to be a general feature of CAP superfamily  
LON-1 is a member of the diverse CAP (cysteine-rich secretory proteins, antigen 
5, and pathogenesis-related 1) superfamily (Maduzia et al 2002), which contains 
28 members in C. elegans, 33 in mice, and 31 in humans (Gibbs et al 2008). This 
designation is based on LON-1 containing a cysteine-rich domain with homology 
to other CAP superfamily members which spans from approximately aa 78 to aa 
217 of LON-1. Both the lon-1(e185) and lon-1(qv10) mutations fall within this 
conserved region ((Maduzia et al 2002); Fig. 4.7), highlighting the functional 
importance of this sequence.  CAP superfamily molecules are often secreted or 
associated with the membrane via a GPI-anchor (Gibbs et al 2008) and LON-1 
contains a signal peptide sequence at the N-terminus (Maduzia et al 2002). We 
wondered whether the lon-1-mediated suppression of sax-7 neuronal 
maintenance defects could be related to the presence of a CAP domain in LON-1 
and if loss of other members of the CAP superfamily in C. elegans could 
suppress the sax-7 mutant defects. We built double mutants between sax-7(nj48) 
and the three available CAP superfamily mutants, vap-1(ok392) (Cantacessi et al 
2009, Hawdon et al 1999), scl-1(ok1185) (Ookuma et al 2003), and scl-
9(ok1138) (Ashrafi et al 2003). Loss of any of these molecules did not lead to 
neuronal defects (Fig. 4.15). We found that loss of scl-1 or scl-9 did not 
significantly alter the sax-7(nj48) mutant phenotype (Fig 4.15). While loss of vap-
1 in the sax-7(nj48) mutant background decreases the defects compared to sax-
7(nj48) single mutants, this suppression 
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is far from that seen with loss of lon-1 (Fig. 4.15). While we cannot rule out a role 
for other untested CAP superfamily molecules, these results suggest that the lon- 
1-mediated suppression of sax-7 defects does not reflect a general function of 
CAP superfamily members in the maintenance of neuronal architecture.  
 
LON-1 functions in neurons and hypodermis to maintain neuronal 
architecture 
4.15. CAP superfamily mutants are unable to suppress sax-7 mutant defects to the 
same degree as lon-1.  
LON-1 is a member of the CAP superfamily. Mutants for other CAP superfamily members 
such as vap-1(ok392), scl-1(ok1185), and scl-9(ok1138) are able to maintain the relative 
positioning between the ASH/ASI soma and the nerve ring like wild-type and lon-1 mutant 
animals. Loss of scl-1(ok1185) or scl-9(ok1138) does not alter the sax-7(nj48) mutant 
phenotype. While loss of vap-1(ok392) in the sax-7(nj48) mutant background does 
significantly decrease the phenotype compared to sax-7(nj48) alone, this is not to the same 
degree as seen with loss of lon-1. Gray dashed line indicates the degree of suppression of 
sax-7 mutant defects by loss of lon-1. Error bars are standard error of the proportion. 
Asterisks denote significant difference: *** P ≤ 0.001. (z-tests, P values were corrected by 
multiplying by the number of comparisons). ns, not significant. 
195 
 
To gain insight into the function of lon-1 in neuronal maintenance, we 
characterized the focus of action of lon-1. lon-1 is expressed in hypodermal cells 
and in the intestine and has been shown to function in the hypodermis for its role 
in the regulation of body length (Maduzia et al 2002, Morita et al 2002). To 
determine where lon-1 functions to suppress the sax-7 mutant defects, we 
expressed lon-1a(+) cDNA pan-neuronally (under the heterologous promoter 
Punc-14), in hypodermal cells (under the heterologous promoter Pelt-3), in the 
intestine (under the heterologous promoter Pelt-2), and in body wall muscles 
(under the heterologous promoter Pmyo-3) in lon-1; sax-7 double mutants. We 
assayed for rescue of lon-1 in these lon-1; sax-7 double mutants by looking for a 
restoration of the sax-7 mutant phenotype. We observed that the sax-7 mutant 
phenotype resurfaced in lon-1; sax-7 double mutants when lon-1(+) was 
expressed from either the nervous system or the hypodermis (Fig. 4.16A), 
suggesting that lon-1 can function from the nervous system or the hypodermis for 
its role in the suppression of the sax-7 mutant defects. Rescue was not observed 
upon expression of lon-1 from the intestine or the body wall muscles (Fig. 
4.16A). As a control, we ensured that this lon-1-induced reappearance of head 
ganglia disorganization in lon-1; sax-7 double mutants was not due to an 
artefactual lon-1(+)-overexpression phenotype. For this, we expressed lon-1(+) in 
neurons, hypodermis, intestine, or muscles in lon-1 mutants and analyzed the 










Overexpression of lon-1(+) from all tissues tested had no effect on head ganglia 
organization (Fig. 4.16B). This result confirms that the mutant defects seen in 
lon-1; sax-7 double mutants upon expression of lon-1(+) in neurons or 
hypodermis reflects the rescue of the lon-1-mediated suppression of sax-7, and 
suggests that for neuronal maintenance of head ganglia organization, lon-1 
functions from neurons or hypodermis.  
 
SAX-7 functions in multiple adjacent neurons to maintain nervous system 
architecture 
sax-7 functions in the nervous system to maintain the relative positioning 
between the ASH/ASI soma and the nerve ring ((Pocock et al 2008); Fig. 4.3). 
To learn more about how sax-7 functions to maintain the architecture of the 
nervous system and how it might interact with lon-1, we investigated whether 
Figure 4.16. lon-1 functions in the nervous system and hypodermis to maintain head 
ganglia organization.  
A. Expression of lon-1(+) in the nervous system (under the heterologous promoter Punc-14) 
or the hypodermis (under the heterologous promoter Pelt-3), brings back the sax-7(nj48) 
mutant phenotype in the lon-1(e185); sax-7(nj48) double mutant, indicating LON-1 functions in 
the nervous system or hypodermis to maintain head ganglia organization. Expression of lon-
1(+) in the intestine (under the heterologous promoter Pelt-2), or muscles (under the 
heterologous promoter Pmyo-3), could not rescue. Transgenic animals were compared to 
non-transgenic sibling controls.   
B. Overexpression of lon-1(+) in lon-1(qv10) mutants in the nervous system (using the 
heterologous promoter Punc-14), the hypodermis (using the heterologous promoter Pelt-3), 
the intestine (using the heterologous promoter Pelt-2), or the muscles (using the heterologous 
promoter Pmyo-3), did not affect the maintenance of head ganglia organization. This indicates 
the resurfaced mutant phenotype in 4.16A is due to rescue and not due to a lon-1(+) 
overexpression phenotype.  
Error bars are standard error of the proportion. Asterisks denote significant difference: *** P ≤ 




sax-7 could function cell-autonomously or whether multi-neuron expression was 
required to maintain the relative positioning between the ASH/ASI soma and the 
nerve ring. To test this, we expressed sax-7S in sax-7(nj48) mutants under the 
heterologous promoter Psra-6, which restricts expression to the head neurons 
ASH and ASI, and to tail neurons PVQ. This restricted expression did not rescue 
the sax-7(nj48) mutant defects, suggesting that sax-7 cannot function cell-
autonomously in this context and is instead required from multiple neurons. To 
test this, we used the heterologous promoter Posm-6, to drive sax-7S in the 
ciliated sensory neurons, including ASH and ASI, in sax-7(nj48) mutants (this 
expression is much more restricted than the pan-neuronal Punc-14 promoter that 
had previously conferred robust rescue of the sax-7 mutant defects ((Pocock et 
al 2008); Fig. 4.3). Expression of sax-7S in the ciliated sensory neurons was 
sufficient to rescue the sax-7(nj48) defects in the maintenance of the relative 
positioning between the ASH/ASI soma and the nerve ring (Fig. 4.17). Our 
results indicate that sax-7S needs to be expressed from multiple neurons in close 
proximity to ASH/ASI, suggesting that homophilic interactions between SAX-7S 
molecules across neurons are required to maintain the relative positioning of the 
ASH/ASI soma with respect to the nerve ring, as has been observed in other 





Post-embryonic loss of lon-1 is sufficient to suppress sax-7 mutant defects 
To help understand the function of lon-1 in neuronal maintenance, we studied the 
timing of action of lon-1. Since we uncovered a post-embryonic role for sax-7 in 
maintaining head ganglia organization (Fig. 4.4), we speculated that loss of lon-1 
function post-embryonically might be sufficient to suppress this sax-7 mutant 
defect. To test this, we knocked down lon-1 function at different times of larval 
development using RNAi against lon-1 in sax-7(nj48) mutants. We used three 
different timing strategies (Fig. 4.18A). First, we verified that chronic lon-1(RNAi) 
4.17. sax-7 functions in multiple 
neurons to maintain head ganglia 
organization.  
Expression of wild-type copies of 
sax-7(+) in the ASH/ASI head 
neurons and PVQ tail neurons (using 
the heterologous promoter Psra-6) is 
not sufficient to rescue the sax-
7(nj48) mutant defects in head 
ganglia organization. Expression of 
wild-type copies of sax-7(+) in all 
ciliated sensory neurons (using the 
heterologous promoter Posm-6) is 
sufficient to rescue the sax-7(nj48) 
mutant defects. This indicates sax-7 
does not function cell autonomously 
but rather in multiple neurons to 
maintain head ganglia organization. 
Error bars are standard error of the 
proportion. Asterisks denote 
significant difference: *** P ≤ 0.001. 
(z-tests, P values were corrected by 
multiplying by the number of 
comparisons). ns, not significant. 
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phenocopied the suppression of sax-7 by lon-1 mutations. P0 sax-7(nj48) 
mutants were allowed to lay progeny on lon-1(RNAi), and these F1 progeny were 
maintained under lon-1(RNAi) conditions until they were 1-day old adults, when 
their neuroanatomy was examined (Fig. 4.18A). In this chronic lon-1(RNAi) 
condition, we found that sax-7(nj48) mutants grown on lon-1(RNAi) were 
significantly suppressed for head ganglia defects compared to the empty vector 
RNAi controls (Fig. 4.18B), indicating that lon-1(RNAi) phenocopied the lon-1 
loss-of-function mutations in suppressing sax-7 defects.  
  
Second, we addressed whether knock down of lon-1 function post-embryonically 
would be sufficient to suppress sax-7 head ganglia disorganization. For this, we 
collected freshly hatched first larval stage sax-7(nj48) mutants and raised them 
on lon-1(RNAi) bacteria until they were 1-day old adults, when we completed the 
analysis (Fig. 4.18A). Despite developing and hatching as a sax-7 mutant and 
with wild-type lon-1(+), the worms subjected to post-embryonic knock down of 
lon-1 by lon-1(RNAi) displayed a significant reduction in the penetrance of 
defects as compared to empty vector RNAi controls (Fig. 4.18B). This result 
suggests that loss of lon-1 function from the first larval stage onwards, well after 
the development of the head ganglia and of the nerve ring had been completed 
during embryogenesis, is sufficient to suppress the sax-7 defects in head ganglia 
maintenance. These observations point to a post-embryonic role of lon-1 in 




Third, we knocked down lon-1 function from the second larval stage onwards and 
asked whether this could suppress sax-7 head ganglia disorganization. For this, 
we collected second larval stage sax-7(nj48) mutants and raised them on lon-
1(RNAi) until they were 1-day old adults, when we completed the analysis (Fig. 
4.18A). We found that sax-7 mutants on lon-1(RNAi) from the second larval 
stage onwards did not exhibit a significant difference from the control RNAi 
worms (Fig. 4.18B), indicating that loss of lon-1 during and after the second 
larval stage is not sufficient to suppress these sax-7 defects. This suggests that 
for the sax-7 mutant defects to be suppressed the function of lon-1 must be lost 
from the first larval stage; alternatively, lon-1 might function during later larval 
stages as well, but the lon-1 RNAi knockdown might be less efficient when 
started at the second larval stage. Nonetheless, these results indicate that sax-7 
mutants that undergo embryonic development and hatch lacking sax-7 function 
can still become phenotypically wild type in adulthood through a post-embryonic 











Although a handful of molecules that maintain the architecture of the nervous 
system have been identified, the mechanisms by which they function remain 
poorly understood. In this study we have identified a conserved, novel neuronal 
maintenance factor, lon-1, and determined that it functions from the neurons 
themselves or the nearby hypodermis during larval development, to somehow 
impact the maintenance factor sax-7 in maintaining nervous system architecture.  
 
Novel and specific interaction between lon-1 and sax-7 mediates the 
maintenance of head ganglia organization  
Our study has identified lon-1 as a suppressor of the sax-7 defects in the 
maintenance of head ganglia organization. The lon-1-mediated suppression of 
sax-7 defects is context dependent, as loss of lon-1 does not impact all defects in 
neuronal architecture resulting from the disruption of sax-7. Although loss of lon-
1 powerfully suppresses the head ganglia disorganization defects of sax-7 
4.18. Post-embryonic loss of lon-1 is sufficient to suppress sax-7 mutant defects. 
A. Diagram showing experimental set up of chronic RNAi, RNAi from L1, and RNAi from 
L2. sax-7(nj48) mutants were either on RNAi (gray bars) starting at P
0
, L1, or L2 (ages on 
top), or off RNAi (white bars), and analyzed as adults (black vertical bar).  
B. sax-7(nj48) mutants subjected to either chronic lon-1 RNAi or lon-1 RNAi from L1 exhibit 
a significant suppression of sax-7(nj48) mutant defects in the maintenance of head ganglia 
organization compared to control RNAi, while knockdown of lon-1 from L2 in sax-7(nj48) 
mutants did not significantly alter the phenotype compared to control RNAi. This indicates 
that loss of lon-1 function post-embryonically is sufficient to suppress sax-7(nj48) mutant 
defects. Error bars are standard error of proportion. Asterisks denote significant difference: 
*** P ≤ 0.001. (z-tests, P values were corrected by multiplying by the number of 




mutants, loss of lon-1 does not modify the defective maintenance of axon 
positioning in the ventral nerve cord, or the abnormal development of PVD 
dendrites of sax-7 mutants (Fig. 4.10). 
 
Several factors may contribute to the specificity of action of lon-1 in neuronal 
maintenance. One factor may be the timing of action of lon-1. sax-7 is required to 
maintain aspects of neuronal architecture at different time points during larval 
and adult stages, and defects resulting from the loss of sax-7 manifest at 
different ages. For instance, it is during the first larval stage that axons of the 
ventral nerve cord lose their normal position and flip over into the opposite 
fascicle in sax-7 mutants (Pocock et al 2008), as well as in other neuronal 
maintenance mutants (Aurelio et al 2002, Benard et al 2009, Benard et al 2006). 
On the other hand, head ganglia disorganization emerges in the third larval stage 
and progresses through adulthood in sax-7 mutants ((Benard et al 2012); Fig. 
4.2B). Perhaps lon-1 functions at later larval stages, interacting with sax-7 in a 
way that influences head ganglia organization at the third larval stage and 
onwards, but cannot impact the maintenance of the ventral nerve cord during the 
first larval stage.  
 
Consistent with this possibility, we found that knock down of lon-1 from post-
hatch and throughout larval stages via RNAi is sufficient to suppress sax-7 head 
ganglia defects (Fig. 4.18), indicating that lon-1 acts during larval stages. It is 
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unclear, however, how quickly lon-1 actually gets knocked down via RNAi, 
precluding our conclusion about its role during the first larval stage. Perhaps 
onset of PVQ axon flipover defects in sax-7 mutants during the first larval stage 
occurs at a time when lon-1 is not normally functionally required. In agreement 
with this, lon-1 appears to have very low expression in embryos and L1s, with 
peak expression in L2 and L3 (Celniker et al 2009), when the sax-7 PVQ axon 
flipover events have already occurred (Pocock et al 2008). It is possible that 
other early-acting molecular components function to maintain this structure along 
with sax-7. As a note, lon-1 function is also temporally restricted in the context of 
its role in body length regulation, as lon-1 mutants are initially wild type and 
display their Lon phenotype only at later larval stages (Maduzia et al 2002, Morita 
et al 2002).  
 
A second factor that may contribute to lon-1 suppressing specific neuronal 
defects of sax-7 mutants relates to the distinct cellular contexts in which the 
neuronal structures exist, and the associated molecular differences in the 
extracellular milieu and neighboring tissues. For instance, the soma of the ASI 
and ASH neurons are located in head ganglia, in close proximity with numerous 
other neurons, which are all ensheathed by a basement membrane that defines 
each of the ganglia (White et al 1986), and are located sandwiched between the 
pharynx on one side and the muscles and hypodermis on the other side. The 
axons of ASI and ASH are part of the nerve ring, which is composed of 
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numerous other axons and runs around the pharyngeal isthmus, and is also 
wrapped by cephalic sheath glia (Ware et al 1975, White et al 1986). On the 
other hand, the PVD neurons are located along the body wall on the sides of the 
animal, and are largely isolated from other neurons (White et al., 1986). The PVQ 
axons are yet in a different context, spanning the length of the ventral midline 
where they run along the fascicles of the ventral nerve cord, along with other 
axons, and in close proximity to the hypodermis (White et al 1986).  
 
One possible level of molecular specificity could come from interactions with the 
underlying basement membrane. The basement membrane is a specialized form 
of extracellular matrix that covers the interior surfaces of muscles, gonad, 
intestine, hypodermis, and pharynx (White et al 1976), structures which the 
nervous system is in contact with. Diversity in composition and thickness of 
basement membranes can vary in a tissue and temporal-specific manner 
(reviewed (Clay & Sherwood 2015, Kramer 2005) and could play a key role in 
creating a diverse environment for cell-cell interactions required for the 
development and maintenance of specific neuronal structures. Consistent with 
this, the large secreted maintenance factor DIG-1 plays important roles in 
maintaining the structure of the basement membrane (Benard et al 2006). 
Further research into the effect these maintenance factors, including LON-1, 
have on basement membrane regulation may provide insight into how these 
molecules function in long-term maintenance of neuronal architecture.  
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A third factor that may contribute to the specificity of action of lon-1 in 
suppressing some of the neuronal defects of the sax-7 mutants is the different 
tissue requirements for sax-7 function by a given neuronal structure. Consistent 
with this, SAX-7 functions in distinct tissues to mediate its developmental and 
maintenance roles. For example, SAX-7 functions within the nervous system in 
trans across different neurons in a non-cell-autonomous manner for maintaining 
head ganglia (Pocock et al 2008, Sasakura et al 2005), but functions in the 
hypodermis to guide developing PVD dendrites (Dong et al 2013, Salzberg et al 
2013), and loss of lon-1 could suppress the maintenance of head ganglia 
organization but not PVD development. Also, for a pair of neurons in the 
retrovesicular ganglion, AIY and AVK, expression of sax-7S(+) in both cells is 
required for maintaining proper cell contact (Pocock et al 2008). Likewise, we find 
that expression of sax-7S(+) in only the ASH/ASI and PVQ neurons is not 
sufficient for rescue, but rather that expression in multiple neurons within the 
head ganglia is required (Fig. 4.3 and 4.17). This suggests that neuron-to-
neuron interactions are an important aspect of the maintenance of head ganglia 
organization, which is distinct from the neuronal-hypodermal interaction which 
dictates the proper development of the PVD dendrites. Perhaps lon-1 function is 
specifically important for certain neuron-to-neuron sax-7-mediated interactions, 




Specificity of action in neuronal maintenance has also been observed in other 
mutants defective for the maintenance of neuronal architecture. While sax-7 and 
the large secreted maintenance factor dig-1 are required to maintain both the 
organization of the head ganglia and PVQ axon positioning, the two-Ig domain 
molecules zig-3 and zig-4 and a specific isoform of the FGF receptor egl-15 are 
required to maintain PVQ axon positioning but are dispensable for the 
maintenance of head ganglia organization (Aurelio et al 2002, Benard et al 2009, 
Benard et al 2006, Bülow et al 2004, Pocock et al 2008). This highlights that the 
maintenance of these different structures requires different molecular 
interactions, and our results indicate that lon-1 likely provides a level of molecular 
specificity in the maintenance of nervous system architecture.  
 
lon-1 specifically, and not other CAP superfamily molecules, functions to 
maintain nervous system architecture 
LON-1 is a member of the highly conserved CAP superfamily of molecules 
(Gibbs et al 2008, Maduzia et al 2002, Morita et al 2002), which is characterized 
by signature sequence motifs (Gibbs et al 2008). The CAP superfamily contains 
28 members in C. elegans, 33 in mice, and 31 in humans (Gibbs et al 2008). The 
functions of CAP superfamily molecules are not well understood, yet are 
implicated in a diverse set of functions (Gibbs et al 2008). In C. elegans, CAP 
superfamily molecules (reviewed in (Cantacessi et al 2009)) function to regulate 
body length (Maduzia et al 2002, Morita et al 2002), stress resistance, longevity 
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and aging (Patterson 2003), fat storage (Ashrafi et al 2003), as well as apoptosis 
and immune responses (Pinkston-Gosse & Kenyon 2007). In mammals, CAP 
superfamily proteins are implicated in the regulation of extracellular matrix, 
regulation of ion channels, cell-cell adhesion, and cancer (Gibbs et al 2008).  
 
We found that loss of three other CAP superfamily molecules (vap-1, scl-1, and 
scl-9), unlike loss of lon-1, did not affect the sax-7 mutant phenotype, highlighting 
the specificity of lon-1 function (Fig. 4.15). It is possible that the function of LON-
1 in neuronal maintenance involves its conserved CAP domain. In fact, both the 
e185 and qv10 mutations fall within this conserved domain ((Maduzia et al 2002, 
Morita et al 2002); Fig. 4.7), suggesting that this area of the protein is functionally 
important for neuronal maintenance. Future work will likely shed light on the 
relevance of this new function of lon-1 to its characterization as a CAP 
superfamily molecule.   
 
lon-1 functions to maintain nervous system architecture independent of 
body length and the TGF-β pathway  
lon-1 was first identified by its Lon phenotype (Brenner 1974) and was later 
characterized as a downstream target of the TGF-β signaling pathway to regulate 
body length (Maduzia et al 2002, Morita et al 2002). We find that the lon-1-
mediated suppression of sax-7 defects is independent of body length and the 
TGF-β signaling pathway (Fig. 4.12, 4.14, 4.16). Through this analysis we found 
210 
 
that both Lon and Sma mutants, which have drastically different body lengths 
and diameters, are able to consistently maintain the organization of head ganglia 
(Fig. 4.6, 4.12). Additionally, we have focused our attention on the Sma/Mab 
DBL-1 branch of the TGF-β pathway in which lon-1 functions as a downstream 
target (Maduzia et al 2002, Morita et al 2002), as lon-1 is not known to function in 
the other DAF-7/TGF-β branch of the pathway, which regulates dauer formation. 
DAF-7 functions from the ASI neurons to control dauer formation (Ren et al 1996, 
Schackwitz et al 1996), and the DAF-7 pathway regulates chemoreceptor 
expression in the ASH and ASI neurons (Lesch & Bargmann 2010, Nolan et al 
2002). Therefore, we expect that future work investigating the impact of this 
branch of the pathway on the maintenance of nervous system architecture either 
alone or in a sax-7-dependent way might be informative. 
 
lon-1 functions from the neurons or the underlying hypodermis to maintain 
nervous system architecture 
LON-1 is expressed in the hypodermis and intestine, which overlaps with its 
transcriptional expression pattern (Maduzia et al 2002, Morita et al 2002). CAP 
superfamily molecules, like LON-1, are often either secreted or GPI-anchored 
(Gibbs et al 2008). The primary amino acid sequence of LON-1 contains an N-
terminal signal peptide sequence (Maduzia et al 2002); therefore, it is possible 
that after being produced, LON-1 is secreted into the extracellular milieu. While it 
has been proposed that LON-1 could possibly function as a transmembrane 
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molecule, the data are lacking proper controls, and the hydrophobic sequence 
proposed to be the LON-1 transmembrane domain (Morita et al 2002) is instead 
where the signal peptide sequence and cleavage site reside (Maduzia et al 
2002). Therefore, it seems likely that LON-1 functions as a secreted molecule. 
Our work finds that LON-1 must be expressed in the neurons or underlying 
hypodermis to function in the maintenance of head ganglia organization (Fig. 
4.16). We found that expression from more distant tissues such as the body wall 
muscles or gut did not rescue. This suggests that if LON-1 is indeed a secreted 
molecule, it may function locally to maintain head ganglia organization. In support 
of LON-1 acting locally to its secretion site, LON-1 antibody staining reveals co-
localization with adherens junction marker MH27 in hypodermal and seam cells 
(Morita et al 2002). This puts LON-1 in a position to function in close proximity to 
transmembrane SAX-7 molecules, which act in the nervous system to maintain 
head ganglia organization. 
 
lon-1 and sax-7 function post-embryonically to maintain nervous system 
architecture  
Thus far, only a handful of molecules have been identified that function to 
maintain specific aspects of the nervous system. This likely is a reflection of the 
difficulty associated with determining an adult role for molecules that also play 
critical roles during development. Through the use of a heat-shock-induced 
expression system and temporally regulated gene knockdown by RNAi, we 
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determined that both sax-7 and lon-1 are actively required during larval 
development to maintain the organization of the head ganglia (ASH/ASI soma) 
and the nerve ring (Fig. 4.4 and 4.18), which are structures that develop during 
embryogenesis. This finding ruled out the possibility that the neuronal 
maintenance defects of sax-7 mutants were a result of an embryonic defect that 
was amplified by growth and movement of the animal. Instead, our finding is 
consistent with an active requirement for sax-7 and lon-1 post-embryonically to 
subsequently maintain the organization of an already established nervous 
system structure.  
  
A post-embryonic neuronal role for sax-7, the C. elegans homologue of the 
mammalian L1CAM family, is a conserved property of this gene family. Indeed, 
loss of L1CAM specifically from the adult mouse brain led to an increase in basal 
excitatory synaptic transmission and behavioral alterations (Law et al 2003).  In 
rats, post-developmental nervous system knockdown of Neurofascin severely 
compromised the already established composition of the axon initial segment 
and led to an onset of motor deficits (Kriebel et al 2011, Zonta et al 2011). 
Postnatal disruption of CHL1 in excitatory neurons of the forebrain affected the 
duration of working memory (Kolata et al 2008). Together these results highlight 
the continued importance of L1 family members in the adult nervous system for 
proper function, and also underscore the power of conditional loss of molecules 
to determine post-developmental roles. These results also point to a high degree 
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of functional conservation between sax-7 and L1CAM and indicate that findings 
from our work in C. elegans will likely have broad implications in other organisms. 
Through this work, we have identified LON-1 as a novel maintenance factor that 
functions with SAX-7 post-embryonically to maintain the architecture of the 
nervous system. Future studies that identify and characterize the other isolated 
sax-7 suppressor mutations from our screen might also shed light into the cellular 
and molecular basis of neuronal maintenance. 
 
MATERIALS AND METHODS 
 
Nematode strains and genetics 
Nematode cultures were maintained at 20oC (unless otherwise noted) on NGM 
plates seeded with OP50 bacteria as described (Brenner 1974). Alleles used 
listed in Table 4.1. Strains were constructed using standard genetic procedures 
and are all listed in Table 4.2. Genotypes were confirmed by genotyping PCR or 
sequencing when needed, using primers listed in Table 4.3, or by visible 
phenotypes for lon-1(qv10), lon-1(e185), lon-2(e678), lon-3(e2175), lon-
8(hu187), sma-6(wk7), sma-2(e502), sma-3(e491), and sma-4(e729). All mutant 
alleles and reporters were outcrossed at least three times prior to use for 
analysis or strain building.  
 
Neuroanatomical observations  
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Animals were mounted on agarose pads, anaesthetized with 100 mM sodium 
azide, and examined under a Zeiss Axio Scope.A1 or Zeiss Axioskop 2 Plus.  
Analysis of ASH/ASI cell body positioning with respect to the nerve ring 
Cell bodies of ASH/ASI and the nerve ring were visualized in adults using oyIs14 
(Sarafi-Reinach et al 2001), an integrated Psra-6::gfp reporter; hdIs29 (Schmitz 
et al 2008), an integrated Psra-6::DsRed2; Podr-2::gfp reporter; or hdIs26 (Hutter 
2003), an independent integrated Psra-6::DsRed2; Podr-2::gfp reporter. Unless 
otherwise noted, animals were selected as L4s and analyzed as 1-day adults. 
Animals were only analyzed when in a lateral orientation. Normally, both the two 
ASH and also the two ASI soma are located posterior to the nerve ring. Animals 
were counted as mutant when at least one ASH or ASI soma was touching, on 
top of, or anterior to the nerve ring. Animals were counted as wild type when all 
ASH/ASI soma were positioned posterior to the nerve ring.  
Analysis of PVQ axon flipover defects 
PVQ axons were visualized in L4 animals using oyIs14, an integrated Psra-6::gfp 
reporter (Sarafi-Reinach et al 2001). The axon of the PVQL and the PVQR 
neurons are normally maintained within the left and right fascicle of the ventral 
nerve cord, respectively. Animals were counted as having an axon flipover defect 
when one of the PVQ axons was flipped to the opposite fascicle at any point 
along the ventral nerve cord.  
Analysis of PVD dendritic branch development 
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PVD dendritic branches were visualized in L4 animals using wdIs52, an 
integrated F49H12.4::gfp reporter (Smith et al 2010, Watson et al 2008). The 
shape of the structure formed by the secondary and tertiary dendritic branches of 
PVD normally resembles a “T” shape, as described (Dong et al 2013, Smith et al 
2010). For each genotype, this shape was analyzed for multiple branches within 
a region anterior to the PVD cell body and categorized as the normal “T” shape, 
or abnormal variations such as “L”, “I”, loop, closed “Y”, open “Y”, or diagonally 
shaped. Percentage of animals with two or more non-T shaped branches was 
calculated.  
 
Identification of sax-7(qv24)  
Initially we were carrying out a zig-5(ok1065) zig-8(ok561) double mutant 
suppressor screen, as we were studying two members of the ZIG family of two-Ig 
domain proteins, zig-5 and zig-8, and their role in the maintenance of neuronal 
architecture. Our zig-5(ok1065) zig-8(ok561) double mutant strain exhibited 
defects similar to sax-7 mutants in the relative positioning between the ASH/ASI 
soma and the nerve ring (Benard et al 2012). We later found out, after the screen 
had been completed, that this neuronal maintenance defect in the zig-5(ok1065) 
zig-8(ok561) double mutant strain was in fact due to the presence of a 
spontaneous novel background mutation, which we have called sax-7(qv24). 
Following the screen, we determined that the phenotypic defects observed in our 
zig-5(ok1065) zig-8(ok561); sax-7(qv24) strain were solely due to the presence 
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of the sax-7(qv24) mutation and that loss of zig-5(ok1065) and zig-8(ok561) was 
dispensable for this phenotype.  
 
EMS forward genetic screen 
We carried out our forward screen for suppressors of neuronal maintenance 
defects using VQ90 sax-7(qv24); zig-5(ok1065) zig-8(ok561); glp-4(bn2ts); 
oyIs14) as our screening strain. glp-4(bn2ts), a temperature sensitive sterile 
mutation (Beanan & Strome 1992), was used to ease the analysis of populations 
of adult worms on a large scale, without being confused by their progeny. VQ90 
worms were grown at 15°C, mutagenized with 25 µM EMS, and allowed to 
recover at 15°C. Following recovery, five P0 mutagenized worms were plated 
onto five plates (25 P0s in total) and put back at 15°C to lay broods. From P0 
broods, 250 F1s were singled at the L4 or young adult stage (approximately 50 
F1s from each P0 plate). From each of the 250 F1 plates, seven F2s were singled 
for a total of 1750 F2s per mutagenesis round. After two days, these F2 plates 
were shifted to 25°C to prevent the production of progeny. Once reaching at least 
day five of adulthood, animals were incubated on ice to temporarily immobilize 
them and screened using Zeiss M2 Discovery stereo fluorescence microscopes 
to find broods that exhibited a high frequency of animals with the ASH/ASI soma 




Upon identification of a candidate suppressor, animals were re-singled from the 
corresponding F1 plate to re-isolate the suppressor and analyze the animals 
mounted on slides and quantify the degree of suppression using the Zeiss 
Axioskop 2 Plus.  
 
Outcrossing candidate suppressors 
Successfully re-isolated alleles were outcrossed with the strain VQ47 sax-
7(qv24); zig-5(ok1065) zig-8(ok561); hdIs29 to confirm candidates, clean 
background EMS-induced mutations, and get rid of the glp-4(bn2ts) mutant allele 
when possible. F3s were analyzed for re-isolation of the sax-7 suppression using 
the Zeiss Axioskop 2 Plus microscope.   
 
Removing the zig-5 and zig-8 mutations from the background of all the sax-
7(qv24) and lon-1(qv10) suppressor strains 
Due to the presence of zig-5(ok1065) and zig-8(ok561) mutations in our 
screening and outcrossing strains, all isolated suppressors and outcrossed 
suppressors also contained these mutations. For isolated sax-7 suppressor lon-
1(qv10), we crossed lon-1(qv10) away from zig-5(ok1065), zig-8(ok561), glp-
4(bn2ts), and sax7(qv24), before rebuilding as a double mutant with sax-7(qv24) 
to generate the lon-1(qv10); sax-7(qv24) double mutant. We ensured that all 
strains constructed and used in this work are wild type for zig-5(ok1065), zig-
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8(ok561), and glp-4(bn2ts) to be confident that our suppressor was not 
dependent upon the presence of these mutations. 
 
C. elegans constructs and microinjections to generate transgenic animals 
All inserts of finalized clones were verified by sequencing.  
Plon-1::lon-1a cDNA (pCB315): Vector Prgef-1::lon-1a (pCB254) was digested 
with PstI and BamHI to release Prgef-1 and ligated with insert of Plon-1 3-kb 
promoter (coordinates on cosmid F48E8: 28,244 to 31,288) amplified out of N2 
genomic DNA using nested primers oCB1266 (TTCAGCGTGTAAGAGTTGAG) 
and oCB1267 (TAGGTCTTCAAATACGAAGG) followed by oCB1268 
(CATGATCTGCAGTTTGATGGCTTGTACCTTGG) and oCB1269 
(ATCATGGGATCCTTTGCCATATGTCGTGACG) to add on PstI and BamHI 
sites. 
Plon-1::lon-1b cDNA (pCB316): Vector Prgef-1::lon-1b (pCB255) was digested 
with PstI and BamHI to release Prgef-1 and ligated with insert of Plon-1 3-kb 
promoter (coordinates on cosmid F48E8: 28,244 to 31,288) amplified out of N2 
genomic DNA using nested primers oCB1266 (TTCAGCGTGTAAGAGTTGAG) 
and oCB1267 (TAGGTCTTCAAATACGAAGG) followed by oCB1268 
(CATGATCTGCAGTTTGATGGCTTGTACCTTGG) and oCB1269 




Plon-1::lon-1 genomic (pCB317): Vector Plon-1::lon-1a (pCB315) was digested 
with XmaI and NcoI to release lon-1a cDNA and ligated with insert of lon-1 3.3-kb 
genomic (coordinates on cosmid F48E8: 31,289 to 34,582) amplified out of N2 
genomic DNA using nested primers oCB1270 (AGATACTCTCTTTCCACTGG) 
and oCB1271 (ATAAATGCAGCGGTATGCAC) followed by oCB957 
(CATGATCCCGGGATGAATTATCTGTTGACTGC) and oCB958 
(ATCATGCCATGGTTAAACTCTCATTCGGAACC) to add on XmaI and NcoI 
sites. 
Punc-14::lon-1a  cDNA (pCB318): Vector Pdpy-7::lon-1a (pCB249) was 
digested with HindIII and XmaI to release Pdpy-7 and ligated with insert of Punc-
14 1.4-kb promoter digested with HindIII and XmaI from Punc-14::sax-7L 
(pCB174). 
Pelt-2::lon-1a cDNA (pCB320): Vector Pdpy-7::lon-1a (pCB249) was digested 
with HindIII and XmaI to release Pdpy-7 and ligated with insert of Pelt-2 1-kb 
promoter (coordinates on cosmid C33D3: 2933 to 3875) amplified out of N2 
genomic DNA using nested primers oCB1058 (ACTTTGTAGGGTAATTGAGG) 
and oCB1061 (TCGGCTCATAGTTATTTGTGC) followed by oCB1059 
(CATGATAAGCTTTTGATTTTGTTTCACTCTGTG) and oCB1060 




Pelt-3::lon-1a cDNA (pCB322): Vector Prgef-1::lon-1a (pCB254) was digested 
with PstI and BamHI to release Prgef-1 and ligated with insert of Pelt-3 2-Kb 
promoter amplified out of Pelt-3::lon-2 (pCB218) using oCB1272 
(CATGATCTGCAGTGTGACACGTTGTTTCACG) and oCB1273 
(ATCATGGGATCCGAAGTTTGAAATACCAGGTAG) to add on PstI and BamHI 
sites. 
lon-1 RNAi (pCB328): Vector L4440 was digested with XmaI and NcoI and 
ligated with insert of lon-1 3.3-kb genomic (coordinates on cosmid F48E8: 31,289 
to 34,582) amplified out of N2 genomic DNA using nested primers oCB1270 
(AGATACTCTCTTTCCACTGG) and oCB1271 (ATAAATGCAGCGGTATGCAC) 
followed by oCB957 (CATGATCCCGGGATGAATTATCTGTTGACTGC) and 
oCB958 (ATCATGCCATGGTTAAACTCTCATTCGGAACC) to add on XmaI and 
NcoI sites. 
Psra-6:: sax-7S (pCB329): Vector Psra-6 was digested with XhoI and ApaI and 
ligated with insert of sax-7S 4.2-kb cDNA amplified out of Punc-14::sax-7S 
(pRP100) using oCB924 (CATGATCTCGAGATGGGGTTACGAGAGACGATG) 
and oCB886 (ATCATGGGGCCCGTACGGCCGACTAGTAGG) to add XhoI and 
ApaI sites. 
Pmyo-3::lon-1a cDNA (pCB352): Vector Pmyo-3 was digested with XbaI and 
NcoI and ligated with insert of lon-1a 1-kb cDNA digested out of Pdpy-7::lon-1a 
(pCB249) using XbaI and NcoI. 
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Posm-6::sax-7S (pCB363): Vector Punc-14::sax-7s (pRP100) was digested with 
HindIII and BamHI to release Punc-14 and ligated with Posm-6 2.1-kb promoter 
digested out of Posm-6::gfp::unc-54 3’ UTR (in pPD95.75 backbone) using 
HindIII and BamHI.  
Transgenic animals were generated by standard microinjection techniques (Mello 
& Fire 1995). Each construct was injected at 1 ng/μL (pCB191), 5 ng/μL 
(pRP100, pCB317, pCB315, pCB316, pCB318, pCB322, pCB320, and pCB352), 
or 75 ng/μL (pCB329 and pCB363), with two coinjection markers Pttx-3::mCherry 
at 50 ng/µL and Punc-122::rfp at 50 ng/µL. pBSK+ (25-99 ng/µL) was used to 
increase total DNA concentration of the injection mixes to 200 ng/µL.  
 
RT-PCR for sax-7 and lon-1 alleles 
Total RNA was extracted from worm samples using Trizol (Invitrogen) according 
to manufacturer’s instructions. 500 ng RNA was used to reverse transcribe using 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and 
random primers. PCR reactions were carried out with 1st strand cDNA template 
and primers oCB985 (CGATTTGCAACTCAACAGGA) and oCB987 
(GTGTCCCGAACTGATTCGAT) were used for sax-7 cDNA amplification. 
Primers oCB977 (TCCCACATGGTTTTCTCACA) and oCB979 
(CTGAACATAGTGACCGCAACA) were used for lon-1 cDNA amplification of all 
isoforms, while primers oCB977 (TCCCACATGGTTTTCTCACA) and oCB980 
(AAAGCTGTCCTCTCGCAGTG) were used specifically for lon-1a and primers 
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oCB977 (TCCCACATGGTTTTCTCACA) and oCB981 
(CCAGGTGAAAGCTGGCATCGTA) were used specifically for lon-1b.   Primers 
oCB992 (TCGCTTCAAATCAGTTCAGC) and oCB993 
(GCGAGCATTGAACAGTGAAG) were used for the control gene Y45F10D.4 
(Hoogewijs et al 2008) cDNA amplification. 
 
Heat-shock induced expression of sax-7S(+)  
Worms were maintained at 15°C for at least two generations prior to analysis. To 
generate freshly hatched pools of L1s, plates were washed three times with M9 
buffer to remove adults and larvae, leaving only embryos on the plates. These 
plates were put back at 15°C for three hours, after which freshly hatched L1s 
were pooled onto new plates. Animals were either heat shocked immediately as 
L1s, as L2s (~24 hours post-hatch), or as L3s (~42 hours post-hatch). Heat 
shock treatment consisted of 30 minutes at 37°C, 60 minutes recovery at 15°C, 
30 minutes at 37°C, followed by 15°C until analysis as adults. All experiments 
were repeated twice. Animals were examined as 1-day-old adults. 
 
lon-1 RNAi knockdown 
RNAi by feeding was based on previous methods (Kamath et al 2000, Timmons 
& Fire 1998). NGM plates were prepared with Ampicillin (Amp, 50 µg/ml) and 
IPTG (6 mM) and then kept unseeded at 4°C for a one week prior to starting 
experiment. RNAi bacteria from -80°C was streaked onto LB Amp (50 µg/ml) 
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Tetracyclin (12.5 µg/ml) plates and grown overnight at 37°C. Single colonies from 
these plates were grown overnight in LB Amp (50 µg/ml) liquid culture, and 
pelleted the next day to concentrate the bacteria. This concentrated bacteria was 
seeded onto NGM Amp/IPTG plates (room temperature), and these were then 
allowed to dry and induce overnight.  
Chronic RNAi condition. L4 sax-7(nj48); oyIs14 worms were put onto RNAi plates 
(lon-1, L4440 empty vector control (Timmons & Fire 1998), and pos-1 RNAi-
positive control (pos-1 RNAi control leads to embryonic lethality and serves as a 
control for effectiveness of RNAi technique (Tabara et al 1999)) and kept on 
these plates overnight. The next day, these worms were repeatedly transferred to 
fresh RNAi plates, and allowed to lay embryos for three hour windows before 
being transferred to a fresh plate. This was repeated to create multiple plates. 
Worms were maintained on freshly seeded RNAi plates, no more than three days 
old, until being analyzed as adults.  
RNAi from L1. Freshly hatched sax-7(nj48); oyIs14 L1s were maintained on 
freshly seeded RNAi plates, no more than three days old (as above) until being 
analyzed as adults.  
RNAi from L2. sax-7(nj48); oyIs14 L2s were maintained on freshly seeded RNAi 
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Table 4.1 List of mutant alleles used 
Gene Allele Nature of allele Reference 
sax-7 nj48 582 bp deletion, 12457-13038 on 
cosmid C18F3. 
(Sasakura et al 2005) 





e185 C185Y. Partial loss of function.  (Maduzia et al 2002, 
Morita et al 2002) 
lon-1 
 
qv10 G to A at position 33,209 on cosmid 
F48E8, introducing an early STOP. 




e678 ~9 kb deletion.  (Gumienny et al 2007) 
lon-3 e2175 Deletion of -2001 bp to +388 bp in 
relation to the initiator ATG codon and 
insertion of part of the transposon Tc5 
(1 bp to 2779 bp). DNA 
rearrangement in the lon-3 locus by 
Southern blot.  
(Nystrom et al 2002, 
Suzuki et al 2002) 
lon-8 hu187 360 bp deletion of the first exon and 
surrounding sequence corresponding 
to on 71710…72069 YAC Y59A8B. 
Short transcript still detected by 
Northern blot. 
(Soete et al 2007) 
dbl-1 nk3 5595 bp deletion, including almost all 
exons. Null. 
(Morita et al 1999) 
crm-1 tm2218 192 bp deletion and 1 bp insertion, 
with deletion corresponding to 
38330…38521 on cosmid B0024. 
Makes two truncated mRNA species. 
Loss of function allele.  
(Mitani lab at NBRP C. 
elegans; (Fung et al 2007)) 
sma-10 ok2224 906 bp deletion corresponding to 
20922…21827 on cosmid T21D12.  
(Consortium 2012) 
drag-1 tm3773 892 bp deletion corresponding to 
41703…42594 on YAC Y71G12B. 
(Mitani lab at NBRP C. 
elegans) 
sma-6 wk7 Y72 changed to an early STOP.  (Krishna et al 1999) 
sma-2 e502 G372D. (Savage et al 1996) 
sma-3 e491 G350R. (Savage et al 1996) 
sma-4 e729 Molecularly uncharacterized.  (Brenner 1974, Savage et 
al 1996) 
unc-129 tm5461 660 bp deletion corresponding to 
8166…8825 on cosmid C53D6.  







































tig-2 ok3416 ~800 bp deletion.  (Consortium 2012) 
adt-2 wk156 G364S. Partial loss of function.  (Fernando et al 2011) 
dig-1 ky188 Molecularly uncharacterized.  (Benard et al 2006, Zallen 
et al 1999) 
vap-1 ok392 576 bp deletion corresponding to 
3013…3588 on cosmid F11C7. 
(Consortium 2012) 
scl-1 ok1185 ~1600 bp deletion.  (Consortium 2012) 
scl-9 ok1138 910 bp deletion corresponding to 




Table 4.2 List of strains used.  
Strain  Genotype Transgene Reference 
N2   (Brenner 1974) 
VQ51 oyIs14 V Psra-6::gfp (Sarafi-Reinach et al 
2001) 
 hdIs29 V Psra-6::DsRed2; Podr-
2::gfp 
(Schmitz et al 2008) 
VH648 hdIs26 III Psra-6::DsRed2; Podr-
2::gfp 
(Hutter 2003) 
Strains for EMS suppressor screen 
VQ90 sax-7(qv24) IV; zig-5(ok1065) 
zig-8(ok561) III; glp-4(bn2ts) I; 
oyIs14 V 
 This study 
VQ47 sax-7(qv24) IV; zig-5(ok1065) 
zig-8(ok561) III; hdIs29 V 
 This study 
lon-1 and sax-7 mutants as single and double mutants   
VQ357 lon-1(e185) III; oyIs14 V  This study 
VQ484 lon-1(qv10) III; oyIs14 V  This study 
OH7984 sax-7(nj48) IV; oyIs14 V  (Benard et al 2012) 
VQ307 sax-7(qv24) IV; oyIs14 V  This study 
VQ397 sax-7(nj48) IV; hdIs29 V  This study 
VQ348 lon-1(e185) III; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ905 lon-1(e185) III; sax-7(qv24) IV; 
oyIs14 V 
 This study 
VQ909 lon-1(qv10) III; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ906 lon-1(qv10) III; sax-7(qv24) IV; 
oyIs14 V 
 This study 
Other lon mutants alone and with sax-7(nj48)  
VQ179 lon-2(e678) X; oyIs14 V  This study 
VQ619 lon-3(e2175) oyIs14 V  This study 
VQ620 lon-8(hu187) oyIs14 V  This study 
VQ358 lon-2(e678) X; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ849 sax-7(nj48) IV; lon-3(e2175) 
oyIs14 V 
 This study 
VQ677 sax-7(nj48) IV; lon-8(hu187) 
oyIs14 V 
 This study 
PVD labeled strains 
VQ787 wdIs52  This study 
VQ788 lon-1(e185) III; wdIs52   This study 
VQ789 sax-7(nj48) IV; wdIs52   




TGF-β pathway mutants alone and with sax-7(nj48) 
VQ796 dbl-1(nk3) V; hdIs26 III  This study 
VQ821 crm-1(tm2218) oyIs14 V  This study 
VQ836  sma-10(ok2224) IV; oyIs14 V  This study 
VQ822 drag-1(tm3773) I; oyIs14 V  This study 
VQ811 sma-6(wk7) II; oyIs14 V  This study 
VQ833 sma-2(e502) III; oyIs14 V  This study 
VQ834 sma-3(e491) III; oyIs14 V  This study 
VQ835 sma-4(e729) III; oyIs14 V  This study 
VQ775 unc-129(tm5461) IV; oyIs14 V  This study 
VQ777 tig-2(ok3416) oyIs14 V  This study 
VQ812 adt-2(wk156) X; oyIs14 V  This study 
VQ802 dbl-1(nk3) V; sax-7(nj48) IV; 
hdIs26 III 
 This study 
VQ857 sax-7(nj48) IV; crm-1(tm2218) 
oyIs14 V 
 This study 
VQ902 sma-10(ok2224) sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ850 drag-1(tm3773) I; sax-7(nj48) 
IV; oyIs14 V 
 This study 
VQ877 sma-6(wk7) II; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ842 sma-2(e502) III; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ869  sma-3(e491) III; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ870 sma-4(e729) III; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ794 unc-129(tm5461) sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ803 sax-7(nj48) IV; tig-2(ok3416) 
oyIs14 V 
 This study 
VQ843 adt-2(wk156) X; sax-7(nj48) IV; 
oyIs14 V 
 This study 
SCP domain mutant strains 
VQ863 vap-1(ok392) X; oyIs14  This study 
VQ882 vap-1(ok392) X; sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ871 scl-1(ok1185) IV; oyIs14 V  This study 
VQ884 scl-1(ok1185) sax-7(nj48) IV; 
oyIs14 V 
 This study 
VQ872 scl-9(ok1138) IV; oyIs14 V  This study 
VQ901 scl-9(ok1138) sax-7(nj48) IV; 
oyIs14 V 
 This study 
229 
 
ctIs40 (dbl-1(+++)) strains 
VQ618 ctIs40 X; hdIs29 V  This study 
VQ617 ctIs40 X; sax-7(nj48) IV; hdIs29 
V 
 This study 
dig-1 mutant strains 
OH3534 dig-1(ky188) III; oyIs14 V  This study 
OH3455 dig-1(ky188) lon-1(e185) III; 
oyIs14 V 
 This study 
Balancer strains for injection 
VQ683 lon-1(qv10)/dpy-17(e164) unc-
32(e189) III; oyIs14 V 
 This study 
VQ687 lon-1(e185)/dpy-17(e164) unc-
32(e189) III; sax-7(nj48) IV; 
oyIs14 V 
 This study 
Transgenic Lines    




pBSK+. Line #1   
This study 




pBSK+.  Line #2   
This study 
VQ922 sax-7(nj48); oyIs14; qvEx234 pCB191 (Phsp-16.2::sax-7(+)), 
Pttx-3::mCherry, Punc-122::rfp, 
pBSK+.  Line #1  
This study 




Punc-122::rfp, pBSK+.  Line 1 
This study 




Punc-122::rfp, pBSK+.  Line 2 
This study 




Punc-122::rfp, pBSK+.  Line 3 
This study 




122::rfp, pBSK+.  Line 1 
This study 




122::rfp, pBSK+.  Line 2 
This study 




122::rfp, pBSK+.  Line 3 
This study 




122::rfp, pBSK+.  Line 1 
This study 












122::rfp, pBSK+.  Line 3 
This study 
VQ697 lon-1(qv10); oyIs14; qvEx156 pCB317 (Plon-1::lon-1(+) 
genomic), Pttx-3::mCherry, 
Punc-122::rfp, pBSK+.  Line 1 
This study 
VQ930 lon-1(qv10); oyIs14; qvEx241 pCB317 (Plon-1::lon-1(+) 
genomic), Pttx-3::mCherry, 
Punc-122::rfp, pBSK+.  Line 2 
This study 
VQ931 lon-1(qv10); oyIs14; qvEx242 pCB317 (Plon-1::lon-1(+) 
genomic), Pttx-3::mCherry, 
Punc-122::rfp, pBSK+.  Line 3 
This study 
VQ934 lon-1(qv10); oyIs14; qvEx245 pCB315 (Plon-1::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 
VQ935 lon-1(qv10); oyIs14; qvEx246 pCB315 (Plon-1::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 2 
This study 
VQ936 lon-1(qv10); oyIs14; qvEx247 pCB315 (Plon-1::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 3 
This study 
VQ937 lon-1(qv10); oyIs14; qvEx248 pCB316 (Plon-1::lon-1b(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 
VQ938 lon-1(qv10); oyIs14; qvEx249 pCB316 (Plon-1::lon-1b(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 2 
This study 
VQ939 lon-1(qv10); oyIs14; qvEx250 pCB316 (Plon-1::lon-1b(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 3 
This study 
VQ940 sax-7(nj48); oyIs14; qvEx251 pCB317 (Plon-1::lon-1(+) 
genomic), Pttx-3::mCherry, 
Punc-122::rfp, pBSK+.  Line 1 
This study 
VQ941 sax-7(nj48); oyIs14; qvEx252 pCB317 (Plon-1::lon-1(+) 
genomic), Pttx-3::mCherry, 
Punc-122::rfp, pBSK+.  Line 2 
This study 
VQ942 sax-7(nj48); oyIs14; qvEx253 pCB317 (Plon-1::lon-1(+) 
genomic), Pttx-3::mCherry, 
Punc-122::rfp, pBSK+.  Line 3 
This study 
VQ943 sax-7(nj48); oyIs14; qvEx254 pCB363 (Posm-6::sax-7S(+)), 
Pttx-3::mCherry, Punc-122::rfp, 
pBSK+.  Line 1 
This study 
VQ944 sax-7(nj48); oyIs14; qvEx255 pCB363 (Posm-6::sax-7S(+)), 
Pttx-3::mCherry, Punc-122::rfp, 
pBSK+.  Line 2 
This study 
VQ945 sax-7(nj48); oyIs14; qvEx256 pCB363 (Posm-6::sax-7S(+)), 
Pttx-3::mCherry, Punc-122::rfp, 
pBSK+.  Line 3 
This study 
VQ946 sax-7(nj48); oyIs14; qvEx257 pCB329 (Psra-6::sax-7S(+)), 
Pttx-3::mCherry, Punc-122::rfp, 
pBSK+.  Line 1 
This study 




pBSK+.  Line 2 
VQ948 sax-7(nj48); oyIs14; qvEx259 pCB329 (Psra-6::sax-7S(+)), 
Pttx-3::mCherry, Punc-122::rfp, 
pBSK+.  Line 3 
This study 




122::rfp, pBSK+.  Line 1 
This study 




122::rfp, pBSK+.  Line 2 
This study 




122::rfp, pBSK+.  Line 3 
This study 




122::rfp, pBSK+.  Line 1 
This study 




122::rfp, pBSK+.  Line 2 
This study 




122::rfp, pBSK+.  Line 3 
This study 




122::rfp, pBSK+.  Line 1 
This study 




122::rfp, pBSK+.  Line 2 
This study 




122::rfp, pBSK+.  Line 3 
This study 




122::rfp, pBSK+.  Line 1 
This study 




122::rfp, pBSK+.  Line 2 
This study 
VQ949 lon-1(qv10); oyIs14; qvEx260 pCB318 (Punc-14::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 
VQ950 lon-1(qv10); oyIs14; qvEx261 pCB318 (Punc-14::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 2 
This study 
VQ951 lon-1(qv10); oyIs14; qvEx262 pCB318 (Punc-14::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 3 
This study 
VQ952 lon-1(qv10); oyIs14; qvEx263 pCB322 (Pelt-3::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 





122::rfp, pBSK+.  Line 2 
VQ954 lon-1(qv10); oyIs14; qvEx265 pCB322 (Pelt-3::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 3 
This study 
VQ955 lon-1(qv10); oyIs14; qvEx266 pCB320 (Pelt-2::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 
VQ956 lon-1(qv10); oyIs14; qvEx267 pCB320 (Pelt-2::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 2 
This study 
VQ957 lon-1(qv10); oyIs14; qvEx268 pCB320 (Pelt-2::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 3 
This study 
VQ958 lon-1(qv10); oyIs14; qvEx269 pCB352 (Pmyo-3::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 
VQ959 lon-1(qv10); oyIs14; qvEx270 pCB352 (Pmyo-3::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-
122::rfp, pBSK+.  Line 1 
This study 
VQ960 lon-1(qv10); oyIs14; qvEx271 pCB352 (Pmyo-3::lon-1a(+) 
cDNA), Pttx-3::mCherry, Punc-





























Table 4.3 Primers used for strain building  
Gene Primer Sequence PCR product 
(bp) 
sax-7(nj48)    
Mutant specific oCB1022 tggtggtagcgatggtgtag 257 
 oCB208 gagttattggggtattttagcg  
Wild-type specific oCB212 gaaatacacacaaatacgagtgc 592 
 oCB723 tagttgattaaaatgtttcaagattg  
sax-7(qv24)  dCAPS primers   
Mutant specific oCB916 cgaacattcaatgttgtagtggcgg 264 
 oCB917 ccatttaaaaaattatattcgaccccaatatttcc  
Wild-type specific oCB915 ggatattgatcgaacattcaatgttgtagtccagg 264 
 oCB917 ccatttaaaaaattatattcgaccccaatatttcc  
PCR products digested to determine genotype. Mutant specific product digested with EciI only cuts qv24 
sequence, wild-type specific product digested with BsaJI only cuts wild type sequence. 
dbl-1(nk3)    
Mutant specific oCB1336 ttctgcatcgtatcagttcc 633 
 oCB1338 aaggatcagtgcatacagac  
Wild-type specific oCB1336 ttctgcatcgtatcagttcc 307 
 oCB1337 tttgacgatagacgaagagc  
crm-1(tm2218)    
Mutant specific oCB1368 atgcttgtggcactgatgg 562 
 oCB1370 agagacaaccacttgaaacc  
Wild-type specific oCB1368 atgcttgtggcactgatgg 577 
 oCB1369 tgcacttggatcggcatacc  
sma-10(ok2224)    
Mutant specific oCB1393 tattgctaaatgttcctacc 533 
 oCB1395 aatcagagaacgtcgtctgg  
Wild-type specific oCB1393 tattgctaaatgttcctacc 651 
 oCB1394 tcaaaataatggtgcgtcagc  
drag-1(tm3773)    
Mutant specific oCB1390 tatgagacggcactggaagg 346 
 oCB1392 ttctcacgagaacagtaacc  
Wild-type specific oCB1390 tatgagacggcactggaagg 1028 
 oCB1391 tgaaatagcatctggaacag  
unc-129(tm5461)    
Mutant specific oCB1333 agaaatgtaatgccactcacc 538 
 oCB1335 agatggtaatctggtacgtgc  
Wild-type specific oCB1333 agaaatgtaatgccactcacc 517 
 oCB1334 taatgatgttcgagttgtgc  
Mutant specific oCB1341 agtgtttccagacaggccac 600 
 oCB1342 gagttgtggaggcggatcta  
Wild-type specific oCB1341 agtgtttccagacaggccac 588 
 oCB1345 agtgtgaccatctatcgacc  
adt-2(wk156)    
 oCB1388 ttaccagacaaccggtaggg 553 
 oCB1389 tgatgacatgatatgcttgg  
PCR product sent to sequence with oCB1388 to determine genotype. 




 oCB1414 aaaacgttgtggtagaatggc  
Wild-type specific oCB1413 agtaggtggtgcattcagc 609 
 oCB1415 ttagaaccgtaggacttacg  




Mutant specific oCB1421 atacctgtatactttttctcgg 616 
 oCB1422 agttccttttgccacgtagg  
Wild-type specific oCB1421 atacctgtatactttttctcgg ~500 
 oCB1423 accaattgctaggaggcagag  
scl-9(ok1138)    
Mutant specific oCB1424 tgacaagtataccgaagagc 434 
 oCB1425 agtcccatccattggtttcg  
Wild-type specific oCB1424 tgacaagtataccgaagagc 396 













































Part I: Heparan sulfate synthesis is required for guidance during 
development 
Heparan sulfate proteoglycans (HSPGs) have critical and diverse functions in 
development, owing in part to their interactions with receptors and ligands of 
numerous signaling pathways. While HSPGs were previously thought of as 
extracellular space-filling molecules, it has become clear that they play dedicated 
and specific roles in the modulation of signaling pathways to ensure proper 
development. One level of added complexity in the study of HSPGs is that 
functions attributed to specific HSPGs can be mediated by the core protein, the 
heparan sulfate (HS) chains, or a combination of both. Research focused on HS 
biosynthesis will likely improve our understanding of the regulation of HS chains 
on core proteins and how specifically the HS chains function to affect biological 
processes.  
 
Although C. elegans is a strong model for the investigation of biological questions 
concerning HS biosynthesis, previously available mutants for the enzymes that 
synthesize HS chains in C. elegans were lethal (Franks et al 2006, Kitagawa et al 
2007, Morio et al 2003). We have now isolated and identified viable mutations in 
the two subunits of the HS co-polymerase, rib-1 and rib-2, that function together 
to synthesize HS chains onto core proteins to generate HSPGs. These mutants 
have allowed us to study the impact of impaired HS biosynthesis using C. 
elegans in a manner that was previously unavailable. My thesis work has 
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characterized the axon and cell guidance defects exhibited by our rib-1 and rib-2 
mutants as a result of compromised HS biosynthesis. We have confirmed that 
HS biosynthesis is impaired in our rib-1 and rib-2 mutants, both in general and 
onto specific core proteins. We analyzed the expression pattern and localization 
of RIB-1 and found that it is expressed dynamically during development with 
continued expression through adulthood. Our work demonstrates that modified 
HS chains function with both the SLT-1/Slit and UNC-6/netrin signaling pathways 
in axon guidance. In addition, we have found that the coordinated expression of 
HS from multiple tissue types is required to properly guide axons. This work 
provides an avenue for the future use of the powerful model organism C. elegans 
to study HS biology and how it relates to many biological processes.   
 
Insights from the RIB-1 expression pattern and the requirement for coordinated 
expression of HSPGs in development    
HS chains are synthesized and modified in the Golgi to generate HSPGs which 
are subsequently transported to the membrane or secreted. Our analysis of the 
expression and localization of RIB-1, one of the enzymes that functions to 
polymerize HS chains, sheds light on the specific sites where HS biosynthesis 
takes place in C. elegans. In particular, we saw expression in a number of 
tissues including the pharynx, neurons, muscles of the digestive and reproductive 
system, and some hypodermal cells. This overlaps with known expression 
patterns of specific HSPG core proteins. For example, membrane bound SDN-
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1/syndecan is expressed in neurons, hypodermis, and pharynx (Rhiner et al 
2005), and GPI-linked LON-2/glypican shows expression in the intestine and 
hypodermis (Gumienny et al 2007). UNC-52/perlecan, a secreted HSPG, is 
expressed in body wall muscles, digestive system muscles, and pharynx (Mullen 
et al 1999, Rogalski et al 1993); Mullen et al., 1999). Overlap between 
expression of HS biosynthetic machinery, such as RIB-1, and the localization of 
specific HSPGs, suggests that HSPGs may remain near cells where HS 
synthesis occurs. This may have functional relevance, as glypicans in fibroblast 
cells were shown to be internalized through endocytosis, returned to the Golgi, 
and then transported back to the membrane with HS chains altered both in length 
and modification pattern (Edgren et al 1997, Fransson et al 1995). Whether an 
internal recycling of HSPGs back to the HS biosynthetic machinery in the Golgi 
occurs in C. elegans, or whether it has functional relevance to guidance, remains 
to be determined.      
 
We demonstrated that HS synthesis is functionally required in multiple tissues, 
specifically the muscles, hypodermis, and neurons, for PVQ axon guidance. This 
suggests that a coordinated multi-tissue interaction between HSPGs drives PVQ 
axon guidance, and that likely the rescue is a result of restored HS synthesis 
onto core proteins that function in those tissues. Consistent with the idea that 
multiple HSPGs function together to guide the PVQ axons, double mutants 
lacking  lon-2/glypican and sdn-1/syndecan exhibit a higher penetrance of PVQ 
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axon guidance defects than either single mutant alone (Diaz-Balzac et al 2014). 
It is likely that not only HS, but modified HS chains on specific core proteins are 
required to guide the PVQ axons, as loss of HS-modifying enzymes in different 
combinations leads to enhanced PVQ axon guidance defects compared to the 
single mutants alone (Bülow & Hobert 2004). This is not an isolated example, as 
we also found that rib-1 is required either in the neuron itself, or in the underlying 
hypodermis for proper AVM axon guidance. We expect that analysis of our rib-1 
and rib-2 mutants will provide insight into more examples where the coordinated 
interactions between HSPGs are required for cell and axon guidance during 
development.  
 
Continued post-embryonic requirement for HS and relevance to synapses 
Through our analysis of the expression and localization of rib-1, we found that 
rib-1 continues to be expressed in adult worms, and in some tissues expression 
levels visibly increased with age. This is consistent with C. elegans expression 
profiling datasets which show continued expression of both rib-1 and rib-2 from 
the beginning of embryogenesis through adulthood (Celniker et al 2009). This 
hints that HS synthesis may not only be critical for early development, but also 
may have continued functions in adulthood as well. Indeed, there is evidence for 
a critical function of HS synthesis in the post-natal mouse brain. Conditional loss 
of EXT1 in postnatal excitatory neurons led to autism-like behavioral deficits as 
well as defects in excitatory synaptic transmission resulting from reduced surface 
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expression of glutamatergic receptors (Irie et al 2012). An association with 
autism has also been seen in humans with mutations in EXT1 (Li et al 2002). 
 
Work from the conditional EXT1 knockout mouse suggests that HS plays 
important roles at the post-natal synapse (Irie et al 2012). Consistent with this, 
HSPGs have been shown to have synaptic functions, for example agrin and 
perlecan are involved in the clustering of acetylcholine receptors and 
acetylcholinesterase at the NMJ, respectively (Arikawa-Hirasawa et al 2002, 
Glass et al 1996, Godfrey et al 1984, Nitkin et al 1987, Peng et al 1999). 
Syndecan promotes mature dendritic spine formation in hippocampal neurons, 
while also being important for synaptic growth at Drosophila NMJs (Ethell & 
Yamaguchi 1999, Johnson et al 2006), and glypicans have implicated roles in 
synaptogenesis such as the formation of the active zone and the regulation of 
glutamatergic receptor clustering (Allen et al 2012, Johnson et al 2006). In some 
cases the HS chains on the core proteins were shown to be required for these 
functions (Allen et al 2012, Johnson et al 2006). 
 
Despite the involvement of multiple HSPGs in different aspects of synapse 
biology, our understanding of the role that the HS chains play in synaptogenesis 
remains limited. While it is clear from the EXT1 conditional knockout mouse 
study that HS chains are important for receptor clustering and synaptic 
transmission (Irie et al 2012), there is still much more for us to learn about the 
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role of HS chains in the regulation of synapses. Our newly isolated, viable rib-1 
and rib-2 mutants, as well as the knowledge that RIB-1 expression persists post-
embryonically, provide an opportunity to study the impact of HS biosynthesis on 
synapses in C. elegans. This type of work could help to clarify the importance of 
the HSPG core protein versus the HS chains in these processes, and expand our 
knowledge on the role of HS in synaptogenesis and how that relates to the 
function of the nervous system.  
 
Parallels between rib-1/rib-2 mutants and hereditary multiple exostoses  
We characterized various guidance events in our rib-1 and rib-2 mutants to 
determine the impact of impaired HS biosynthesis, and found guidance defects in 
cells and axons that migrate both embryonically and post-hatch. During this 
analysis we also observed in multiple cases a tendency for overgrowth of 
material. For example, when analyzing AVM ventral axon guidance in our rib-1 
and rib-2 mutants we observed AVM neurons with bipolar axon projections 
emanating from the cell body. We also saw instances in our rib-1 and rib-2 
mutants where the HSN axon sent out two projections from the cell body, each 
projecting in opposite directions. This was not limited to the nervous system; 
when we analyzed the canals of the excretory cell which consists of four canals 
(two anterior and two posterior), we found examples of rib-1 and rib-2 mutant 
animals with five canals. These phenotypes suggested that somehow the loss of 
normal HS biosynthesis created an environment which favored extra growth. 
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RIB-1 and RIB-2 are homologous to the mammalian EXT1 and EXT2/EXTL3, 
respectively (Clines et al 1997, Kitagawa et al 2001). These phenotypes of 
overgrowth observed in the rib-1 and rib-2 mutants draw intriguing parallels with 
the disorder hereditary multiple exostoses (HME), which is an autosomal 
dominant disorder linked to mutations in human EXT1 and EXT2 (Cook et al 
1993, Francannet et al 2001, Le Merrer et al 1994, Wu et al 1994, Wuyts & Van 
Hul 2000). HME is characterized by cartilaginous bone tumors known as 
osteochondromas which form at the growth plates of long bones and are often, 
but not always, benign (Schmale et al 1994, Solomon 1964). It remains unknown 
how loss of function of EXT1 or EXT2, or the consequent reduction in HS 
synthesis, can lead to HME. Our isolated hypomorphic rib-1 and rib-2 mutants 
provide us with the opportunity to use C. elegans as a model to decipher how 
loss of HS biosynthesis can lead to overgrowth of specific tissues.  
 
 
Part II: Glypican is a modulator of netrin-mediated guidance  
While many of the signaling molecules, receptors, and downstream cascades 
involved in wiring a complex nervous system have been identified, simply 
knowing the key players is not enough. The number of guidance decisions 
required to pattern a functional nervous system far outnumber the combinations 
of implicated signaling pathways involved in this process. Therefore, 
mechanisms must exist to precisely modulate in space and time how developing 
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axons respond to these cues. While some signaling pathways have been shown 
to be modulated in this manner, how the netrin signaling pathway is regulated 
extracellularly was unknown.  
 
The C. elegans nervous system provided us with single cell resolution with which 
to study netrin-mediated axon guidance, and we used this system to provide 
insight into how the netrin signaling pathway is regulated by extracellular 
molecules. My thesis work identified that LON-2/glypican, a HSPG, modulates 
the netrin pathway that guides migrating axons and cells. This work sheds light 
on how UNC-6/netrin signals are modulated extracellularly to properly wire the 
nervous system. We provide evidence that LON-2/glypican functions both in the 
attractive and repulsive UNC-6/netrin-mediated guidance pathways. Our work 
demonstrates that the N-terminal globular region of LON-2/glypican, which lacks 
HS chains, is sufficient for its function in netrin-mediated guidance. We 
determined that LON-2/glypican functions non-autonomously in the hypodermis 
to exert its effects on migrating cells and axons. We broadened our genetic 
results by demonstrating that LON-2/glypican associates with UNC-40/DCC 
receptor-expressing cells. This work has identified a novel interaction between a 
HSPG core protein, LON-2/glypican, and the UNC-40/DCC netrin receptor, to 




Domains required for the interaction between LON-2/glypican and UNC-40/DCC 
in UNC-6/netrin-mediated guidance  
Our cellular assays investigated the interactions between LON-2/glypican, UNC-
6/netrin, and the UNC-40/DCC receptor, and indicated that LON-2/glypican 
molecules were preferentially transferred from the LON-2/glypican-expressing 
cells to the UNC-40/DCC receptor-expressing cells. We found that the interaction 
between LON-2/glypican and the UNC-40/DCC-expressing cells required the 
extracellular portion of UNC-40/DCC, yet was independent of the fourth and fifth 
FnIII domains, which are required for UNC-6/netrin binding (Geisbrecht et al 
2003, Kruger et al 2004). Therefore, an extracellular UNC-40/DCC domain or 
sequence motif, aside from the fourth and fifth FnIII domains, likely mediates this 
interaction with LON-2/glypican.  
 
UNC-40/DCC is an immunoglobulin superfamily transmembrane receptor (Chan 
et al 1996) that consists of four Ig-like domains, six fibronectin type III domains 
(FnIII), a transmembrane domain, and a cytoplasmic tail which contains 
conserved sequence motifs P1, P2, and P3 (Keino-Masu et al 1996). It will be 
important to test which parts of the UNC-40/DCC receptor mediate this 
interaction with LON-2/glypican, by deleting parts of the UNC-40/DCC receptor 
and testing in our cellular assays to determine the critical sequences required for 
an interaction with LON-2/glypican. It would also be informative to test the 
interactions between LON-2/glypican and UNC-40/DCC in a pull-down assay, to 
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provide more direct evidence of a possible physical interaction, either directly or 
within a complex, between LON-2/glypican and the UNC-40/DCC receptor.  
 
LON-2/glypican is a GPI-anchored HSPG that has an N-terminal globular head 
structured by cysteine disulfide bonds, and a C-terminal neck region where three 
HS chain attachment sites reside (Gumienny et al 2007, Taneja-Bageshwar & 
Gumienny 2012). We found that the N-terminal globular head of LON-2/glypican, 
independent of HS chains, was sufficient for function in netrin-mediated 
guidance.  Future experiments addressing the sequences within this region of 
LON-2/glypican required for its function will complement the UNC-40/DCC 
domain analysis. Together these experiments have the potential to provide 
mechanistic insight into how LON-2/glypican and UNC-40/DCC function together 
either directly or within a complex to modulate netrin signaling.  
 
Possibility that LON-2/glypican interacts with UNC-6/netrin  
While we found that UNC-6/netrin and LON-2/glypican could both interact with 
UNC-40/DCC-expressing cells at the same time, we were unable to detect an 
interaction between UNC-6/netrin and LON-2/glypican in our cellular assays.  We 
speculated this may be due to both molecules being secreted into the medium, 
and based on our results, we cannot rule out a possible interaction between the 
UNC-6/netrin and LON-2/glypican molecules. In the future it will be important to 
use an alternative assay, such as a pull-down, to possibly detect an interaction 
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between UNC-6/netrin and LON-2/glypican that was previously undetectable with 
our cellular assays, especially considering netrin has been shown to bind heparin 
in vitro (Kappler et al 2000, Kennedy et al 1994, Shipp & Hsieh-Wilson 2007). 
Determining whether LON-2/glypican molecules interact with UNC-40/DCC 
alone, or with both UNC-40/DCC and UNC-6/netrin, will provide mechanistic 
insight into how LON-2/glypican might function to regulate netrin signaling. For 
example, if LON-2/glypican interacts with both UNC-6/netrin and UNC-40/DCC, it 
could play a role in facilitating receptor-ligand interactions. Alternatively, if LON-
2/glypican specifically interacts with UNC-40/DCC but not UNC-6/netrin, it may 
point to a modulation of netrin-mediated guidance through effects on the receptor 
alone.   
 
Potential for regulation of UNC-40/DCC receptor by LON-2/glypican  
We demonstrated that LON-2/glypican molecules are shed from the cell surface 
to then interact with UNC-40/DCC expressing cells. To elucidate the mechanism 
by which LON-2/glypican modulates UNC-6/netrin signaling, it is critical to 
determine the effect of this interaction between LON-2/glypican and UNC-
40/DCC expressing cells. It has been shown in C. elegans that the UNC-40/DCC 
receptors ventrally cluster during ventral axon outgrowth of the HSN neurons, 
and that this is controlled by UNC-6/netrin (Adler et al 2006). We wondered if 
LON-2/glypican, like UNC-6/netrin, could play a role in clustering or organizing 
UNC-40/DCC receptors ventrally to mediate axon outgrowth. Our analysis of 
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UNC-40/DCC clustering in AVM was hindered by UNC-40::GFP being 
undetectable until after AVM axon outgrowth had occurred (data not shown). We 
were able to detect the ventral accumulation of UNC-40::GFP in the HSN soma 
at the time of axon outgrowth, and while we did see a disruption of this in unc-6 
mutants (Adler et al 2006), we did not detect a difference in this between wild 
type and lon-2/glypican mutants (data not shown).  
 
While we did not detect any gross differences in UNC-40::GFP localization in the 
HSNs, this does not completely rule out a role for LON-2/glypican in directional 
UNC-40/DCC receptor clustering. For example, there could be subtle defects in 
timing of ventral clustering which our analysis did not pick up, that could have an 
impact on a temporally-controlled axon guidance event. In addition, our 
quantification was done in a binary fashion where either UNC-40::GFP was, or 
was not, ventrally localized at a specific time point. Future analysis of the levels 
of ventrally localized UNC-40::GFP between wild type and lon-2/glypican mutants 
may provide insight into the regulation of the UNC-40/DCC receptor localization 
and whether LON-2/glypican plays a role.  
 
Alternatively, perhaps this negative result points to an interaction between LON-
2/glypican and UNC-40/DCC that does not strictly affect localization of the UNC-
40/DCC receptor. DCC dimerizes when bound to netrin (Stein et al 2001) and 
crystal structures of DCC bound to netrin-1 have revealed that in these dimerized 
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DCC molecules, netrin-1 bridges the two DCC molecules through interactions 
with the fourth fibronectin type III domain of one DCC molecule and the fifth 
fibronectin type III domain of the other (Finci et al 2015, Xu et al 2014). An 
interaction between HS and the dimerization of receptors has been shown for 
another signaling pathway critical for development, the fibroblast growth factor 
(FGF) pathway. Crystal structure analysis revealed that two fibroblast growth 
factor receptors (FGFRs) dimerize with two FGF molecules (Plotnikov et al 1999) 
and that HS is critically involved in forming, and likely stabilizing this dimerized 
structure (Pellegrini et al 2000, Schlessinger et al 2000). Perhaps LON-
2/glypican could play a role in some aspect of the dimerization of UNC-40/DCC 
receptors, and impact UNC-6/netrin signaling through this type of mechanism.  
    
Insight into this possibility comes from the crystal structure of Netrin-1 either 
bound to two DCC receptors to mediate attraction, or to one DCC and one 
UNC5A receptor to mediate repulsion (Finci et al 2015). This work uncovered 
that Netrin-1 has one binding site that is DCC specific, and another generic 
binding site which can bind either DCC or the repulsive netrin receptor, UNC5A 
(Finci et al 2015). However, it is unknown how the netrin-1 molecule switches 
between the DCC dimer alone, to the dimer of DCC with UNC5A. Finci et al., 
2015 speculates that HSPGs could be the missing link in determining which 
receptor Netrin-1 will interact with. They propose that Netrin-1, bound to one 
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HSPG, could preferentially interact with DCC whereas when bound to a different 
HSPG could instead favor an interaction with UNC5A (Finci et al 2015).  
 
In C. elegans UNC-40/DCC mediates attractive guidance towards UNC-6/netrin, 
while UNC-40/DCC with UNC-5/UNC5, or UNC-5/UNC5 alone mediates 
repulsive guidance away from UNC-6/netrin (Chan et al 1996, Hedgecock et al 
1990, Leung-Hagesteijn et al 1992). We have shown that LON-2/glypican 
functions with UNC-6/netrin signaling to mediate both attractive and repulsive 
guidance processes, and that LON-2/glypican molecules interact with cells 
expressing the UNC-40/DCC receptor which is involved in both processes. 
Perhaps LON-2/glypican could function as the molecular switch which assists 
UNC-6/netrin molecules in determining which netrin receptor to associate with to 
carry out a given guidance process. It will be important to test with our cellular 
assays whether LON-2/glypican can interact with cells expressing the UNC-
5/UNC5 receptor, as this would provide insight into whether the function of LON-
2/glypican in netrin-mediated attractive and repulsive guidance is due to 
interactions with the UNC-40/DCC receptor alone, or whether it functions with 
both UNC-40/DCC and UNC-5/UNC5 in these processes.  
 
It is possible that other HSPGs may function in netrin-mediated repulsive 
guidance, though specifically through interactions with the UNC-5/UNC5 receptor 
alone. For example, sdn-1/syndecan mutants exhibit defects in motorneuron 
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axon guidance (Gysi et al 2013, Rhiner et al 2005), a process driven by unc-
6/netrin-mediated repulsive signaling (Hedgecock et al 1990, Hedgecock et al 
1987). We demonstrate that for ventral axon guidance of AVM, sdn-1/syndecan 
functions with the repulsive slt-1/slit signaling pathway, and independently of unc-
40/DCC. Furthermore, through our cellular assays we determined that SDN-
1/syndecan molecules do not get transferred to UNC-40/DCC expressing cells. It 
would therefore be interesting to investigate using our cellular assays whether 
SDN-1/syndecan molecules interact with UNC-5/UNC5 receptor expressing cells, 
as perhaps SDN-1/syndecan functions in repulsive netrin-mediated guidance 
with the UNC-5/UNC5 receptor.  
   
Mode of action of LON-2/glypican on UNC-6/netrin signaling  
While our work provides novel insight into how netrin-mediated signals are 
modulated extracellularly, we still aim to determine the specific impact LON-
2/glypican has on UNC-6/netrin signaling. Our results suggest that LON-
2/glypican functions to enhance UNC-6/netrin signals. For example, we showed 
that loss of lon-2/glypican reduced the penetrance of netrin-dependent 
dorsalization of PVM upon expression of Pmec-7::unc-5. This suggested that 
unc-6/netrin signaling was somehow compromised in the lon-2/glypican mutant 
background. In addition, we have evidence from our cellular assays that the 
presence of LON-2/glypican enhances UNC-6/netrin downstream signaling. 
Previous literature has shown that cells expressing DCC exhibited an increase in 
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membrane extensions due to an overactivation of DCC downstream signaling 
pathways (Shekarabi & Kennedy 2002). We also demonstrated in our cellular 
assays that the expression of UNC-40/DCC in cells led to an increase in 
membrane extensions, which was enhanced by the presence of LON-2/glypican. 
It will be important to directly test whether LON-2/glypican functions to enhance 
UNC-6/netrin signals, and there are hints from the literature that a HSPG, like 
LON-2/glypican, could function to amplify netrin signals.   
 
When netrin was first purified, a second component termed “NSA” was present 
that potentiated the axon outgrowth activity of netrin. Its identity has remained a 
mystery, though its biochemical properties were consistent with the possibility of 
it being a HSPG (Kennedy et al 1994). Perhaps the function of LON-2/glypican, 
similar to what was seen with NSA, is to boost netrin signals. This could be 
useful in situations where increased netrin sensitivity is required for proper 
guidance, such as in situations where concentrations of netrin are low. We could 
test this using spinal cord explant assays which examine axon outgrowth in 
response to netrin. If LON-2/glypican does function to boost netrin signals, like 
NSA, we would expect to see an enhancement in netrin-mediated axon 
outgrowth in the presence of LON-2/glypican with netrin, as compared to netrin 
alone. This would provide direct evidence as to the role LON-2/glypican plays in 
modulating UNC-6/netrin signaling to mediate axon guidance, and perhaps may 
serve to identify that LON-2/glypican is the thus far unidentified NSA molecule. 
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Part III: LON-1 functions with SAX-7/L1CAM to maintain nervous system 
architecture 
After the complex process of nervous system development, the challenge of how 
to preserve its structure and function begins. Although research using C. elegans 
has identified a handful of molecules with dedicated roles in the maintenance of 
neuronal architecture, our knowledge of the mechanisms by which these 
molecules function to preserve established nervous system structures remains 
limited. One molecule that functions to maintain nervous system architecture is 
SAX-7/L1CAM. In order to determine the molecular mechanisms by which SAX-7 
functions to maintain the nervous system, and identify conserved neuronal 
protection molecules, we carried out a forward genetic screen for suppressors of 
the sax-7 mutant defects in the maintenance of head ganglia organization.  
 
Through this screen, we identified lon-1 as a novel suppressor of the sax-7 
defects in the maintenance of head ganglia organization. Although the known 
function of lon-1 resides in its function in body length regulation through the TGF-
β signaling pathway, we determined that the lon-1-mediated suppression of sax-7 
defects is independent of body length and the TGF-β signaling pathway. We 
determined that lon-1 is a context-dependent suppressor of sax-7 as loss of lon-1 
is unable to suppress all sax-7 defects. Expression of lon-1 in the nervous 
system or hypodermis is sufficient for its function in the maintenance of neuronal 
architecture, and this overlaps with the requirement of sax-7 in multiple adjacent 
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neurons for proper maintenance. We found that post-embryonic expression of 
sax-7 or loss of lon-1 was sufficient to maintain nervous system architecture in 
sax-7 mutants, highlighting a post-embryonic role for both sax-7 and lon-1 in 
nervous system maintenance. My thesis work has identified lon-1 as a novel 
maintenance factor that functions with sax-7 to post-embryonically maintain the 
architecture of the nervous system.  
 
Manifestation of head ganglia disorganization  
While we know that the relative positioning between the ASH/ASI soma and the 
nerve ring fails to be maintained in sax-7 mutants, yet is able to be maintained in 
lon-1; sax-7 double mutants, whether this is a result of an effect on the nerve ring 
positioning, soma positioning, or both, remains to be determined. Two mutants 
that show this phenotype, dig-1 and sax-7, were both initially identified as having 
a posterior displacement of nerve ring axons despite their initial wild-type position 
(Zallen et al 1999). A thorough analysis of this phenotype from the first larval 
stage through adulthood in wild type, lon-1, sax-7, and lon-1; sax-7 mutant 
animals will provide insight into how the positioning and organization of these 
structures changes over time in these genotypes. This will also provide 
information as to how loss of lon-1 might be able to suppress these defects in 





Molecular interactions that maintain nervous system architecture  
The function of SAX-7/L1CAM in the maintenance of neuronal architecture is 
closely tied to its adhesive properties. The two SAX-7 isoforms, SAX-7L and 
SAX-7S, differ not only in their extracellular domain structure (Chen et al 2001) 
but also in their adhesive and functional properties (Pocock et al 2008, Sasakura 
et al 2005). SAX-7S is the more adhesive isoform as it can induce cellular 
aggregation when expressed in cultured cells, and its expression can also force 
attachment between two neighboring neurons, which are properties not seen with 
SAX-7L (Sasakura et al 2005). Homophilic interactions between SAX-7S 
molecules are important for cell-cell adhesion. For instance, sax-7 mutants 
exhibit a disruption of cell contact between the AIY and AVK neurons which can 
only be restored through expression of SAX-7S in both neurons (and not through 
expression of SAX-7L) (Pocock et al 2008). Our work demonstrates that 
expression of sax-7S(+) in multiple adjacent neurons is required to maintain head 
ganglia organization, highlighting the importance of SAX-7-mediated cell-cell 
adhesion in the maintenance of nervous system architecture.    
 
In addition, intracellular interactions with the actin cytoskeleton are also important 
for cell-cell adhesion, and the maintenance of neuronal architecture. Prior work 
has shown that intracellularly, SAX-7 interacts with UNC-44/ankyrin through its 
C-terminal ankyrin binding motif, with STN-2/γ-syntrophin through its PDZ 
binding domain, and that DYS-1/dystrophin interacts with STN-2/γ-syntrophin. 
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These intracellular interactions link SAX-7 to the actin cytoskeleton to maintain 
the positioning of motorneurons (Zhou & Chen 2011, Zhou et al 2008). 
Vertebrate L1 family members also mediate cell-cell adhesion through ankyrin-
mediated interactions with the actin cytoskeleton. For example, deletion of the 
ankyrin binding motif or the entire intracellular domain of L1 family member 
neurofascin reduced its cell-cell adhesion activity in aggregation assays (Tuvia et 
al 1997). Likewise, a version of SAX-7S with either the entire intracellular domain 
or the ankyrin binding motif deleted is no longer able to restore cell contact 
between the AIY and AVK neurons in sax-7 mutants, indicating that loss of 
ankyrin binding renders the SAX-7 molecule less adhesive (Pocock et al 2008).  
 
Our results demonstrate that in a sax-7 mutant the loss of lon-1, even post-
embryonically, is sufficient to restore the maintenance of relative positioning 
between the ASH/ASI soma and the nerve ring. Even in the absence of these 
critical SAX-7 extracellular and intracellular interactions, the organization of the 
head ganglia can be properly maintained upon loss of lon-1, which raises an 
important question. Which molecules are maintaining this structure in the lon-1; 
sax-7 double mutant, which are not sufficient for maintenance in the sax-7 
mutant alone? Some potential candidates include molecules that SAX-7 is known 
to interact with intracellularly, such as UNC-44/ankyrin, STN-2/γ-syntrophin, and 
DYS-1/dystrophin (Zhou & Chen 2011, Zhou et al 2008). Other candidates 
include extracellular molecules that L1CAM heterophilically interacts with, such 
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as contactin (De Angelis et al 1999), which is homologous to RIG-6 in C. elegans 
(Katidou et al 2013). It is possible that upon loss of sax-7 and lon-1, these 
molecules that might normally interact with SAX-7 to maintain nervous system 
architecture, instead interact with additional molecules to carry out this function. 
Perhaps loss of one of these molecules in the lon-1; sax-7 double mutant would 
abolish the lon-1-mediated suppression of sax-7 maintenance defects, thus 
providing insight into the molecular interactions maintaining head ganglia 
organization in the lon-1; sax-7 double mutant.  
 
Possibility that LON-1 and SAX-7 molecules interact  
Our results indicate that the sax-7 mutant defects in the maintenance of head 
ganglia organization are suppressed by loss of lon-1, which points to a novel 
interaction between lon-1 and sax-7 in neuronal maintenance. We speculated 
that perhaps the genetic interaction we uncovered between lon-1 and sax-7 
could indicate a close association between the LON-1 and SAX-7 molecules. 
Expression of LON-1 and SAX-7 is required in nearby and overlapping tissues for 
each of their functions in the maintenance of neuronal architecture, and 
therefore, it is feasible that these molecules exist in close proximity and could 
possibly physically interact.  
 
To test whether LON-1 and SAX-7 physically interact, we could carry out yeast 
two-hybrid assays, a technique which has successfully detected physical 
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intracellular interactions between SAX-7 and other proteins in the past (Zhou & 
Chen 2011, Zhou et al 2008). If we did detect a physical interaction between 
LON-1 and SAX-7, we could also test different parts of the SAX-7 protein to 
determine which domains are required for the interaction. Although this method 
has worked to detect intracellular interactions, we may need to use an alternative 
assay to test for extracellular interactions. It is also possible that LON-1 and 
SAX-7 physically function together, but in an indirect manner within a complex 
through interactions with other molecules. For this type of interaction, we could 
use a pull-down assay which would allow for the detection of an interaction that 
may occur within a complex.   
 
One related question that would provide insight into how the SAX-7 and LON-1 
molecules might function together is testing whether LON-1 indeed functions as a 
secreted protein, as has been previously predicted (Maduzia et al 2002). Based 
on its classification as a CAP superfamily member, and its N-terminal signal 
peptide sequence (Maduzia et al 2002), it is possible that LON-1 functions as a 
secreted molecule. We could test this by engineering a LON-1 molecule with a 
transmembrane domain and assaying whether this molecule is functional. 
Whether LON-1 functions as a secreted protein or as a membrane-associated 
protein could affect the ways it might potentially interact with SAX-7, or other 




Possible mechanisms of lon-1-mediated suppression of sax-7 defects 
Head neurons ASH and ASI do not exist in isolation and instead are located 
within a densely packed multi-tissue environment. The ASH and ASI soma are 
part of the lateral ganglion and are in contact with multiple other head neurons 
within this same region (White et al 1986). More than half of C. elegans neurons, 
including ASH and ASI, send projections into the nerve ring, which is a synapse-
rich bundle of axons that encircles the isthmus of the pharynx and is ensheathed 
by glial cells (Ware et al 1975, White et al 1986). Head neurons, including ASH 
and ASI, are sandwiched between the pharynx on one side, and the hypodermis 
and muscles on the other (White et al 1986). In addition, these structures are all 
ensheathed with a specialized type of extracellular matrix called the basement 
membrane (Albertson & Thomson 1976, White et al 1976).  
 
sax-7 mutants were initially identified by their failure to maintain the positioning of 
the nerve ring, which became posteriorly displaced compared to wild type, while 
the position of the soma remained unchanged (Zallen et al 1999). While it 
deserves more careful analysis in the future, we have preliminarily observed that 
in the lon-1; sax-7 double mutants, the ASH and ASI soma of adults are often 
more posteriorly positioned than we see in wild type or sax-7 mutants alone. This 
favors the possibility that in the lon-1; sax-7 double mutants a posterior 
displacement of the ASH/ASI soma may restore the relative positioning between 
the ASH/ASI soma and the nerve ring. However, this raises the question of how 
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structures such as the nerve ring or the ASH/ASI soma are able to become 
disorganized and displaced despite their densely packed environment filled with 
potential physical barriers to mobility.   
 
One attractive possibility is that the basement membrane, surrounding the 
neuronal ganglion, nerve ring, pharynx, hypodermis, and muscles (Albertson & 
Thomson 1976, White et al 1976), could somehow be affected in the lon-1; sax-7 
double mutants to allow for the ASH/ASI soma to be displaced posteriorly. There 
is a precedent from research in C. elegans that molecules required to maintain 
the architecture of the nervous system could function to maintain basement 
membrane integrity. For instance, the large secreted maintenance factor DIG-1, 
is required for proper basement membrane maintenance as well as the 
maintenance of nervous system architecture (Benard et al 2006). Additionally, 
the F-spondin extracellular matrix protein, SPON-1, functions in part to maintain 
the precise positioning of axons within fascicles (Woo et al 2008). Furthermore, 
LON-1 is classified as a CAP superfamily protein (Cantacessi et al 2009, 
Maduzia et al 2002), a family which in vertebrates has implicated functions in 
processes such as the regulation of the extracellular matrix and how it relates to 
branching morphogenesis (Gibbs et al 2008).   
 
We can gain insight into the possible role the extracellular matrix plays in the 
positioning of neuronal soma and axons and how this relates to the lon-1-
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mediated suppression of sax-7 defects through comparisons with the mechanism 
of cell motility. Motile cells require an optimum density of extracellular matrix and 
show a tendency to move from areas of low extracellular matrix concentration 
towards areas with a higher concentration. Though it is important to note that if 
the density is too low, cells will lack the adhesion necessary for movement, and 
conversely if the density is too high, cells may be stuck and unable to move 
((Palecek et al 1997); reviewed in (Rozario & DeSimone 2010)). For example, T 
cells were found to be motile in regions with low densities of fibronectin and 
collagen, yet were less able to migrate in areas of higher density (Salmon et al 
2012). In addition to changes to the extracellular matrix itself, cells can also 
reduce their degree of adhesion to the extracellular matrix to allow for increased 
mobility (Alford et al 1998). In the context of the maintenance of head ganglia 
organization, for a cell to be displaced from its normal position it seems feasible 
that either the basement membrane itself or the interaction of the cell with the 
basement membrane may be altered.  
 
To investigate whether the lon-1-mediated suppression of sax-7 defects in head 
ganglia organization is a result of a change to the basement membrane, we 
could analyze fluorescently tagged or immunostained molecules associated with 
the basement membrane, including LAM-1/laminin (Kao et al 2006), NID-
1/nidogen (Kang & Kramer 2000), SPON-1/F-spondin (Woo et al 2008), CLE-
1/collagen type XVIII (Ackley et al 2001, Ackley et al 2003), HSPGs such as 
261 
 
SDN-1/syndecan (Rhiner et al 2005) and LON-2/glypican (Gumienny et al 2007), 
as well as others, and assess whether their expression or localization is altered 
in our lon-1; sax-7 double mutants compared to wild type or the single mutants 
alone. If it is too technically challenging to visualize changes in basement 
membrane composition or expression within the head ganglia environment of C. 
elegans, perhaps we could investigate the role of lon-1 and sax-7 in basement 
membrane regulation in the context of C. elegans anchor cell invasion, which is 
an established model of basement membrane regulation in C. elegans 
(Hagedorn et al 2014, Hagedorn et al 2009, Hagedorn et al 2013, Sherwood et al 
2005, Sherwood & Sternberg 2003, Ziel et al 2009). A potential mechanism of 
lon-1-mediated suppression of sax-7 that involves basement membrane 
regulation could have broader implications beyond the maintenance of nervous 
system architecture including the biology diseases such as fibrosis or cancer 
(Frantz et al 2010).  
 
Concluding remarks  
Nervous system development is a beautifully orchestrated and complex process, 
requiring precise regulation for proper execution. Once assembled, the structures 
of the nervous system must persist as they endure a lifetime of challenges. My 
thesis work provides contributions to both our understanding of nervous system 
development and also its subsequent long-term maintenance. In this work, we 
have shed light on the molecular mechanisms required for proper wiring of the 
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nervous system as well as its long-term maintenance. We specifically focused on 
the role of HS in cell and axon guidance, both the importance of HS chain 
synthesis as well as the role of specific HSPGs in guidance processes. We 
identified and characterized viable loss-of-function alleles in the HS co-
polymerase enzymes and found that the coordinated expression of HS is 
required to properly guide axons. We identified that the HSPG LON-2/glypican 
functions to modulate netrin-mediated axon guidance and may do this through 
interactions with the UNC-40/DCC netrin receptor. After the proper establishment 
of the nervous system, molecules such as SAX-7/L1CAM function to actively 
preserve its integrity. Through a forward genetic screen we identified LON-1 as a 
novel maintenance factor that functions with SAX-7 to post-embryonically 
preserve the architecture of the nervous system. My thesis sheds light on the 
molecular interactions important for both the initial establishment and the long-
term maintenance of the nervous system, and provides avenues for future 
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